CYLD Data Analysis

HGNC Gene Name: CYLD lysine 63 deubiquitinase
HGNC Gene Symbol: CYLD
Identifiers: hgnc:2584 NCBIGene:1540 uniprot:Q9NQC7
Orthologs: mgi:1921506 rgd:1308346
INDRA Statements: deubiquitinations all statements
Pathway Commons: Search for CYLD
Number of Papers: 801 retrieved on 2023-02-19

DepMap Analysis

The Dependency Map (DepMap) is a genome-wide pooled CRISPR-Cas9 knockout proliferation screen conducted in more than 700 cancer cell lines spanning many different tumor lineages. Each cell line in the DepMap contains a unique barcode, and each gene knockout is assigned a “dependency score” on a per cell-line basis which quantifies the rate of CRISPR-Cas9 guide drop. It has been found that proteins with similar DepMap scores across cell lines, a phenomenon known as co-dependent genes, have closely related biological functions. This can include activity in the same or parallel pathways or membership in the same protein complex or the same pathway.

We identified the strongest seven co-dependent genes (“Symbol”) for DUBs and ran GO enrichment analysis. We used Biogrid, IntAct, and Pathway Commons PPIDs, and the NURSA protein-protein interaction databases (PPIDs) to determine whether co-dependent genes interact with one another. The “Evidence” column contains the PPIDs in which the interaction appears as well as whether there is support for the association by an INDRA statement. As another approach to identify potential interactors, we looked at proteomics data from the Broad Institute's Cancer Cell Line Encyclopedia (CCLE) for proteins whose expression across ~375 cell lines strongly correlated with the abundance of each DUB; it has previously been observed that proteins in the same complex are frequently significantly co-expressed. The correlations and associated p-values in the CCLE proteomics dataset are provided. And, we determined whether co-dependent genes yield similar transcriptomic signatures in the Broad Institute's Connectivity Map (CMap). A CMap score greater than 90 is considered significantly similar.

DepMap Correlations

Symbol	Name	DepMap Correlation	Evidence	CCLE Correlation	CCLE Z-score	CCLE p-value (adj)	CMAP Score	CMAP Type
N4BP1	NEDD4 binding protein 1	0.466	Reactome (2)	0.32	1.69	1.40e-07
TRAF3	TNF receptor associated factor 3	0.383	INDRA (3) Reactome (7)	0.11	0.53	1.36e-01	99.44	kd
NFKBIA	NFKB inhibitor alpha	0.283	INDRA (7) Reactome (9)	0.14	0.66	1.22e-01	90.25	oe
TNFAIP3	TNF alpha induced protein 3	0.272	INDRA (10) Reactome (15)	0.14	0.66	7.05e-02	-94.74	oe
TRAF2	TNF receptor associated factor 2	0.242	BioGRID Pathway Commons INDRA (19) Reactome (13)	0.25	1.30	6.91e-05	99.91	oe
BCL10	BCL10 immune signaling adaptor	-0.233	Reactome (4)	0.24	1.21	2.22e-04	99.95	oe
CHUK	component of inhibitor of nuclear factor kappa B kinase complex	-0.231	Pathway Commons INDRA (11) Reactome (10)	0.27	1.38	2.23e-05

Dependency GO Term Enrichment

Gene set enrichment analysis was done on the genes correlated with CYLDusing the terms from Gene Ontology and gene sets derived from the Gene Ontology Annotations database via MSigDB.

Using the biological processes and other Gene Ontology terms from well characterized DUBs as a positive control, several gene set enrichment analyses were considered. Threshold-less methods like GSEA had relatively poor results. Over-representation analysis with a threshold of of the top 7 highest absolute value Dependency Map correlations yielded the best results and is reported below.

GO Identifier	GO Name	GO Type	p-value	p-value (adj.)	q-value
GO:0002224	toll-like receptor signaling pathway	Biological Process	4.87e-10	2.23e-07	4.52e-08
GO:0051090	regulation of DNA-binding transcription factor activity	Biological Process	9.24e-10	4.23e-07	4.52e-08
GO:0033209	tumor necrosis factor-mediated signaling pathway	Biological Process	1.03e-09	4.72e-07	4.52e-08
GO:0002221	pattern recognition receptor signaling pathway	Biological Process	2.25e-09	1.03e-06	7.40e-08
GO:0035631	CD40 receptor complex	Cellular Component	5.07e-09	2.32e-06	1.33e-07
GO:0007249	I-kappaB kinase/NF-kappaB signaling	Biological Process	1.05e-08	4.81e-06	2.30e-07
GO:0032088	negative regulation of NF-kappaB transcription factor activity	Biological Process	1.57e-08	7.17e-06	2.94e-07
GO:0034612	response to tumor necrosis factor	Biological Process	2.30e-08	1.06e-05	3.65e-07
GO:0002218	activation of innate immune response	Biological Process	2.50e-08	1.14e-05	3.65e-07
GO:0045088	regulation of innate immune response	Biological Process	1.33e-07	6.07e-05	1.74e-06
GO:0043433	negative regulation of DNA-binding transcription factor activity	Biological Process	2.13e-07	9.76e-05	2.55e-06
GO:0031663	lipopolysaccharide-mediated signaling pathway	Biological Process	8.92e-07	4.09e-04	9.78e-06
GO:0010803	regulation of tumor necrosis factor-mediated signaling pathway	Biological Process	1.10e-06	5.02e-04	1.11e-05
GO:0070646	protein modification by small protein removal	Biological Process	2.04e-06	9.33e-04	1.92e-05
GO:0044389	ubiquitin-like protein ligase binding	Molecular Function	2.23e-06	1.02e-03	1.96e-05
GO:0002237	response to molecule of bacterial origin	Biological Process	3.44e-06	1.57e-03	2.83e-05
GO:0031996	thioesterase binding	Molecular Function	6.41e-06	2.93e-03	4.96e-05
GO:0070431	nucleotide-binding oligomerization domain containing 2 signaling pathway	Biological Process	9.08e-06	4.16e-03	6.64e-05
GO:0032606	type I interferon production	Biological Process	9.82e-06	4.50e-03	6.80e-05
GO:0002697	regulation of immune effector process	Biological Process	1.08e-05	4.94e-03	7.10e-05
GO:0051092	positive regulation of NF-kappaB transcription factor activity	Biological Process	1.69e-05	7.74e-03	1.06e-04
GO:0007252	I-kappaB phosphorylation	Biological Process	1.78e-05	8.15e-03	1.06e-04
GO:2001236	regulation of extrinsic apoptotic signaling pathway	Biological Process	1.86e-05	8.53e-03	1.07e-04
GO:0032495	response to muramyl dipeptide	Biological Process	2.21e-05	1.01e-02	1.21e-04
GO:0034614	cellular response to reactive oxygen species	Biological Process	2.33e-05	1.06e-02	1.22e-04
GO:0098562	cytoplasmic side of membrane	Cellular Component	2.58e-05	1.18e-02	1.28e-04
GO:0060759	regulation of response to cytokine stimulus	Biological Process	2.67e-05	1.22e-02	1.28e-04
GO:0038061	NIK/NF-kappaB signaling	Biological Process	2.72e-05	1.24e-02	1.28e-04
GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	Biological Process	2.95e-05	1.35e-02	1.34e-04
GO:0051059	NF-kappaB binding	Molecular Function	4.71e-05	2.16e-02	2.00e-04
GO:0097191	extrinsic apoptotic signaling pathway	Biological Process	5.49e-05	2.51e-02	2.06e-04
GO:0005164	tumor necrosis factor receptor binding	Molecular Function	5.40e-05	2.47e-02	2.06e-04
GO:0001782	B cell homeostasis	Biological Process	5.05e-05	2.31e-02	2.06e-04
GO:1903320	regulation of protein modification by small protein conjugation or removal	Biological Process	5.27e-05	2.41e-02	2.06e-04
GO:0002756	MyD88-independent toll-like receptor signaling pathway	Biological Process	5.76e-05	2.64e-02	2.10e-04
GO:0000302	response to reactive oxygen species	Biological Process	6.01e-05	2.75e-02	2.14e-04
GO:0071216	cellular response to biotic stimulus	Biological Process	6.17e-05	2.83e-02	2.14e-04
GO:0034142	toll-like receptor 4 signaling pathway	Biological Process	6.51e-05	2.98e-02	2.20e-04
GO:0035872	nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway	Biological Process	7.31e-05	3.35e-02	2.40e-04
GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	Biological Process	7.72e-05	3.54e-02	2.48e-04
GO:0051091	positive regulation of DNA-binding transcription factor activity	Biological Process	8.84e-05	4.05e-02	2.77e-04

Transcriptomics

The following table shows the significantly differentially expressed genes after knocking out CYLD using CRISPR-Cas9.

Knockout Differential Expression

Symbol	Name	log₂-fold-change	p-value	p-value (adj.)
BIRC3	baculoviral IAP repeat containing 3	1.01e+00	1.57e-18	1.99e-14
CXCL8	C-X-C motif chemokine ligand 8	1.49e+00	3.06e-17	1.94e-13
CSF2	colony stimulating factor 2	1.20e+00	5.02e-16	2.12e-12
CXCL2	C-X-C motif chemokine ligand 2	1.27e+00	5.83e-10	1.73e-06
CXCL3	C-X-C motif chemokine ligand 3	1.34e+00	7.57e-10	1.73e-06
LAMC2	laminin subunit gamma 2	9.68e-01	8.20e-10	1.73e-06
SOD2	superoxide dismutase 2	6.95e-01	1.04e-09	1.88e-06
G0S2	G0/G1 switch 2	4.73e-01	1.74e-09	2.76e-06
CXCL1	C-X-C motif chemokine ligand 1	1.10e+00	2.19e-09	3.08e-06
MMP1	matrix metallopeptidase 1	4.45e-01	4.90e-09	6.20e-06
IL1B	interleukin 1 beta	1.34e+00	7.86e-09	9.04e-06
TNFSF15	TNF superfamily member 15	9.28e-01	9.39e-09	9.90e-06
C15orf48	chromosome 15 open reading frame 48	7.19e-01	1.07e-08	1.04e-05
ICAM1	intercellular adhesion molecule 1	1.00e+00	4.30e-08	3.89e-05
NAMPT	nicotinamide phosphoribosyltransferase	5.70e-01	4.62e-08	3.90e-05
TFPI2	tissue factor pathway inhibitor 2	7.05e-01	6.85e-08	5.42e-05
CSF3	colony stimulating factor 3	1.29e+00	1.41e-07	1.05e-04
PTX3	pentraxin 3	6.63e-01	2.45e-07	1.73e-04
SYNGR2	synaptogyrin 2	6.75e-01	7.33e-07	4.88e-04
NFKBIA	NFKB inhibitor alpha	5.70e-01	3.07e-06	1.94e-03
KYNU	kynureninase	7.62e-01	1.35e-05	8.13e-03
DUSP28	dual specificity phosphatase 28	9.38e-01	2.31e-05	1.33e-02
AKR1B1	aldo-keto reductase family 1 member B	3.56e-01	2.97e-05	1.63e-02
SERPIND1	serpin family D member 1	7.78e-01	4.99e-05	2.63e-02
CD44	CD44 molecule (Indian blood group)	3.75e-01	5.72e-05	2.89e-02
IL6	interleukin 6	7.86e-01	7.26e-05	3.54e-02
SAA2	serum amyloid A2	5.76e-01	1.10e-04	4.99e-02
SQSTM1	sequestosome 1	4.96e-01	1.09e-04	4.99e-02

Gene Set Enrichment Analysis

The GSEA method was applied for all genes whose knockout resulted in at least 20 significantly differentially expressed genes.

ID	Name	p-value	p-value (adj.)	log₂ Error	ES	NES
msig:M5890	HALLMARK_TNFA_SIGNALING_VIA_NFKB	3.96e-17	1.55e-13	1.07e+00	6.59e-01	2.81e+00
go:0019221	cytokine-mediated signaling pathway	3.08e-10	6.02e-07	8.14e-01	4.10e-01	2.01e+00
reactome:R-HSA-1640170	Cell Cycle	2.70e-09	3.52e-06	7.75e-01	-3.60e-01	-1.83e+00
go:0030545	receptor regulator activity	8.26e-09	8.07e-06	7.48e-01	5.72e-01	2.35e+00
msig:M5932	HALLMARK_INFLAMMATORY_RESPONSE	1.68e-08	1.29e-05	7.34e-01	5.93e-01	2.38e+00
go:0006954	inflammatory response	1.98e-08	1.29e-05	7.34e-01	4.48e-01	2.10e+00
go:0050900	leukocyte migration	2.33e-08	1.30e-05	7.34e-01	5.05e-01	2.20e+00
go:0005125	cytokine activity	2.82e-08	1.38e-05	7.34e-01	7.31e-01	2.44e+00
go:0006952	defense response	4.21e-08	1.60e-05	7.20e-01	3.29e-01	1.71e+00
go:0034097	response to cytokine	4.51e-08	1.60e-05	7.20e-01	3.37e-01	1.75e+00
msig:M5925	HALLMARK_E2F_TARGETS	4.16e-08	1.60e-05	7.20e-01	-4.41e-01	-2.02e+00
msig:M9809	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1.02e-07	3.34e-05	7.05e-01	6.53e-01	2.38e+00
reactome:R-HSA-69278	Cell Cycle, Mitotic	1.34e-07	4.01e-05	6.90e-01	-3.52e-01	-1.77e+00
go:0098687	chromosomal region	1.51e-06	4.22e-04	6.44e-01	-3.89e-01	-1.86e+00
go:1990266	neutrophil migration	1.89e-06	4.91e-04	6.44e-01	7.05e-01	2.31e+00
go:0005126	cytokine receptor binding	2.06e-06	5.04e-04	6.27e-01	5.40e-01	2.16e+00
go:0048285	organelle fission	3.01e-06	6.93e-04	6.27e-01	-3.72e-01	-1.79e+00
go:0001816	cytokine production	3.60e-06	7.04e-04	6.27e-01	3.69e-01	1.79e+00
go:0005102	signaling receptor binding	3.43e-06	7.04e-04	6.27e-01	3.13e-01	1.61e+00
go:0097530	granulocyte migration	3.60e-06	7.04e-04	6.27e-01	6.63e-01	2.28e+00
go:0030595	leukocyte chemotaxis	3.83e-06	7.13e-04	6.11e-01	5.63e-01	2.15e+00
go:0060326	cell chemotaxis	4.07e-06	7.23e-04	6.11e-01	5.21e-01	2.12e+00
go:0051321	meiotic cell cycle	4.94e-06	8.40e-04	6.11e-01	-4.68e-01	-1.97e+00
go:0010469	regulation of signaling receptor activity	5.68e-06	9.25e-04	6.11e-01	4.68e-01	2.00e+00
msig:M15569	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	6.07e-06	9.49e-04	6.11e-01	6.99e-01	2.22e+00
go:0005694	chromosome	6.69e-06	1.01e-03	6.11e-01	-2.92e-01	-1.53e+00
go:0002237	response to molecule of bacterial origin	7.20e-06	1.04e-03	6.11e-01	4.68e-01	1.99e+00
reactome:R-HSA-68877	Mitotic Prometaphase	7.65e-06	1.07e-03	5.93e-01	-4.09e-01	-1.84e+00
reactome:R-HSA-449147	Signaling by Interleukins	8.11e-06	1.09e-03	5.93e-01	3.60e-01	1.75e+00
go:0000775	chromosome, centromeric region	1.15e-05	1.49e-03	5.93e-01	-4.17e-01	-1.85e+00
go:0060089	molecular transducer activity	1.44e-05	1.82e-03	5.93e-01	3.78e-01	1.77e+00
go:0002682	regulation of immune system process	1.50e-05	1.83e-03	5.93e-01	2.95e-01	1.53e+00
go:0010939	regulation of necrotic cell death	2.35e-05	2.71e-03	5.76e-01	7.38e-01	2.12e+00
go:0097529	myeloid leukocyte migration	2.36e-05	2.71e-03	5.76e-01	5.69e-01	2.11e+00
go:0051240	positive regulation of multicellular organismal process	2.45e-05	2.73e-03	5.76e-01	2.88e-01	1.51e+00
go:0051276	chromosome organization	2.74e-05	2.98e-03	5.76e-01	-2.77e-01	-1.47e+00
go:0001775	cell activation	2.98e-05	3.14e-03	5.76e-01	2.93e-01	1.52e+00
go:0002684	positive regulation of immune system process	3.36e-05	3.46e-03	5.57e-01	3.11e-01	1.57e+00
reactome:R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	4.98e-05	4.60e-03	5.57e-01	5.21e-01	2.00e+00
go:0002685	regulation of leukocyte migration	4.86e-05	4.60e-03	5.57e-01	5.24e-01	2.00e+00
go:0030968	endoplasmic reticulum unfolded protein response	5.06e-05	4.60e-03	5.57e-01	4.90e-01	1.97e+00
reactome:R-HSA-68886	M Phase	4.87e-05	4.60e-03	5.57e-01	-3.33e-01	-1.63e+00
reactome:R-HSA-2500257	Resolution of Sister Chromatid Cohesion	5.19e-05	4.61e-03	5.57e-01	-4.44e-01	-1.85e+00
go:0035967	cellular response to topologically incorrect protein	5.56e-05	4.76e-03	5.57e-01	4.52e-01	1.92e+00
go:0071396	cellular response to lipid	5.60e-05	4.76e-03	5.57e-01	3.57e-01	1.70e+00
msig:M5901	HALLMARK_G2M_CHECKPOINT	6.47e-05	5.38e-03	5.38e-01	-3.76e-01	-1.72e+00
go:0033209	tumor necrosis factor-mediated signaling pathway	6.61e-05	5.38e-03	5.38e-01	4.59e-01	1.90e+00
go:0000793	condensed chromosome	7.19e-05	5.73e-03	5.38e-01	-3.98e-01	-1.76e+00
go:0051235	maintenance of location	7.64e-05	5.97e-03	5.38e-01	4.18e-01	1.82e+00
msig:M5669	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	8.33e-05	6.26e-03	5.38e-01	6.04e-01	2.08e+00
go:0000776	kinetochore	8.32e-05	6.26e-03	5.38e-01	-4.33e-01	-1.82e+00
go:0031226	intrinsic component of plasma membrane	9.02e-05	6.53e-03	5.38e-01	3.28e-01	1.61e+00
msig:M5951	HALLMARK_SPERMATOGENESIS	9.01e-05	6.53e-03	5.38e-01	-5.62e-01	-1.97e+00
go:0042330	taxis	9.88e-05	7.02e-03	5.38e-01	3.74e-01	1.72e+00
go:0045087	innate immune response	1.04e-04	7.02e-03	5.38e-01	3.18e-01	1.59e+00
go:0031349	positive regulation of defense response	1.04e-04	7.02e-03	5.38e-01	3.66e-01	1.71e+00
go:1901701	cellular response to oxygen-containing compound	1.01e-04	7.02e-03	5.38e-01	3.00e-01	1.54e+00
reactome:R-HSA-194315	Signaling by Rho GTPases	1.11e-04	7.23e-03	5.38e-01	-3.45e-01	-1.64e+00
reactome:R-HSA-195258	RHO GTPase Effectors	1.10e-04	7.23e-03	5.38e-01	-3.57e-01	-1.65e+00
msig:M5947	HALLMARK_IL2_STAT5_SIGNALING	1.13e-04	7.27e-03	5.38e-01	4.52e-01	1.87e+00
go:1990868	response to chemokine	1.15e-04	7.27e-03	5.38e-01	7.36e-01	2.08e+00
msig:M5953	HALLMARK_KRAS_SIGNALING_UP	1.22e-04	7.27e-03	5.38e-01	5.12e-01	1.95e+00
reactome:R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	1.23e-04	7.27e-03	5.19e-01	6.39e-01	2.03e+00
msig:M15913	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	1.20e-04	7.27e-03	5.38e-01	6.39e-01	2.03e+00
reactome:R-HSA-1280215	Cytokine Signaling in Immune system	1.21e-04	7.27e-03	5.38e-01	3.13e-01	1.57e+00
go:0051301	cell division	1.28e-04	7.49e-03	5.19e-01	-3.07e-01	-1.54e+00
reactome:R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	1.39e-04	7.96e-03	5.19e-01	5.01e-01	1.94e+00
go:0042698	ovulation cycle	1.57e-04	8.76e-03	5.19e-01	6.69e-01	2.06e+00
go:0034612	response to tumor necrosis factor	1.55e-04	8.76e-03	5.19e-01	4.00e-01	1.76e+00
go:0002274	myeloid leukocyte activation	1.67e-04	9.19e-03	5.19e-01	3.15e-01	1.55e+00
go:0009617	response to bacterium	1.81e-04	9.59e-03	5.19e-01	3.81e-01	1.73e+00
go:0050776	regulation of immune response	1.82e-04	9.59e-03	5.19e-01	3.09e-01	1.55e+00
reactome:R-HSA-69618	Mitotic Spindle Checkpoint	1.77e-04	9.59e-03	5.19e-01	-4.35e-01	-1.78e+00
msig:M16848	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	1.84e-04	9.60e-03	5.19e-01	5.89e-01	2.04e+00
go:0032103	positive regulation of response to external stimulus	1.88e-04	9.61e-03	5.19e-01	4.45e-01	1.84e+00
reactome:R-HSA-1169091	Activation of NF-kappaB in B cells	1.89e-04	9.61e-03	5.19e-01	5.25e-01	1.98e+00
go:1901342	regulation of vasculature development	1.94e-04	9.73e-03	5.19e-01	4.22e-01	1.79e+00
go:0038061	NIK/NF-kappaB signaling	2.24e-04	1.11e-02	5.19e-01	4.36e-01	1.83e+00
go:0009607	response to biotic stimulus	2.33e-04	1.11e-02	5.19e-01	3.11e-01	1.55e+00
go:0002286	T cell activation involved in immune response	2.33e-04	1.11e-02	5.19e-01	6.82e-01	2.02e+00
go:0033993	response to lipid	2.32e-04	1.11e-02	5.19e-01	3.00e-01	1.50e+00
go:0030099	myeloid cell differentiation	2.49e-04	1.16e-02	4.98e-01	3.65e-01	1.68e+00
reactome:R-HSA-2980766	Nuclear Envelope Breakdown	2.50e-04	1.16e-02	4.98e-01	-5.44e-01	-1.96e+00
go:0006259	DNA metabolic process	2.59e-04	1.18e-02	4.98e-01	-2.80e-01	-1.43e+00
go:0046903	secretion	2.58e-04	1.18e-02	4.98e-01	2.67e-01	1.41e+00
go:0002250	adaptive immune response	2.67e-04	1.20e-02	4.98e-01	4.40e-01	1.82e+00
go:0070482	response to oxygen levels	2.88e-04	1.27e-02	4.98e-01	3.40e-01	1.62e+00
go:0023056	positive regulation of signaling	2.86e-04	1.27e-02	4.98e-01	2.67e-01	1.42e+00
go:0001819	positive regulation of cytokine production	2.96e-04	1.29e-02	4.98e-01	3.87e-01	1.71e+00
go:0034976	response to endoplasmic reticulum stress	3.42e-04	1.45e-02	4.98e-01	3.60e-01	1.67e+00
go:0051047	positive regulation of secretion	3.62e-04	1.50e-02	4.98e-01	3.96e-01	1.73e+00
go:0005815	microtubule organizing center	3.64e-04	1.50e-02	4.98e-01	-2.96e-01	-1.49e+00
go:0048511	rhythmic process	3.67e-04	1.50e-02	4.98e-01	4.05e-01	1.75e+00
go:0071103	DNA conformation change	3.69e-04	1.50e-02	4.98e-01	-3.57e-01	-1.62e+00
go:0032101	regulation of response to external stimulus	3.75e-04	1.51e-02	4.98e-01	3.39e-01	1.61e+00
reactome:R-HSA-68875	Mitotic Prophase	3.91e-04	1.56e-02	4.98e-01	-4.51e-01	-1.81e+00
reactome:R-HSA-375276	Peptide ligand-binding receptors	4.05e-04	1.60e-02	4.98e-01	6.65e-01	1.97e+00
go:0071216	cellular response to biotic stimulus	4.15e-04	1.62e-02	4.98e-01	4.59e-01	1.85e+00
go:0022602	ovulation cycle process	4.44e-04	1.72e-02	4.98e-01	7.29e-01	2.02e+00
reactome:R-HSA-5663220	RHO GTPases Activate Formins	4.52e-04	1.73e-02	4.98e-01	-4.16e-01	-1.75e+00
go:0010883	regulation of lipid storage	4.94e-04	1.87e-02	4.77e-01	7.02e-01	1.99e+00
go:0007249	I-kappaB kinase/NF-kappaB signaling	5.11e-04	1.87e-02	4.77e-01	3.87e-01	1.69e+00
go:2001234	negative regulation of apoptotic signaling pathway	5.13e-04	1.87e-02	4.77e-01	3.83e-01	1.68e+00
go:1903046	meiotic cell cycle process	5.08e-04	1.87e-02	4.77e-01	-4.50e-01	-1.81e+00
go:0071622	regulation of granulocyte chemotaxis	5.12e-04	1.87e-02	4.77e-01	6.64e-01	1.91e+00
reactome:R-HSA-1236975	Antigen processing-Cross presentation	5.34e-04	1.93e-02	4.77e-01	4.71e-01	1.83e+00
reactome:R-HSA-5619084	ABC transporter disorders	5.60e-04	2.01e-02	4.77e-01	5.02e-01	1.90e+00
go:0045637	regulation of myeloid cell differentiation	5.66e-04	2.01e-02	4.77e-01	4.32e-01	1.81e+00
go:0015630	microtubule cytoskeleton	5.79e-04	2.04e-02	4.77e-01	-2.61e-01	-1.37e+00
msig:M5930	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	5.87e-04	2.05e-02	4.77e-01	4.27e-01	1.79e+00
go:0000779	condensed chromosome, centromeric region	6.17e-04	2.13e-02	4.77e-01	-4.25e-01	-1.74e+00
msig:M5913	HALLMARK_INTERFERON_GAMMA_RESPONSE	6.72e-04	2.29e-02	4.77e-01	4.18e-01	1.75e+00
go:0002687	positive regulation of leukocyte migration	6.75e-04	2.29e-02	4.77e-01	5.08e-01	1.86e+00
go:1905954	positive regulation of lipid localization	7.43e-04	2.47e-02	4.77e-01	6.52e-01	1.88e+00
go:0045862	positive regulation of proteolysis	7.45e-04	2.47e-02	4.77e-01	3.47e-01	1.62e+00
reactome:R-HSA-500792	GPCR ligand binding	7.75e-04	2.54e-02	4.77e-01	5.15e-01	1.86e+00
go:0000819	sister chromatid segregation	7.98e-04	2.60e-02	4.77e-01	-3.70e-01	-1.63e+00
go:0040017	positive regulation of locomotion	8.16e-04	2.61e-02	4.77e-01	3.26e-01	1.55e+00
go:0006959	humoral immune response	8.13e-04	2.61e-02	4.77e-01	5.84e-01	1.93e+00
msig:M4844	KEGG_CHEMOKINE_SIGNALING_PATHWAY	8.37e-04	2.66e-02	4.77e-01	4.94e-01	1.84e+00
go:0097191	extrinsic apoptotic signaling pathway	8.87e-04	2.79e-02	4.77e-01	3.92e-01	1.68e+00
go:0010952	positive regulation of peptidase activity	9.07e-04	2.80e-02	4.77e-01	4.12e-01	1.73e+00
go:0044430		9.18e-04	2.80e-02	4.77e-01	-2.51e-01	-1.34e+00
go:0023057	negative regulation of signaling	9.04e-04	2.80e-02	4.77e-01	2.62e-01	1.36e+00
go:0002456	T cell mediated immunity	9.18e-04	2.80e-02	4.77e-01	5.90e-01	1.93e+00
go:0046887	positive regulation of hormone secretion	9.41e-04	2.85e-02	4.77e-01	5.23e-01	1.85e+00
go:0045088	regulation of innate immune response	9.63e-04	2.85e-02	4.77e-01	3.42e-01	1.60e+00
go:2001236	regulation of extrinsic apoptotic signaling pathway	9.64e-04	2.85e-02	4.77e-01	4.37e-01	1.77e+00
go:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	9.59e-04	2.85e-02	4.77e-01	4.18e-01	1.75e+00
go:0006323	DNA packaging	1.01e-03	2.95e-02	4.55e-01	-3.97e-01	-1.67e+00
go:0035966	response to topologically incorrect protein	1.05e-03	3.06e-02	4.55e-01	3.78e-01	1.65e+00
go:0000278	mitotic cell cycle	1.10e-03	3.19e-02	4.55e-01	-2.60e-01	-1.36e+00
msig:M12294	KEGG_VIRAL_MYOCARDITIS	1.16e-03	3.33e-02	4.55e-01	6.29e-01	1.92e+00
msig:M12868	KEGG_PATHWAYS_IN_CANCER	1.20e-03	3.35e-02	4.55e-01	3.64e-01	1.61e+00
go:1903706	regulation of hemopoiesis	1.21e-03	3.35e-02	4.55e-01	3.32e-01	1.56e+00
go:0031347	regulation of defense response	1.22e-03	3.35e-02	4.55e-01	3.07e-01	1.49e+00
go:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	1.20e-03	3.35e-02	4.55e-01	4.99e-01	1.82e+00
go:0050727	regulation of inflammatory response	1.22e-03	3.35e-02	4.55e-01	4.18e-01	1.73e+00
reactome:R-HSA-446652	Interleukin-1 family signaling	1.21e-03	3.35e-02	4.55e-01	4.28e-01	1.72e+00
go:0098813	nuclear chromosome segregation	1.30e-03	3.56e-02	4.55e-01	-3.49e-01	-1.57e+00
go:0022402	cell cycle process	1.33e-03	3.60e-02	4.55e-01	-2.45e-01	-1.32e+00
reactome:R-HSA-5218859	Regulated Necrosis	1.35e-03	3.64e-02	4.55e-01	7.00e-01	1.94e+00
go:0019915	lipid storage	1.38e-03	3.68e-02	4.55e-01	5.83e-01	1.85e+00
go:0000070	mitotic sister chromatid segregation	1.38e-03	3.68e-02	4.55e-01	-3.82e-01	-1.64e+00
go:0045185	maintenance of protein location	1.40e-03	3.68e-02	4.55e-01	4.68e-01	1.76e+00
go:0009897	external side of plasma membrane	1.40e-03	3.68e-02	4.55e-01	4.56e-01	1.79e+00
go:0140014	mitotic nuclear division	1.43e-03	3.74e-02	4.55e-01	-3.34e-01	-1.53e+00
go:1904018	positive regulation of vasculature development	1.53e-03	3.96e-02	4.55e-01	4.62e-01	1.76e+00
go:0002218	activation of innate immune response	1.66e-03	4.26e-02	4.55e-01	3.53e-01	1.58e+00
go:1903317	regulation of protein maturation	1.77e-03	4.52e-02	4.55e-01	5.87e-01	1.93e+00
go:0002790	peptide secretion	1.79e-03	4.54e-02	4.55e-01	3.27e-01	1.53e+00
go:0017056	structural constituent of nuclear pore	1.83e-03	4.62e-02	4.55e-01	-6.03e-01	-1.76e+00
go:0051094	positive regulation of developmental process	1.87e-03	4.66e-02	4.55e-01	2.73e-01	1.40e+00
go:0032612	interleukin-1 production	1.87e-03	4.66e-02	4.55e-01	5.69e-01	1.81e+00
go:0032637	interleukin-8 production	1.91e-03	4.73e-02	4.55e-01	6.34e-01	1.89e+00
go:1901655	cellular response to ketone	1.93e-03	4.74e-02	4.55e-01	5.03e-01	1.78e+00
reactome:R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	1.97e-03	4.77e-02	4.32e-01	-5.83e-01	-1.82e+00
go:0008083	growth factor activity	1.96e-03	4.77e-02	4.32e-01	5.24e-01	1.83e+00
go:0002521	leukocyte differentiation	1.98e-03	4.77e-02	4.32e-01	3.46e-01	1.57e+00
go:0006310	DNA recombination	2.07e-03	4.96e-02	4.32e-01	-3.48e-01	-1.55e+00
go:0097300	programmed necrotic cell death	2.11e-03	5.02e-02	4.32e-01	6.13e-01	1.87e+00
reactome:R-HSA-69190	DNA strand elongation	2.12e-03	5.03e-02	4.32e-01	-5.74e-01	-1.82e+00
go:0002688	regulation of leukocyte chemotaxis	2.18e-03	5.13e-02	4.32e-01	5.15e-01	1.81e+00
go:0048585	negative regulation of response to stimulus	2.24e-03	5.24e-02	4.32e-01	2.53e-01	1.33e+00
reactome:R-HSA-5678895	Defective CFTR causes cystic fibrosis	2.30e-03	5.35e-02	4.32e-01	4.71e-01	1.76e+00
go:1904666	regulation of ubiquitin protein ligase activity	2.42e-03	5.46e-02	4.32e-01	-6.69e-01	-1.86e+00
reactome:R-HSA-69205	G1/S-Specific Transcription	2.43e-03	5.46e-02	4.32e-01	-6.35e-01	-1.83e+00
reactome:R-HSA-5632684	Hedgehog 'on' state	2.38e-03	5.46e-02	4.32e-01	4.48e-01	1.70e+00
reactome:R-HSA-168249	Innate Immune System	2.43e-03	5.46e-02	4.32e-01	2.61e-01	1.35e+00
reactome:R-HSA-983705	Signaling by the B Cell Receptor (BCR)	2.43e-03	5.46e-02	4.32e-01	4.33e-01	1.72e+00
go:0032611	interleukin-1 beta production	2.42e-03	5.46e-02	4.32e-01	6.26e-01	1.87e+00
go:0007010	cytoskeleton organization	2.51e-03	5.59e-02	4.32e-01	-2.54e-01	-1.32e+00
go:0001818	negative regulation of cytokine production	2.52e-03	5.59e-02	4.32e-01	3.94e-01	1.62e+00
go:0070265	necrotic cell death	2.54e-03	5.61e-02	4.32e-01	5.77e-01	1.90e+00
reactome:R-HSA-69620	Cell Cycle Checkpoints	2.56e-03	5.63e-02	4.32e-01	-3.21e-01	-1.52e+00
go:1901700	response to oxygen-containing compound	2.58e-03	5.64e-02	4.32e-01	2.50e-01	1.31e+00
go:0071453	cellular response to oxygen levels	2.65e-03	5.76e-02	4.32e-01	3.46e-01	1.55e+00
msig:M5950	HALLMARK_ALLOGRAFT_REJECTION	2.84e-03	6.07e-02	4.32e-01	4.49e-01	1.71e+00
go:0043900	regulation of multi-organism process	2.83e-03	6.07e-02	4.32e-01	3.17e-01	1.49e+00
go:0005813	centrosome	2.82e-03	6.07e-02	4.32e-01	-2.90e-01	-1.42e+00
go:0042110	T cell activation	2.87e-03	6.08e-02	4.32e-01	3.50e-01	1.55e+00
go:1903039	positive regulation of leukocyte cell-cell adhesion	2.90e-03	6.13e-02	4.32e-01	4.52e-01	1.71e+00
go:0040011	locomotion	2.92e-03	6.13e-02	4.32e-01	2.50e-01	1.31e+00
msig:M3261	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	2.95e-03	6.14e-02	4.32e-01	5.72e-01	1.88e+00
go:0007017	microtubule-based process	2.95e-03	6.14e-02	4.32e-01	-2.67e-01	-1.35e+00
go:0050729	positive regulation of inflammatory response	3.01e-03	6.21e-02	4.32e-01	5.22e-01	1.75e+00
reactome:R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	3.03e-03	6.22e-02	4.32e-01	5.08e-01	1.78e+00
go:0035690	cellular response to drug	3.07e-03	6.29e-02	4.32e-01	3.37e-01	1.52e+00
go:0045785	positive regulation of cell adhesion	3.21e-03	6.54e-02	4.32e-01	3.47e-01	1.53e+00
go:0050920	regulation of chemotaxis	3.27e-03	6.62e-02	4.32e-01	4.41e-01	1.70e+00
go:0022624	proteasome accessory complex	3.38e-03	6.82e-02	4.32e-01	5.63e-01	1.76e+00
go:0051345	positive regulation of hydrolase activity	3.44e-03	6.85e-02	4.32e-01	2.92e-01	1.43e+00
go:0002791	regulation of peptide secretion	3.44e-03	6.85e-02	4.32e-01	3.39e-01	1.52e+00
go:0007059	chromosome segregation	3.53e-03	6.99e-02	4.32e-01	-3.21e-01	-1.50e+00
msig:M5893	HALLMARK_MITOTIC_SPINDLE	3.56e-03	7.02e-02	4.32e-01	-3.38e-01	-1.51e+00
go:0009986	cell surface	3.65e-03	7.14e-02	4.32e-01	3.12e-01	1.48e+00
go:0051046	regulation of secretion	3.64e-03	7.14e-02	4.32e-01	3.06e-01	1.46e+00
go:0051149	positive regulation of muscle cell differentiation	3.71e-03	7.14e-02	4.32e-01	5.55e-01	1.81e+00
go:0050778	positive regulation of immune response	3.71e-03	7.14e-02	4.32e-01	2.89e-01	1.42e+00
go:0038095	Fc-epsilon receptor signaling pathway	3.67e-03	7.14e-02	4.32e-01	4.37e-01	1.68e+00
reactome:R-HSA-5357905	Regulation of TNFR1 signaling	3.78e-03	7.18e-02	4.32e-01	6.09e-01	1.75e+00
go:0006892	post-Golgi vesicle-mediated transport	3.79e-03	7.18e-02	4.32e-01	4.42e-01	1.68e+00
msig:M15902	KEGG_GLYCEROLIPID_METABOLISM	3.78e-03	7.18e-02	4.32e-01	6.08e-01	1.75e+00
go:0044057	regulation of system process	3.88e-03	7.25e-02	4.32e-01	3.43e-01	1.54e+00
go:0001541	ovarian follicle development	3.90e-03	7.25e-02	4.32e-01	5.96e-01	1.80e+00
reactome:R-HSA-5658442	Regulation of RAS by GAPs	3.89e-03	7.25e-02	4.32e-01	4.60e-01	1.74e+00
go:0042590	antigen processing and presentation of exogenous peptide antigen via MHC class I	3.98e-03	7.33e-02	4.07e-01	4.59e-01	1.74e+00
go:0006281	DNA repair	4.04e-03	7.41e-02	4.07e-01	-2.75e-01	-1.37e+00
go:0008608	attachment of spindle microtubules to kinetochore	4.10e-03	7.49e-02	4.07e-01	-5.46e-01	-1.76e+00
reactome:R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	4.15e-03	7.53e-02	4.07e-01	-5.77e-01	-1.68e+00
go:0050921	positive regulation of chemotaxis	4.19e-03	7.54e-02	4.07e-01	4.63e-01	1.70e+00
msig:M11675	KEGG_HOMOLOGOUS_RECOMBINATION	4.23e-03	7.54e-02	4.07e-01	-6.30e-01	-1.77e+00
go:0098552	side of membrane	4.24e-03	7.54e-02	4.07e-01	3.41e-01	1.53e+00
go:0050000	chromosome localization	4.24e-03	7.54e-02	4.07e-01	-4.52e-01	-1.67e+00
go:0006261	DNA-dependent DNA replication	4.22e-03	7.54e-02	4.07e-01	-3.73e-01	-1.57e+00
msig:M8492	KEGG_APOPTOSIS	4.31e-03	7.62e-02	4.07e-01	4.87e-01	1.74e+00
go:0051270	regulation of cellular component movement	4.38e-03	7.72e-02	4.07e-01	2.67e-01	1.34e+00
go:2001233	regulation of apoptotic signaling pathway	4.46e-03	7.81e-02	4.07e-01	3.03e-01	1.44e+00
go:0051310	metaphase plate congression	4.58e-03	7.96e-02	4.07e-01	-4.89e-01	-1.72e+00
reactome:R-HSA-5358351	Signaling by Hedgehog	4.57e-03	7.96e-02	4.07e-01	3.90e-01	1.61e+00
reactome:R-HSA-73886	Chromosome Maintenance	4.61e-03	7.97e-02	4.07e-01	-4.26e-01	-1.66e+00
go:0031341	regulation of cell killing	4.68e-03	8.06e-02	4.07e-01	6.37e-01	1.80e+00
go:0005506	iron ion binding	5.04e-03	8.28e-02	4.07e-01	4.78e-01	1.72e+00
go:0140272	exogenous protein binding	4.88e-03	8.28e-02	4.07e-01	5.54e-01	1.82e+00
reactome:R-HSA-382556	ABC-family proteins mediated transport	4.92e-03	8.28e-02	4.07e-01	4.33e-01	1.65e+00
go:0033044	regulation of chromosome organization	4.88e-03	8.28e-02	4.07e-01	-3.01e-01	-1.42e+00
go:0045597	positive regulation of cell differentiation	4.92e-03	8.28e-02	4.07e-01	2.78e-01	1.39e+00
go:0060548	negative regulation of cell death	4.97e-03	8.28e-02	4.07e-01	2.61e-01	1.34e+00
msig:M5915	HALLMARK_APICAL_JUNCTION	4.98e-03	8.28e-02	4.07e-01	3.81e-01	1.56e+00
go:0003779	actin binding	5.02e-03	8.28e-02	4.07e-01	-3.17e-01	-1.45e+00
reactome:R-HSA-69615	G1/S DNA Damage Checkpoints	5.03e-03	8.28e-02	4.07e-01	4.38e-01	1.65e+00
go:0006333	chromatin assembly or disassembly	5.28e-03	8.64e-02	4.07e-01	-3.80e-01	-1.56e+00
go:0034728	nucleosome organization	5.33e-03	8.65e-02	4.07e-01	-3.86e-01	-1.55e+00
go:0002764	immune response-regulating signaling pathway	5.32e-03	8.65e-02	4.07e-01	2.99e-01	1.42e+00
go:0046649	lymphocyte activation	5.43e-03	8.70e-02	4.07e-01	3.00e-01	1.42e+00
go:0042116	macrophage activation	5.43e-03	8.70e-02	4.07e-01	6.31e-01	1.79e+00
go:0002761	regulation of myeloid leukocyte differentiation	5.44e-03	8.70e-02	4.07e-01	5.10e-01	1.76e+00
reactome:R-HSA-1474244	Extracellular matrix organization	5.46e-03	8.71e-02	4.07e-01	3.85e-01	1.61e+00
go:0043044	ATP-dependent chromatin remodeling	5.67e-03	9.01e-02	4.07e-01	-4.48e-01	-1.67e+00
go:0002756	MyD88-independent toll-like receptor signaling pathway	5.70e-03	9.01e-02	4.07e-01	6.57e-01	1.82e+00
go:0006893	Golgi to plasma membrane transport	5.79e-03	9.04e-02	4.07e-01	5.01e-01	1.71e+00
reactome:R-HSA-4641258	Degradation of DVL	5.75e-03	9.04e-02	4.07e-01	4.54e-01	1.67e+00
go:0051336	regulation of hydrolase activity	5.97e-03	9.29e-02	4.07e-01	2.51e-01	1.30e+00
reactome:R-HSA-168898	Toll-like Receptor Cascades	6.08e-03	9.43e-02	4.07e-01	4.13e-01	1.63e+00
go:0046883	regulation of hormone secretion	6.16e-03	9.47e-02	4.07e-01	3.80e-01	1.57e+00
msig:M10680	KEGG_PROTEASOME	6.24e-03	9.53e-02	4.07e-01	4.73e-01	1.67e+00
go:0006997	nucleus organization	6.24e-03	9.53e-02	4.07e-01	-3.87e-01	-1.58e+00
reactome:R-HSA-5689880	Ub-specific processing proteases	6.31e-03	9.55e-02	4.07e-01	3.47e-01	1.51e+00
go:0015893	drug transport	6.37e-03	9.61e-02	4.07e-01	4.56e-01	1.67e+00
go:0051129	negative regulation of cellular component organization	6.45e-03	9.69e-02	4.07e-01	-2.72e-01	-1.35e+00
go:0006260	DNA replication	6.52e-03	9.76e-02	4.07e-01	-3.08e-01	-1.42e+00
go:0061982	meiosis I cell cycle process	6.56e-03	9.78e-02	4.07e-01	-4.64e-01	-1.63e+00
go:1902533	positive regulation of intracellular signal transduction	6.63e-03	9.81e-02	4.07e-01	2.66e-01	1.35e+00
go:0010639	negative regulation of organelle organization	6.63e-03	9.81e-02	4.07e-01	-3.04e-01	-1.42e+00
go:0070821	tertiary granule membrane	6.69e-03	9.85e-02	4.07e-01	5.34e-01	1.70e+00
reactome:R-HSA-5673000	RAF activation	6.70e-03	9.85e-02	4.07e-01	-5.59e-01	-1.63e+00
go:0019748	secondary metabolic process	6.77e-03	9.87e-02	4.07e-01	5.81e-01	1.75e+00
go:0043001	Golgi to plasma membrane protein transport	6.77e-03	9.87e-02	4.07e-01	5.80e-01	1.75e+00
reactome:R-HSA-2871837	FCERI mediated NF-kB activation	6.83e-03	9.92e-02	4.07e-01	4.23e-01	1.60e+00

Literature Mining

INDRA was used to automatically assemble known mechanisms related to CYLD from literature and knowledge bases. The first section shows only DUB activity and the second shows all other results.

Deubiquitinase Activity

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach

CYLD deubiquitinates RIPK1. 10 / 56

1 | 55

➶

reach

Another possibility is that in cells lacking normal Optn, some other protein may act as an adaptor to facilitate CYLD dependent deubiquitination of RIP.

29951055

➶

reach

Deubiquitination of RIP by over-expressed CYLD was abrogated in optineurin knockdown cells.

21408173

➶

reach

32 Last but not least, CYLD interacts with and deubiquitinates RIP1.

27383048

➶

reach

This process starts with the accelerated degradation of cIAP1/2 induced by Smac protein (or Smac mimetics), and proceeds with release of RIPK1 from the TNFRI, deubiquitination of RIPK1 by the deubiqui[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

19524512

➶

reach

Conversely, deubiquitination of RIP1 by CYLD or the absence of cIAPs and LUBAC renders complex I unstable and facilitates other complexes assembled to initiate apoptosis or necroptosis.

26938298

➶

reach

Then, a tumor suppressor cylindromatosis (CYLD) protein promotes the deubiquitination of RIP1 in either complex I or complex II.

28789335

➶

reach

It does this by binding to ubiquitinated RIP (receptor interacting protein) to displace IKBKG (inhibitor of kappaB kinase gamma), and then bringing in cylindromatosis (CYLD) to deubiquitinate RIP and terminate the signaling pathway XREF_BIBR - XREF_BIBR.

25329564

➶

reach

In the course of complex II formation, RIP1 deubiquitination by CYLD, a deubiquitinase that cleaves linear- and K63-ubiquitin chains, plays a crucial role.

33815386

➶

reach

Thus, apoptosis and necrosis induced by death inducing cytokines share a common biochemical pathway down to the step of RIPK1 activation following receptor activation, cIAP1/2 degradation, and deubiqu[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

19524512

➶

reach

XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR Deubiquitination of RIPK1 by CYLD 81 stimulates the dissociation of Complex I into a secondary cytoplasmic Complex IIa where RIPK1 and/or TRADD recruit FADD via their DDs.

26313917

CYLD deubiquitinates TRAF2. 10 / 17

1 1 | 15

➶

reach

For instance, CYLD deubiquitinates the K63-Ub chains of TRAF2 and, to some extent, TRAF6, and inhibits NF-kappaB activity.

19392652

➶

signor

Cyld also interacts directly with tumour-necrosis factor receptor (tnfr)-associated factor 2 (traf2), an adaptor molecule involved in by members of the family of tnf/nerve growth factor receptors. (articolo-abstract)

12917691

➶

reach

Using an shRNA approach, Brummelkamp et al. showed that CYLD inhibits NF-kappaB signaling by counteracting TRAF2 ubiquitination [XREF_BIBR].

21119682

➶

reach

The steady state association of TRAF2 with MLKL was diminished upon TNF induced necroptosis induction, and this correlated with CYLD dependent deubiquitylation of TRAF2.

27158445

➶

reach

CYLD, a protease that specifically cleaves K63-ubiquitin chains, de-ubiquitinates TRAF2, thereby inhibiting the recruitment of TAB and TAK and activation of IKK [15], and A20 deactivates RIP1 by remov[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

24746195

➶

reach

CYLD mediated regulation of the JNK signaling pathway appears to target TRAF2 ubiquitylation, as CYLD knockdown increases both TRAF2 ubiquitylation and JNK activation, further enhancing cell survival [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

20347313

➶

reach

The Cylindroma tumour suppressor protein (CYLD) de-ubiquitinates NEMO and TRAF2 [XREF_BIBR - XREF_BIBR], while USP15 reverses betaTRCP mediated ubiquitination of IkappaBalpha [XREF_BIBR].

22212761

➶

reach

Here we described that the adenoviral vector expressing CYLD (Ad/hTERT-CYLD) augmented the cytotoxicity of TRAIL in HCC cells by negatively regulating NF-kappaB activity since CYLD could reverse the ubiquitination of TNF receptor associated factor 2 (TRAF2) and interact with the IkappaB kinasegamma (IKKgamma).

16627981

➶

reach

Contributing to the " death signal ", CYLD deubiquitylates TRAF2 and RIPK1, allowing the formation of the ripoptosome.

| PMC

➶

reach

Another example is already mentioned CYLD, which is an important inflammatory mediator that deubiquitinates TRAF2 and TRAF6, resulting in negative regulation of the NF-kappaB pathway [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR].

23151130

CYLD deubiquitinates TRAF6. 10 / 16

1 1 | 14

➶

reach

CYLD binding to one of its targets, TRAF6, requires the adaptor protein p62, which promotes the deubiquitylation of TRAF6 by CYLD 17 and probably also modulates the DUB activity of CYLD through induction of CYLD ubiquitylation 34.

18535581

➶

reach

Previously it has been known that TNF receptor associated factor 6 (TRAF6) acts as an E3 ligase for Akt-K63 polyubiquitination, and CYLD deubiquitinates TRAF6.

22491319

➶

reach

CYLD also decreased IFN promotor activation by deubiquitinating TRAF2 and TRAF6 in HEK293 T cells, respectively [29, 30] .

31208841

➶

reach

Then we investigated the roles A20 and CYLD in CK8 mediated inhibition of TRAF6 ubiquitination.

27586056

➶

reach

Conversely, the PB1 domain of p62 also interacts with CYLD, a deubiquitinase, which inhibits TRAF6 polyubiquitination and serves as a negative regulator for RANK mediated NF-kappaB activation and osteoclastogenesis 113.

23856904

➶

reach

In support of this notion, in vivo poly-ubiquitination assays demonstrate that depletion of beta-TRCP impaired TRAF6 self ubiquitination likely due to enhancement of TRAF6 deubiquitination by CYLD, concomitant with a reduction in beta-TRCP-dependent ubiquitination of CYLD and impairment of auto-phosphorylation of TRAF6-downstream kinase IKKalpha.

24961988

➶

ubibrowser

Moreover, additional studies showed that CYLD specifically deubiquitinates polyubiquitin chains at K63 of different substrates (e.g., TRAF2 and TRAF6), or tyrosine kinase receptors such as TrkA.

28335430

➶

reach

Specifically, as suggested by Jin et al. [XREF_BIBR], deubiquitinating enzyme CYLD negatively regulated TRAF6 ubiquitination by interacting with P62 and subsequently inhibited proangiogenesis function of TRAF6.

29081889

➶

reach

For instance, p62, one adaptor protein, can promote the deubiquitylation of TRAF6 (one of p62 targets) by CYLD.

32850399

➶

reach

Here we demonstrated that during the RANKL dependent signaling pathway, CYLD stabilization by depletion of beta-TRCP decreased the ubiquitination of TRAF6 and impaired auto-phosphorylation of the TRAF6-downstream kinase IKKalpha.

24961988

CYLD deubiquitinates BCL3. 10 / 12

1 1 | 10

➶

reach

In these cases, mutated CYLD is unable to deubiquitinate Bcl-3, allowing increased proliferation in cell of the skin adnexa [XREF_BIBR].

22195643

➶

reach

The CYLD protein deubiquitinates Bcl-3 and inhibits its nuclear translocation, so alterations in these gene or upstream events to it present an additional layer of regulation.

22195643

➶

reach

CYLD is also able to deubiquitinate Bcl-3 and prevent it from entering nucleus, where Bcl-3 can interact with NFkappaB family members (p50 and p52) to activate the transcription of NFkappaB target genes.

19037995

➶

reach

In addition to its deubiquitination effects on TRAFs and IKKgamma, CYLD also deubiquitinates Bcl-3, and in so doing prevents its nuclear localization.

18977328

➶

reach

CYLD deubiquitinates several NF-kappaB regulators, including TRAF2, TRAF6, and NEMO as well as BCL3, a member of the NF-kappaB family of transcription factors.

19481526

➶

reach

In this issue of Cell, Massoumi et al. (2006) show that CYLD deubiquitinates the coactivator Bcl-3, thereby preventing its translocation into the nucleus, where it normally interacts with NF-kappaB and activates transcription of proliferation genes in response to growth signals.

16713556

➶

reach

As for CYLD, studies have shown that CYLD binds to and deubiquitylates BCL-3 inhibiting its nuclear translocation, leading to decreased transcription of CCND, and delayed cells from entering S-phase 35.

33654169

➶

reach

In our experiments, the inhibitory effect of CYLD on the nuclear accumulation of phosphorylated STAT3 resembles CYLD-Bcl3 interaction, since CYLD also deubiquitinates Bcl-3 in perinuclear regions and prevents its translocation to the nucleus, a process which significantly contributes to the development of keratinocyte hyperproliferation and development of benign tumors of the skin appendage called cylindromatosis XREF_BIBR.

23825949

➶

reach

CYLD deubiquitylates BCL-3 inhibiting its nuclear translocation and so decreases the transcription of BCL-3 target genes including CCND [XREF_BIBR].

28900014

➶

ubibrowser

In this region, CYLD associates with its substrate Bcl-3 and prevents the nuclear localization of Bcl3

26763122

CYLD deubiquitinates IKBKG. 10 / 10

1 | 9

➶

reach

To confirm that Tax- or TRAF6 induced polyubiquitination of NEMO is blocked by CYLD expression, NEMO and an HA tagged ubiquitin mutant (HA-K63Ub) were co-expressed with Tax or TRAF6 in the presence or[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

17418100

➶

reach

The Cylindroma tumour suppressor protein (CYLD) de-ubiquitinates NEMO and TRAF2 [XREF_BIBR - XREF_BIBR], while USP15 reverses betaTRCP mediated ubiquitination of IkappaBalpha [XREF_BIBR].

22212761

➶

reach

CYLD also deubiquitinates IkappaB kinase gamma (IKKgamma, also known as NEMO), the regulatory subunit of IKK thus inhibiting the activation of IKK.

19489724

➶

reach

When transfected into mammalian cells, CYLD deubiquitinates NEMO as well as several IKK upstream regulators, including TRAF2, TRAF6, TRAF7, RIP1, and Tak1.

19373246

➶

ubibrowser

Other identified CYLD substrates include TNF receptor associated factor 7 (TRAF7), TRAF interacting protein (TRIP), transforming growth factor beta-activated kinase 1 (TAK1), NF-kappa-B essential modifier (NEMO), lymphocyte cell specific protein-tyrosine kinase (LCK), receptor-interacting protein 1 (RIP1), retinoic acid inducible gene (RIG), and polo-like kinase 1 (PLK1)

26763122

➶

reach

CYLD physically interacts with and deubiquitinates NEMO, thereby negatively regulating NF-kappaB activation [XREF_BIBR].

18775672

➶

reach

CYLD deubiquitinates NEMO, thus decreasing its stability and preventing the IKK complex from phosphorylating IkappaB, and NF-kappaB activation.

28295216

➶

reach

Deubiquitinating enzyme CYLD inhibits NEMO linear ubiquitination, possibly by disassembling both K63 linked and linear polyubiquitin.

21811235

➶

reach

CYLD can deubiquitinate NEMO, preventing it from causing phosphorylation of IkB, thereby killing the signal [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR].

25342597

➶

reach

In the absence of any robust stimulation of NF-kappaB (such as TCR engagement or cytokine signaling), CYLD deubiquitylates TRAF2, TRAF6, and NEMO, dampening NF-kappaB signaling by removing activating K63 chains formed by TRAF2/6.

26732666

CYLD deubiquitinates TP53. 9 / 9

1 | 8

➶

ubibrowser

Mechanistically, CYLD interacts with and deubiquitinates p53 facilitating its stabilization in response to genotoxic stress.| Collectively, our results identify CYLD as a deubiquitinase facilitating DNA damage-induced p53 activation and suggest that regulation of p53 responses to genotoxic stress contributes to the tumour suppressor function of CYLD.

27561390

➶

reach

As shown in XREF_FIG and XREF_SUPPLEMENTARY, in contrast to WT CYLD, the catalytically inactive CYLDR936X (R/X) and CYLDH871N (H/N) mutants did not diminish p53 ubiquitination although they bound p53, demonstrating that CYLD DUB activity is required to reduce p53 ubiquitination.

27561390

➶

reach

To address this question, we first assessed the capacity of CYLD to reduce p53 ubiquitination in cells overexpressing HA tagged Lys-to-Arg ubiquitin mutants that can only form K48- or K63 linked chains.

27561390

➶

reach

Together, these results suggested that CYLD directly interacts with and deubiquitinates p53 facilitating its optimal stabilization in response to DNA damage.

27561390

➶

reach

Mechanistically, we show that CYLD interacts with and deubiquitinates p53 in response to DNA damage.

27561390

➶

reach

Furthermore, recombinant His CYLD reduced ubiquitination of Flag-p53 immunoprecipitated from CpT treated HEK293T cells, showing that CYLD can directly deubiquitinate p53 in a cell-free in vitro assay (XREF_SUPPLEMENTARY).

27561390

➶

reach

CYLD deubiquitinates p53 facilitating its stabilization.

27561390

➶

reach

This experiment showed that CYLD diminishes p53 ubiquitination in cells expressing HA-mutant ubiquitin forming K63 only chains, but also in cells expressing HA-mutant ubiquitin forming K48 only chains (XREF_FIG).

27561390

➶

reach

Mechanistically, CYLD interacts with and deubiquitinates p53 facilitating its stabilization in response to genotoxic stress.

27561390

CYLD deubiquitinates MAP3K7. 9 / 9

1 | 8

➶

reach

CYLD does not inhibit TAK1 and TAB1 co-overexpression-induced TAK1 polyubiquitination.

21331078

➶

ubibrowser

The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation.&CYLD targets a ubiquitin-dependent kinase, transforming growth factor-beta-activated kinase 1 (Tak1), and inhibits its ubiquitination and autoactivation.

22057290

➶

reach

Indeed, our data suggest that CYLD directly targets Tak1 and inhibits Tak1 ubiquitination.

17548520

➶

reach

Although it is not yet clear precisely how CYLD regulates the function of the CARMA1-BCL-10-MALT1 signalosome, CYLD deubiquitylates TAK1 and thereby suppresses its catalytic activity 19.

18535581

➶

reach

These results indicate that USP4 mainly inhibits inducible TAK1 polyubiquitination and activation whereas CYLD mainly inhibits basal level of TAK1 polyubiquitination and activation.

21331078

➶

reach

Finally, we showed that CYLD interacts with and deubiquitinates TAK1 to negatively regulate the activation of the downstream MKK3/6-p 38alpha/beta pathway.

18332137

➶

reach

In this investigation, we found that CYLD failed to inhibit TAK1 and TAB1 co-overexpression-induced TAK1 polyubiquitination and NF-kappaB activation (XREF_FIG, XREF_SUPPLEMENTARY).

21331078

➶

reach

Koga et al. had reported that CYLD interacted with and deubiquitinates TAK1 by negatively regulating the activation of the downstream MKK3/6-p 38alpha/beta pathway to resist the infection of gram positive bacterium Streptococcus pneumonia [XREF_BIBR].

27738385

➶

reach

Inclusion of Cyld (WT) (XREF_FIG, lane3) but not Cyld (C601A) mutant (XREF_FIG, lane4) that lacks the DUB activity 37 resulted in diminished Tak1 ubiquitination suggesting that Cyld deubiquitinated Tak1.

22057290

CYLD deubiquitinates DDX58. 9 / 9

1 | 8

➶

reach

CYLD can inhibit ubiquitination of the RIG1 cytoplasmic viral RNA sensor and also downregulate antiviral Interferon production by controlling IKK activation [XREF_BIBR].

25342597

➶

ubibrowser

SDC4 likely promotes redistribution of RIG-I and CYLD in a perinuclear pattern post viral infection, and thus enhances the RIG-I-CYLD interaction and potentiates the K63-linked deubiquitination of RIG-I.

27279133

➶

reach

XREF_BIBR, XREF_BIBR We and others have recently shown that RIG-I ubiquitination and TBK1 and IKKepsilon activation are negatively regulated by CYLD, XREF_BIBR, XREF_BIBR a deubiquitinase known to digest K63 linked ubiquitin chains.

21946435

➶

reach

CYLD (cylindromatosis) deubiquitinates RIG-I and several downstream molecules to prevent premature RIG-I activation in uninfected cells [17], while USP3 deubiquitinates RIG-I specifically after viral infection, likely serving as a negative feedback regulator [18].

25644461

➶

reach

ORF64, USP25, USP21, USP15, USP3, Cylindromatosis (CYLD), porcine epidemic diarrhea virus papain-like protease 2 (PEDV PLP2) and transmissible gastroenteritis virus papain-like protease1 (TGEV PL1) are the DUBs found to deubiquitinate RIG-I.

31208841

➶

reach

CYLD has been shown to deubiquitinate, or prevent ubiquitination of RIG-I in cells.

21135871

➶

reach

CYLD (cylindromatosis) deubiquitinates RIG-I and several downstream molecules to prevent premature RIG-I activation in uninfected cells [XREF_BIBR], while USP3 deubiquitinates RIG-I specifically after viral infection, likely serving as a negative feedback regulator [XREF_BIBR].

25644461

➶

reach

Tumor suppressor protein cylindromatosis (CYLD) reduced the baseline Lys63-linked ubiquitination of RIG-I in uninfected cells [69].

25023063

➶

reach

A simple explanation for this result is that the carboxyl-terminal fragment of SDC4 brings RIG-I and CYLD close together, which promotes the deubiquitination of RIG-I by CYLD.

27279133

CYLD deubiquitinates AKT. 8 / 8

| 8

➶

reach

To determine whether CYLD is a direct DUB for Akt, we performed in vitro deubiquitination assays and found that deubiquitination of Akt was mediated by wild-type CYLD but not the C601A mutant (XREF_FIG).

23300340

➶

reach

Because CYLD is a known deubiquitinase and Akt ubiquitination is critical for its functional activity XREF_BIBR, we next investigated whether CYLD deubiquitinates Akt.

22491319

➶

reach

In this study we provided experimental evidences for direct interaction between Akt and CYLD, and also showed that CYLD does directly deubiquitinate Akt under both endogenous and exogenous conditions.

22491319

➶

reach

Among the DUBs, only CYLD effectively reduced the ubiquitination of Akt (XREF_FIG and XREF_SUPPLEMENTARY).

23300340

➶

reach

Both E3 ligases TRAF6 [158] and Skp2 [159] regulate Akt activity through K63 linked ubiquitination while CYLD promotes deubiquitination of Akt [160].

30217566

➶

reach

Reversely, CYLD negatively regulates Akt signaling by deubiquitinating Akt in TGFbeta signaling [XREF_BIBR].

27119228

➶

reach

Because CYLD suppresses ubiquitination and activation of Akt, it is possible that CYLD may also inhibit cancer cell proliferation and survival.

23300340

➶

reach

CYLD repression by miR-130b restores Akt ubiquitination and activation, GSK3beta and FoxO3a phosphorylation, FoxO3a removal from Bim promoter as well as Bim downregulation during 6-OHDA administration.

28412322

CYLD deubiquitinates NFkappaB. 7 / 7

| 7

➶

reach

In vivo, CYLD also reduced hepatic STAT3 K63 ubiquitination and activation, NF-kappaB activation, IL-6 and NOX2 mRNA production as well as fibrin production in murine listeriosis.

23825949

➶

reach

Deubiquitination of NF-kappaB members by CYLD is crucial in controlling the magnitude and nature of cell activation.

19342479

➶

reach

CYLD deubiquitinates NEMO, thus decreasing its stability and preventing the IKK complex from phosphorylating IkappaB, and NF-kappaB activation.

28295216

➶

reach

In this investigation, we found that CYLD failed to inhibit TAK1 and TAB1 co-overexpression-induced TAK1 polyubiquitination and NF-kappaB activation (XREF_FIG, XREF_SUPPLEMENTARY).

21331078

➶

reach

CYLD deubiquitinates several NF-kappaB regulators, including TRAF2, TRAF6, and NEMO as well as BCL3, a member of the NF-kappaB family of transcription factors.

19481526

➶

reach

18 CYLD 's deubiquitination of NFkappaB inhibits NFkappaB activity without decreasing NFkappaB protein expression.

23034333

➶

reach

Mechanistically, our results reveal that miR-135b directly targets the 3 '-untranslated region (UTR) of the deubiquitinase CYLD, thereby modulating ubiquitination and activation of NF-kappaB signaling.

33990540

CYLD deubiquitinates NLRP6. 5 / 5

| 5

➶

reach

Cyld deubiquitinated NLRP6, suggesting that Cyld directly deubiquitinates NLRP6 (XREF_FIG).

32424362

➶

reach

Coexpression of Cyld with NLRP6 and UbK63 markedly inhibited ubiquitination of NLRP6 (XREF_FIG, lane 4), suggesting that Cyld cleaves K63 linked Ub chains.

32424362

➶

reach

To confirm that Cyld directly deubiquitinates NLRP6, we coexpressed Flag -- NLRP6 with Ub.

32424362

➶

reach

NLRP6 ubiquitination was diminished in the presence of wild-type Cyld but not with the Cyld (C601A) deubiquitinase defective mutant, suggesting that Cyld deubiquitinates NLRP6 (XREF_FIG).

32424362

➶

reach

Deubiquitination of NLRP6 inflammasome by Cyld critically regulates intestinal inflammation.

32424362

CYLD deubiquitinates Tax. 4 / 4

| 4

➶

reach

CYLD inhibits Tax ubiquitination.

21824392

➶

reach

Since CYLD deubiquitinates Tax, we examined the effect of CYLD on these Tax specific signaling events.

21824392

➶

reach

Since CYLD is a K63 specific DUB, we examined whether the ubiquitination of Tax is negatively regulated by CYLD.

21824392

➶

reach

As expected, the wildtype CYLD, but not its catalytically inactive mutant, efficiently inhibited Tax ubiquitination.

21824392

CYLD leads to the deubiquitination of TBK1. 4 / 4

1 | 3

➶

ubibrowser

CYLD removes polyubiquitin chains from RIG-I as well as from TANK binding kinase 1 (TBK1), the kinase that phosphorylates IRF3, coincident with an inhibition of the IRF3 signalling pathway.

25923723

➶

reach

21946435

➶

reach

In addition, CYLD also inhibits the ubiquitination of TBK1 and IKKepsilon, which also contributes to the negative regulation of IFN responses by CYLD 79.

27012466

➶

reach

CYLD also inhibits the ubiquitylation of TBK1 and IKKε, which contributes to the negative regulation of IFN responses 171 .

28959952

CYLD leads to the deubiquitination of DVL. 3 / 3

| 3

➶

reach

It is also reported that a tumor suppressor CYLD deubiquitinase inhibits the ubiquitination of Dvl.

27536874

➶

reach

Knockout of CYLD in tumor cells can prevent K63 linked deubiquitination of Dvl [Dishevelled], which enhances Wnt and beta-catenin signaling [XREF_BIBR].

25342597

➶

reach

Based on the established role of Wnt signaling in self-renewal of the skin, associated cell lineage decisions, and skin appendage formation (Fuchs, 2007), we propose that increased or prolonged activa[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

20227366

CYLD deubiquitinates ARHGEF12. 3 / 3

1 | 2

➶

reach

In the present study, we show that CYLD deubiquitinates LARG, thus adding LARG to the growing list of CYLD substrates.

23405219

➶

ubibrowser

Mechanistically, CYLD does not interact with RhoA; instead, it interacts with and deubiquitinates leukemia-associated RhoGEF (LARG).

23405219

➶

reach

Taken together, our data provide the first evidence that CYLD deubiquitinates LARG and increases its ability to catalyze the GDP/GTP exchange on RhoA.

23405219

Mutated CYLD deubiquitinates Tax. 3 / 3

| 3

➶

reach

Consistently, a phospho-mimetic CYLD mutant fails to inhibit Tax ubiquitination.

21824392

➶

reach

A phospho-mimetic CYLD mutant failed to inhibit Tax ubiquitination.

21824392

➶

reach

Importantly, a phospho-mimetic CYLD mutant harboring serine to glutamic acid substitutions at the phosphorylation sites completely failed to deubiquitinate Tax, whereas a mutant harboring serine to analine mutations at the phsphorylation sites of CYLD (CYLD7SA) remained active in Tax deubiquitination.

21824392

1 | 1

➶

reach

Ubiquitination of Dvl1 was diminished by overexpression of wild-type CYLD and enhanced by overexpression of a catalytically inactive CYLD (CYLD C601S).

20227366

➶

ubibrowser

CYLD negatively regulates the Wnt/β-catenin signaling pathway by deubiquitinating Dvl proteins.

28840581

CYLD deubiquitinates CEP70. 2 / 2

1 | 1

➶

reach

It has been shown previously that the cylindromatosis (CYLD) tumor suppressor deubiquitinates Cep70 and promotes its centrosomal localization, thereby contributing to ciliogenesis XREF_BIBR.

26893288

➶

ubibrowser

The ciliary function of CYLD is attributed to its deconjugation of the polyubiquitin chain from centrosomal protein of 70 kDa (Cep70), a requirement for Cep70 to interact with γ -tubulin and localize at the centrosome

26763122

CYLD deubiquitinates SMAD7. 2 / 2

1 | 1

➶

reach

CYLD deubiquitinates Smad7 and thereby inhibits the activation of TAK1 and p38, thus inhibiting the TGFbeta induced development of regulatory T cells.

22335355

➶

ubibrowser

This showed that CYLD can bind to SMAD7 and deubiquitinate SMAD7 at Lysine 360 and 374 residues, which are required for the activation of TAK1 and p38 signaling

24756567

Modified CYLD leads to the deubiquitination of TRAF2. 2 / 2

| 2

➶

reach

Indeed, immunoprecipitation analysis showed that overexpression of CYLD induced deubiquitination of TRAF2 in ECs.

18245814

➶

reach

Of importance, overexpression of catalytically inactive CYLD did not induce deubiquitination of TRAF2.

18245814

CYLD leads to the deubiquitination of AKT1. 2 / 2

1 | 1

➶

ubibrowser

We showed that CYLD was a DUB for Akt and suppressed growth factor-mediated ubiquitination and activation of Akt.

23300340

➶

reach

Because Akt has three isoforms (Akt1, Akt2 and Akt3), we next examined whether CYLD displays differential specificity for various Akt isoforms and found that CYLD promoted deubiquitination of Akt1 and Akt2 (XREF_SUPPLEMENTARY).

23300340

CYLD deubiquitinates PLK1. 2 / 2

1 | 1

➶

reach

It is currently unknown how deubiquitylation of PLK1 by CYLD regulates mitotic cell division.

20347313

➶

ubibrowser

26763122

CYLD deubiquitinates RIPK2. 2 / 2

1 | 1

➶

reach

The authors showed that CYLD deubiquitinated RIPK2 in macrophages infected with L. monocytogenes, leading to impaired activation of NF-kappaB, reduced production of proinflammatory cytokines and reactive oxygen and nitrogen species, which ultimately resulted in impaired infection control.

29520263

➶

ubibrowser

CYLD-mediated K63 deubiquitination of RIPK2 resulted in an impaired activation of both NF-kappaB and ERK1/2 pathways, reduced production of proinflammatory cytokines interleukin-6 (IL-6), IL-12, anti-listerial reactive oxygen species (ROS) and nitric oxide (NO), and, finally, impaired pathogen control.

26834734

CYLD deubiquitinates IKBKG on K285. 2 / 2

2 |

➶

biopax:reactome

No evidence text available

➶

biopax:pid

No evidence text available

CYLD leads to the deubiquitination of TAB1. 1 / 1

| 1

➶

reach

CYLD does not inhibit TAK1 and TAB1 co-overexpression-induced TAK1 polyubiquitination.

21331078

Modified CYLD leads to the deubiquitination of TRAF6. 1 / 1

| 1

➶

reach

We showed that CYLD over-expression largely inhibited TRAF-6 ubiquitination, a step that is required for its activation.

26056944

CYLD leads to the deubiquitination of FOXO3. 1 / 1

| 1

➶

reach

28412322

CYLD leads to the deubiquitination of IL6. 1 / 1

| 1

➶

reach

In vivo, CYLD also reduced hepatic STAT3 K63 ubiquitination and activation, NF-kappaB activation, IL-6 and NOX2 mRNA production as well as fibrin production in murine listeriosis.

23825949

| 1

➶

reach

28412322

Mutated CYLD leads to the deubiquitination of AKT. 1 / 1

| 1

➶

reach

We found that the inhibitory effect of CYLD on ubiquitination of Akt depended on its catalytic activity, because the catalytically dead mutant of CYLD (Cys 601 --> Ala 601; C601A) failed to attenuate ubiquitination of Akt (XREF_FIG).

23300340

CYLD deubiquitinates forkhead. 1 / 1

| 1

➶

reach

CYLD : cylindromatosis; DUB : deubiquitylating enzyme; EBNA : Epstein-Barr nuclear antigen; FOXO : forkhead box O; HAUSP : herpesvirus associated ubiquitin specific peptidase; JAMM : Jab1 and MPN domain associated metalloisopeptidase; MJD : Machado-Joseph disease; OUT : ovarian tumor; PD : Parkinson 's disease; RIP : receptor interacting protein; TNF : tumor necrosis factor; TRAF : tumor necrosis factor receptor associated factor; UBP : ubiquitin processing peptidase; USP : ubiquitin specific peptidase; UCH : ubiquitin C-terminal hydrolase; VHL : von Hippel-Lindau.

19007433

Modified CYLD leads to the deubiquitination of ARHGEF12. 1 / 1

CYLD deubiquitinates NOX4. 1 / 1

1 |

➶

ubibrowser

Moreover, Nox4 was deubiquitinated via a direct interaction with the ubiquitin-specific protease domain of CYLD.

28751569

CYLD leads to the deubiquitination of TNF. 1 / 1

| 1

➶

reach

The DUB function of CYLD was first revealed by in vitro work showing that CYLD inhibits the ubiquitination of certain TNF receptor associated factors and the regulatory subunit of IkappaB kinase.

17548520

CYLD phosphorylated on S418 deubiquitinates RIPK1 on K377. 1 / 1

1 |

➶

biopax:reactome

No evidence text available

1 |

➶

ubibrowser

26763122

Modified CYLD leads to the deubiquitination of DDX58. 1 / 1

| 1

➶

reach

Loss of CYLD in DCs causes accumulation of ubiquitination of RIG-I indicating that RIG-I is constantly in the cycle of ubiquitination deubiquitination with deubiquitination being a dominant event in steady state.

18703349

Modified CYLD leads to the deubiquitination of BCL3. 1 / 1

| 1

➶

reach

Loss of CYLD expression in melanoma promoted ubiquitination of BCL-3, which is a transcriptional regulator of N-cadherin expression [28].

22085498

1 |

➶

ubibrowser

26763122

CYLD deubiquitinates NADP(+). 1 / 1

| 1

➶

reach

CYLD Deubiquitinates Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4 Contributing to Adventitial Remodeling.

28751569

CYLD deubiquitinates USP7. 1 / 1

| 1

➶

reach

19007433

CYLD leads to the deubiquitination of FOS. 1 / 1

| 1

➶

reach

CYLD suppresses AP1 function by regulating c-Jun and c-Fos ubiquitination.

21478324

Other Statements

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach

CYLD affects NFkappaB

| 7 14 280

CYLD inhibits NFkappaB.

| 6 8 211

CYLD inhibits NFkappaB. 10 / 259

| 6 8 207

➶

reach

Our results show that reconsitituted expression of CYLD in miR-19a-replete cells only partially deactivates NF-kappaB, suggesting that CYLD might cooperate with other DUBs to switch off NF-kappaB signalling.

29050336

➶

reach

CYLD has been shown to negatively regulate the activation of NF-kappaB XREF_BIBR.

25909817

➶

reach

The results established that CYLD down-regulates NF-kappaB activation by TNF-alpha.

14676304

➶

reach

For instance, CYLD negatively regulates NFkappaB activation and is involved in other immune response mechanisms.39 When TSGs such as CYLD are down-regulated, excessive inflammation occurs and tumorigenic factors can be promoted.40 Conversely, TSGs that were up-regulated were more likely to be involved in cell cycle regulation, apoptosis, and cell growth, possibly as a response to cell stress in early stages of tumorigenesis.

28675510

➶

reach

Because CYLD inhibits NF-kappaB activation, it is probable that both PI3K-Akt and NF-kappaB signaling pathways are involved in CYLD regulated cell proliferation and survival.

23300340

➶

reach

In TLR mediated signaling, CYLD negatively regulates NF-kappaB signaling by cleaving K63 linked polyubiquitin chains and M1 linked polyubiquitin chains from RIPK1, TRAF2, and NEMO.

33511009

➶

reach

As both CYLD and OTULIN negatively regulate the NF-kappaB signalling cascade, the impact of these deubiquitinases in different LUBAC dependent signalling cascades may be context dependent.

28446710

➶

reach

Interestingly, loss of CYLD causes constitutive NF-kappaB activation in developing NKT cells, which contributes to their defective IL-7 response and attenuated ICOS expression.

20224552

➶

reach

When transfected in cell lines, CYLD inhibits the activation of NF-kappaB and mitogen activated protein kinases stimulated by innate immune receptors, such as the Toll like receptors and TNF receptors.

17548520

➶

reach

CYLD inhibits activation of NF-kappaB by the TNFR family members CD40, XEDAR and EDAR in a manner that depends on the deubiquitinating activity of CYLD.

12917689

Mutated CYLD inhibits NFkappaB. 2 / 2

| 2

➶

reach

Furthermore, nuclear translocation of Bcl-3, a component of reported NPC associated activated NF-kappaB signal p50/p50/Bcl -3, was inhibited upon CYLD WT expression, but not by CYLD mutants (XREF_SUPPLEMENTARY).

28098136

➶

reach

Surprisingly, a non cleavable CYLD mutant does not impair TCR dependent canonical NF-kappaB activation, but does block activation of JNK, a critical step in TCR induced stimulation of multiple transcription factors and production of IL-2.

21868762

CYLD-S418A inhibits NFkappaB. 1 / 1

| 1

➶

reach

As observed in MCF-7 cells, however, CYLD S418A more strongly inhibited IKKepsilon induced NF-kappaB activation.

19481526

CYLD bound to Tax inhibits NFkappaB. 1 / 1

| 1

➶

reach

We found that Tax interacts with CYLD, a deubiquitinase that negatively regulates NF-kappaB activity, by inactivating it.

22865346

CYLD activates NFkappaB.

| 1 6 69

CYLD activates NFkappaB. 10 / 79

| 1 6 65

➶

sparser

Although comparable CYLD mRNA levels were present in both tumor and normal tissue, direct binding of miR-182 to 3′UTR of CYLD activated NF-κB in tumor cells.

25220353

➶

reach

However, subsequent studies have indicated that although CYLD targets NF-kappaB signaling factors, its function may depend on the cell type and stimulating receptor [XREF_BIBR].

29259980

➶

reach

These miR then directly target the tumor suppressor genes, phosphatase and tensin homolog (PTEN) and cylindomatosis (CYLD), thereby promote NF-kappaB activity which is required to maintain the transformed state [XREF_BIBR].

22210182

➶

reach

Across all solid tumor types, frequent inactivating TRAF3 and CYLD alterations that are predicted to constitutively activate NF-kappaB pathways, while inhibiting innate immunity, occur only in HPV+ HNSCC.

28295222

➶

reach

The inhibition of NF-kappaB activation by CYLD is mediated, at least in part, by the deubiquitination and inactivation of TNFR associated factor 2 (TRAF2) and, to a lesser extent, TRAF6.

12917689

➶

reach

miR-181b (activated by STAT3), has recently been identified as involved in a positive feedback loop by inhibiting CYLD (negative regulator of NF-kappaB), which in turn causes increased NF-kappaB, that completes the loop by leading to STAT3 activation.

22114691

➶

reach

Further examination showed that phosphorylation of CYLD at S418 decreases its deubiquitinase activity and increases NF-kappaB activation.

19481526

➶

reach

Deubiquitinases A20 and Cezanne, but not CYLD, are induced by NF-kappaB to negatively regulate TAK1 and NF-kappaB activity by removing K63 polyubiquitin chains [XREF_BIBR].

24443058

➶

reach

In addition, NF-kappaB deubiquitinases CYLD and A20, which negatively regulate canonical NF-kappaB signaling, can induce NF-kappaB downstream of the BCR in miR-17 ~ 92 overexpressing B cells, and thus, have also been proposed as targets of oncomiR-1, [XREF_BIBR].

28694140

➶

sparser

The inhibition of NF-kB activation by CYLD is mediated, at least in part, by the deubiquitination and inactivation of TRAF2 and, to a lesser extent, TRAF6 [ xref ].

18687060

Mutated CYLD activates NFkappaB. 3 / 3

| 3

➶

reach

On the other hand, ectopic expression of CYLD mutants was found to elevate NF-kappaB activity in NPC cells, thus demonstrating a mutational drive for NF-kappaB signaling by CYLD aberrations in NPC.

29933636

➶

reach

Our data also suggest that TRAF3 or CYLD mutations harbor episomal HPV and have activated NF-kappaB that may be required for episomal maintenance.

28295222

➶

reach

Our data also suggest that TRAF3 or CYLD mutations harbor episomal HPV and have activated NF-kappaB, which may be required for episomal maintenance.

28295222

CYLD-C601A activates NFkappaB. 1 / 1

| 1

➶

reach

Also, activation of NF-kappaB by ectopic XIAP, an essential Ub ligase for NOD2 signaling, was blocked by overexpression of CYLD WT, but not CYLD C601A, which increased NF-kappaB activity (XREF_FIG D and XREF_SUPPLEMENTARY C).

26997266

CYLD affects cell population proliferation

| 4 3 83

CYLD inhibits cell population proliferation.

| 3 3 55

CYLD inhibits cell population proliferation. 10 / 66

| 3 3 55

➶

reach

We then determined the molecular function of CYLD in NPC cells, finding that CYLD inhibited NPC cell proliferation but promoted apoptosis according to CYLD-overexpression and -silencing analyses, respectively.

33149672

➶

reach

As we expected, the MTT assay results showed that overexpression of CYLD obviously decreased the proliferation of A549 cells or H460 cells compared with that of untreated cells (* p < 0.05, ** p < 0.01).

27738385

➶

reach

Together, these results indicate that the increased expression of RIPK1 is responsible for induction of apoptosis in Mel-CV and ME1007 cells with CYLD silenced and that it does not play a role in the promotion of proliferation by CYLD silencing in ME4405 cells.

32252875

➶

reach

Results showed that overexpression of CYLD in HK1-EBV and HONE1-EBV cells inhibits cell proliferation.

33654169

➶

reach

We found that CYLD levels were significantly decreased in both NPC tissues and cell lines, and that CYLD overexpression inhibited NPC cell proliferation and promoted apoptosis.

33149672

➶

eidos

DISCUSSION As a tumor suppressor , CYLD inhibits cell proliferation in many cancer types including melanoma15 .

32252875

➶

reach

71 The gene CYLD is mutated in familial cylindromatosis, an autosomal dominant disease characterized by benign tumors derived from cells of skin appendages 72 and thus it can be considered as a TS, CYLD inhibits tumor cell proliferation by blocking BCL-3-dependent NF-kappaB signaling.

25190145

➶

reach

Ectopic expression of CYLD wild-type gene suppressed C666-1 cell proliferation (XREF_FIG) and anchorage independent growth on soft agar (XREF_FIG), while expression of patient derived CYLD point and truncating mutations resulted in the loss of these tumour-suppressive activities (XREF_FIG).

28098136

➶

reach

In vitro cell proliferation was measured and the result shows that CYLD knockout causes cell proliferation enhancement and CYLD overexpression causes cell proliferation suppression (XREF_FIG C, D).

32708712

➶

reach

MiR-501-5p upregulation corresponded with a downregulation of CYLD in the same tissues and cell lines, and overexpression of MiR-501-5p decreased CYLD expression, increased expression of cyclin D1 and c-myc and promoted the proliferation of hepatocellular carcinoma cells in vitro.

25917358

CYLD activates cell population proliferation.

| 1 28

CYLD activates cell population proliferation. 10 / 31

| 1 28

➶

reach

Silencing of CYLD expression reversed the cell proliferation promotion by miR-1288-in in GBM.

28901464

➶

reach

Catalytic domain mutation in CYLD inactivates its enzyme function by structural perturbation and induces cell migration and proliferation.

29807073

➶

reach

The present study investigated whether abnormal ectopic CYLD expression is sufficient to promote the proliferation of HCC827 and Calu-3 cells.

29286108

➶

reach

CYLD downregulation reversed the inhibitory effects of the proliferation of melanoma cells A375 and WM35 after transfection with miR-767-in.

29054757

➶

reach

Interestingly, in melanoma cells, SNAIL has been shown to inhibit expression of CYLD, which in turn leads to increased melanoma proliferation and invasion [XREF_BIBR].

27448979

➶

reach

CYLD deficiency leads to spontaneous B-cell activation and proliferation.

32850399

➶

reach

In this study we demonstrate that lack of CYLD expression in CYLD-/- MEFs increases proliferation rate of these cells compared to CYLD +/+ in a serum concentration dependent manner without affecting cell survival.

21573132

➶

reach

Knockdown of CYLD promoted cell proliferation of lung cancer cells.

27738385

➶

reach

Elimination of SRF by siRNA or inhibition of p38 MAPK reduced the expression level of CYLD and increased cell proliferation.

21573132

➶

reach

To conclude, we found that downregulation of CYLD induces tumor cell proliferation, consequently contributing to the aggressive growth of HCC.

24104553

CYLD affects apoptotic process

| 3 74

CYLD activates apoptotic process.

| 2 52

CYLD activates apoptotic process. 10 / 59

| 2 52

➶

eidos

Yin et al. reported that CYLD could increase apoptosis and decrease autophagy to improve the chemosensitivity to gemcitabine in bladder cancer [ 26 ] .

| PMC

➶

reach

In the present study, CYLD overexpression inhibited cell growth and promoted cell apoptosis in colon cancer cells, while the expression levels of p-p65 and p65 were decreased and those of p-IkappaBalpha and IkappaBalpha were increased.

32901872

➶

reach

Loss of CYLD inhibits cellular apoptosis by activating NF-kappaB pathway [XREF_BIBR].

26950276

➶

reach

Increased expression of CYLD in BT549 cells induced apoptosis, while its suppression by small interfering RNA inhibited cell death in BAF57 expressing BT549 cells.

16135788

➶

reach

In addition, CYLD overexpression markedly increased apoptosis of HCC827 and Calu-3 cells (XREF_FIG).

29286108

➶

reach

Taken together, our data show that the presence of CYLD promotes brain pathology with increased neuroinflammation and hemorrhage as well as endothelial cell activation and apoptosis.

28203236

➶

reach

Increasing CYLD promotes apoptosis and increasing PNUTL enhances cell death via TGF.

23056957

➶

reach

Additionally, we observed that the CYLD specific promotion of NPC cell apoptosis was reversed by NDRG1 silencing (XREF_FIG and XREF_FIG).

33149672

➶

reach

Firstly, we asked whether overexpression of CYLD-flag could induce cell apoptosis, which probably contributed to CYLD induced cell death.

27738385

➶

reach

Our previous research has demonstrated that adult T-cell leukemia/lymphoma (ATLL) had high level of CYLD phosphorylation, down-regulating CYLD phosphorylation could increase CYLD deubiquitinase activity and then promoted apoptosis in ATLL [XREF_BIBR].

33827598

CYLD inhibits apoptotic process.

| 1 22

CYLD inhibits apoptotic process. 10 / 24

| 1 22

➶

reach

As Fas associated protein with death domain (FADD), cellular inhibitor of apoptosis 1 (cIAP1), and cIAP2 are all known to regulate RIPK1 mediated apoptosis XREF_BIBR, we compared the expression levels of FADD, cIAP1, and cIAP2 between Mel-FH and Mel-CV cells that displayed different sensitivity to apoptosis induced by silencing of CYLD.

32252875

➶

reach

Reversely, overexpression of CYLD could promote cell apoptosis, whereas inhibiting cell proliferation and antibody production.

29766242

➶

reach

Here we show that genetic deficiency of Cyld, a recently identified deubiquitinating enzyme, attenuates the early wave of germ cell apoptosis and causes impaired spermatogenesis in mice.

17981138

➶

reach

To our surprise, amputation induced apoptosis was increased by RNAi of tak1 or p38-1, and decreased by RNAi of cyld-1 (XREF_FIG).

27441386

➶

reach

The mechanism responsible for apoptosis induced by CYLD knockdown in sensitive melanoma cells (Mel-CV and ME1007) appeared to be upregulation of RIPK1.

32252875

➶

reach

CYLD (C/S) tumors are also characterized by their elevated proliferation rate and decreased apoptosis.

20838385

➶

reach

Ablation of CYLD, NFKBIA, TRAF2, or TRAF3 induces hyperactivation of the canonical and/or noncanonical NF-kappaB pathways and subsequently diminishes CC-122-induced apoptosis in 5 of 6 DLBCL cell lines.

33847741

➶

reach

This was demonstrated by the findings that knockdown of CYLD resulted in upregulation of RIPK1 that was associated with enhancement in K63 linked polyubiquitination of the protein and that co-knockdown of RIPK1 diminished CYLD knockdown induced apoptosis in sensitive cells.

32252875

➶

reach

But in OCI-Ly10R cells, BTK inhibitor PCI-32765 but not rituximab could reduce CYLD phosphorylation and induce apoptosis.

33827598

➶

reach

Cointroduction of CYLD or RIPK1 siRNA abolished apoptosis induced by introduction of miR-99b-3p mimics (XREF_FIG), confirming that downregulation of CYLD and subsequent upregulation of RIPK1 are responsible for induction of apoptosis by the mimics.

32252875

CYLD affects inflammatory response

| 2 41

CYLD inhibits inflammatory response.

| 2 24

CYLD inhibits inflammatory response. 10 / 34

| 2 24

➶

reach

In a similar study, CYLD was shown to negatively regulate NF-kappaB activation and lung inflammation in mice infected with non typeable Haemophilus influenzae 22.

18535581

➶

reach

Recent insights into the normal functions and signaling interactions of the CYLD gene product indicate that CYLD interferes with NF-kappaB, JNK, and p38MAPK signaling to limit inflammation and cancer,[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

20347313

➶

eidos

Similarly , deficiency in CYLD or A20 , a master regulator of NFkappaB , lead to overt pathway activation and inflammation ( 132 ) .

33324551

➶

reach

This is in contrast with dysregulated TNFR1 signaling commonly observed in liver disease and cancer and the fact that liver specific deletion of CYLD induces TNFR1 mediated liver inflammation and development of hepatocellular carcinoma [XREF_BIBR, XREF_BIBR].

33288901

➶

reach

CYLD restricts inflammation by inhibiting NFkappaB activation [XREF_BIBR], yet it can induce innate immune responses by stabilizing STING, a cytosolic DNA sensor and a major regulator of type I interferon signaling, via its deubiquitination on K48 linked chains [XREF_BIBR].

| PMC

➶

reach

For example, CYLD has been shown to downregulate the inflammatory response following bacterial infection with Escherichia coli by negatively regulating the innate immune response via inhibition of NF-kappaB signalling.

22730341

➶

reach

Reduced expression of CYLD promotes cell survival and inflammation in gefitinib treated NSCLC PC-9 cells : targeting CYLD may be beneficial for acquired resistance to gefitinib therapy.

32441799

➶

reach

CYLD also inhibited inflammation and proliferation in vascular cells and represented a novel target for the treatment or prevention of atherosclerosis [XREF_BIBR].

27738385

➶

reach

NTHi induced CYLD, in turn, negatively regulates NTHi induced NF-kappaB activation through deubiquitinating TRAF6 and 7 and down-regulates inflammation.

17925880

➶

reach

Focusing on recent data concerning the normal functions and signaling interactions of the CYLD gene product, we explain how CYLD interferes with TNF-alpha or TLR mediated signaling as well as with JNK or NF-kappaB-dependent p65/50 signaling to limit inflammation.

18008375

CYLD activates inflammatory response.

| 17

CYLD activates inflammatory response. 10 / 17

| 17

➶

reach

Indeed, it was found that deletion of CYLD -- which is required for RIPK activation downstream of TNF -- prevented inflammation caused by intestinal deletion of FADD, but not of NF-kB signaling 75.

22016059

➶

reach

These results suggest that PDE4B negatively regulates CYLD expression and mediates inflammation via the JNK pathway.

23575688

➶

reach

Adoptive transfer of CYLD KO T cells into RAG KO mice that lack endogenous lymphocytes induced autoimmune symptoms and intestinal inflammation.

24917867

➶

reach

Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma : possible link to acquired resistance to anti-VEGF therapy.

25071012

➶

reach

Taken together, it is evident that PDE4B negatively regulates CYLD expression and mediates NTHi induced inflammation via specific activation of JNK2 but not JNK1 pathway.

23575688

➶

reach

Thus, we sought to determine whether increased cAMP does have an important role in inhibiting JNK2 activation, which in turn enhances CYLD expression and suppresses inflammation.

23575688

➶

reach

Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer.

22698400

➶

reach

CYLD is upregulated in both COVID-19 and cardiomyopathy and was found to correlate with the activation of FGFR2, an important promoter of inflammation [51], and TXA2, a gene that is upregulated in platelets (See Appendix A, Figure A2A) [52].

34071557

➶

reach

NTHi induced CYLD expression, which in turn leads to negative regulation of NTHi induced NF-kappaB-dependent inflammation [XREF_BIBR].

18664270

➶

reach

These data collectively suggested that Cyld deficiency leads to severe colonic inflammation and increased disruption of the epithelial barrier.

32424362

CYLD affects MAP3K7

| 1 41

CYLD inhibits MAP3K7.

| 1 29

CYLD inhibits MAP3K7. 10 / 27

| 1 25

➶

reach

This is explained by loss of CYLD mediated TAK1 K63 deubiquitination [XREF_BIBR], which suppresses TAK1 activation in wild-type lymphocytes (XREF_FIG).

23474202

➶

reach

Conversely, loss of the K63 specific deubiquitinase CYLD causes spontaneous activation of IKK and JNK as well as their upstream kinase Tak1.

26260210

➶

reach

Genetic deletion of CYLD or ITCH, essential ubiquitin regulators for TAK1 deactivation, causes strong and sustained TAK1 activation with enhanced production of tumor promoting proinflammatory cytokines that mediate liver fibrosis, tumor development, and metastasis [XREF_BIBR, XREF_BIBR].

24443058

➶

reach

161 Cylindromatosis (CYLD) has been shown to inhibit NFkappaB activation 160 and more recent results indicate that this inhibition might be mediated via the ability of CYLD to hydrolyze unanchored polyubiquitin chains and thus inhibit TAK1 and IKK activation.

22223213

➶

reach

(41) Moreover, Itch and Cyld act together to deactivate TAK1 through lysine 48 (Lys48)-linked ubiquitination.

32343849

➶

reach

The loss of CYLD in T cells causes constitutive activation of TAK1 and its downstream signalling molecules, IKK and JNK (JUN N-terminal kinase).

18535581

➶

reach

In keeping with a previous finding that Tak1 ubiquitination mediates its autoactivation, we have shown that CYLD potently inhibits the catalytic activity of Tak1 in transfected cells.

17548520

➶

reach

Thus, CYLD prevents excessive activation of TAK1 and p38, which results in reduced FOXP3 expression and Treg generation.

28524749

➶

reach

Additionally, in both macrophages and T cells, CYLD inhibits the ubiquitylation and subsequent activation of Tak1, a kinase that activates both IKK and JNK.

26732666

➶

reach

The fact that loss of CYLD causes spontaneous activation of TAK1 implies that TAK1 ubiquitylation is a dynamic event that occurs even in resting T cells.

18535581

CYLD-Y485A bound to ITCH inhibits MAP3K7. 2 / 2

| 2

➶

reach

Reconstitution of wild-type Cyld but not the mutant Cyld (Y485A), which can not associate with Itch, blocked sustained Tak1 activation and proinflammatory cytokine production by Cyld (-/-) bone marrow derived macrophages.

22057290

➶

reach

Reconstitution of wild-type Cyld but not mutant Cyld (Y485A), which can not associate with Itch, blocked the sustained Tak1 activation and proinflammatory cytokine production by Cyld -/- bone marrow derived macrophages.

22057290

CYLD inhibits ubiquitinated MAP3K7. 1 / 1

| 1

➶

reach

Loss of CYLD causes accumulation of ubiquitinated TAK1 and aberrant TAK1 activation.

27012466

CYLD bound to ITCH inhibits MAP3K7. 1 / 1

| 1

➶

reach

This finding suggests that Itch and Cyld complex degrades the Tak1 that is associated with TRAF complex but not the entire pool of Tak1 within the cell during an inflammatory response.

22057290

CYLD activates MAP3K7.

| 11

CYLD activates MAP3K7. 10 / 12

| 11

➶

reach

In an analysis of the mechanism of this finding, we noted first that TGF-beta-stimulated T cells lacking CYLD exhibit increased TAK1 and p38 mitogen activated protein kinase (MAP kinase) activity.

21931165

➶

reach

Reconstitution of Cyld -/- MEFs with Cyld (WT) restored transient Tak1 activation (XREF_FIG) and normalized IL-6 production.

22057290

➶

reach

Thus, it was logical to examine whether CYLD targets Tak1 and regulates its ubiquitination.

17548520

➶

reach

CYLD targets and inhibits the ubiquitin dependent IKKbeta kinase TAK1 and therefore prevents aberrant lymphocyte activation [XREF_BIBR, XREF_BIBR], while A20 dampens NF-kappaB activity by trimming K63-ubiquitin chains attached to MALT1 [XREF_BIBR, XREF_BIBR].

23590831

➶

reach

In mature T cells, CYLD targets TAK1 for inactivation to downregulate IKK and NF-kappaB activation [XREF_BIBR].

21119682

➶

reach

Deubiquitinases A20 and Cezanne, but not CYLD, are induced by NF-kappaB to negatively regulate TAK1 and NF-kappaB activity by removing K63 polyubiquitin chains [XREF_BIBR].

24443058

➶

reach

XREF_BIBR, XREF_BIBR Similarly, in a hepatocytespecific cylindromatosis deficient (CYLD Deltahep) mouse model, which typically has increased hepatocyte TAK1 and NF-kappaB activation, TAK1 deletion decreased HCC development.

30809789

➶

reach

It has been reported that an adequate amount of CYLD impairs the progression of NASH by inhibiting TAK1 signaling, and the E3 ligase TRIM47 has been revealed to be a key regulator of CYLD degradation, revealing that both of the above targets could be significant for the treatment of NAFLD.92 Caspase Inhibitor : Emricasan is a caspase inhibitor which can reduce the portal hypertension via blocking the activation of inflammatory caspase and inhibiting hepatocyte cell death.

30828530

➶

reach

By using CYLD knock-out mice, a recent study shows that in TGF-beta-treated T cells, CYLD deficiency causes enhanced TAK1 and p38 mitogen activated protein kinase activities.

24756567

➶

reach

Deficiency in ITCH or CYLD causes sustained activation of TAK1 and increased cytokine production in bone marrow derived macrophages, and tumorigenesis and metastasis of transplanted Lewis lung carcinoma, suggesting that sustained activation of TAK1 leads to the progression of non-small-cell lung cancer (NSCLC) [XREF_BIBR].

28106845

CYLD decreases the amount of MAP3K7.

| 1

Modified CYLD decreases the amount of MAP3K7. 1 / 1

| 1

➶

reach

Surprisingly, we found that overexpression of FLAG-CYLD failed to inhibit TAK1 and TAB1 overexpression induced TAK1 polyubiquitination (XREF_FIG).

21331078

TNF affects CYLD

| 35

TNF activates CYLD.

| 22

TNF activates CYLD. 10 / 25

| 22

➶

reach

Furthermore, the CYLD overexpressed H460 cells were treated with 100ng/mL of TNF-alpha in combination with different concentrations of Nec-1 for 24 hours, including 0muM, 0.1 muM, 1.0 muM, and 10muM, respectively (XREF_FIG).

27738385

➶

reach

Immunoprecipitation of FADD from CYLD expressing and control Cyld -/- MEFs treated with TNF in the presence of zVAD-fmk revealed that recruitment of RIPK1 to the FADD necrosome is strictly dependent on CYLD (XREF_FIG).

22037414

➶

reach

CYLD mRNA is upregulated by TNF alpha and bacterium nontypeable Haemophilus influenza, providing evidence for an inducible autoregulatory feedback loop controlling CYLD expression (Jono et al., 2004).

17851586

➶

reach

In addition, TRAF2 and TRAF6 appear to be differentially involved in NF-kappaB-dependent induction of CYLD by TNF-alpha and NTHi.

15226292

➶

reach

However, although A20 and CYLD are induced by TNFalpha for the establishment of a negative feedback loop, neither OTULIN (XREF_FIG F) nor LUBAC are induced by TNFalpha, again suggesting that they function as a differentially regulated signaling module.

23746843

➶

reach

The stable cell line of CYLD overexpressing A549 cells was treated with 10ng/mL of TNF-alpha alone, or 20ng/mL of TNF-alpha combinated with 10muM of a pancaspase inhibitor, z-VAD-fmk, for 12 hours, and the cell apoptosis rate and necrosis rate were determined by Annexin v-FITC/PI dual staining analysis following the kit protocols (Santa Cruz, USA).

27738385

➶

reach

On the other hand, CYLD also acts as a mediator of immune activation and inflammation.38, 39 We found that both SPATA2 and CYLD are induced by TNF-alpha and IL-1beta in vitro, indicating a similar regulation in OC.

30697874

➶

reach

After 48 h of infection, cells were transfected with CYLD expression plasmid or left untransfected and treated with TNFalpha for 10 min after 30 h of transfection.

21408173

➶

reach

Furthermore, NF-kappaB-dependent induction of CYLD by TNF-alpha triggers an autoregulatory feedback mechanism through deubiquitylation of TRAF2 and TRAF6 [37].

20347313

➶

reach

Knockdown of CYLD had no effect on cell death of NEMO deficient cells treated with TNF in the absence of zVAD, i.e. CYLD is not required when the cell death is apoptotic (XREF_FIG).

22848449

TNF increases the amount of CYLD.

| 10

TNF increases the amount of CYLD. 10 / 13

| 10

➶

reach

Indeed, both TNF-alpha and non typeable Haemophilus influenzae (NTHi), a common Gram negative bacterial pathogen that causes respiratory infections, can upregulate CYLD expression, suggesting that CYL[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

20347313

➶

reach

At this time, the underlying mechanism by which TNFalpha up-regulates the expression of CYLD is not clear.

28900035

➶

reach

Such a function of CYLD was suggested by the finding that the expression of CYLD is induced by proinflammatory cytokines, TNF-alpha and IL-1beta, and the Gram negative bacterium Haemophilus influenzae.

19373246

➶

reach

32 In mouse bone marrow derived macrophages, CYLD expression is strongly induced by RANKL, but not by TNF-alpha or LPS.

19373246

➶

reach

In cultured human tubular epithelial HK-2 cells, tumor necrosis factor-alpha (TNFalpha) up-regulated CYLD expression.

19800320

➶

reach

Similarly, mRNA levels of CYLD or cIAP1, which are involved in the regulation of complex I activity (Annibaldi & Meier, 2018), were not significantly induced by TNF or reduced in RelA-knockout cells (Fig XREF_FIG).

33314666

➶

reach

The expression of CYLD can be induced by TNF treatment or viral infection (Friedman et al., 2008) .

32215003

➶

reach

The expression of CYLD and NF-kappaB mRNAs in HSG cells was increased by TNF-alpha.

18497946

➶

reach

For example, although TNF-alpha stimulates CYLD expression in HeLa cells, human bronchial epithelial cells, and human aortic endothelial cells, XREF_BIBR - XREF_BIBR it fails to induce CYLD expression in 293 cells.

19373246

➶

reach

One possibility is that Cyld expression is upregulated by TNF and IL-1beta, via IKK-NF-kappaB pathway XREF_BIBR, XREF_BIBR, XREF_BIBR triggers its association with Itch.

22057290

TNF inhibits CYLD.

| 3

TNF inhibits CYLD. 3 / 3

| 3

➶

reach

Another protein, CYLD which deubiqitinates TRAF6, and is negatively regulated by specific TNF receptors, might play a role of a silencer of EDAR signaling, since mutations in CYLD predispose not only to skin tumors (cylidromatosis), but also to the development of tumors of eccrine sweat glands and hair follicles.

26294279

➶

reach

This model is consistent with the recent discovery that caspase 8 mediated cleavage of CYLD limits TNF induced programmed necrosis [XREF_BIBR], since caspase 8 is present in the necrosome, but not the TNFR-1 complex.

24098568

➶

reach

Inhibiting CASPASE-8 leads to CYLD dependent necroptosis caused by the TNF produced in response to TLR4 ligation.

27264187

CYLD affects RIPK1

| 2 22

CYLD decreases the amount of RIPK1.

| 2

CYLD decreases the amount of RIPK1. 2 / 12

| 2

➶

reach

In contrast, overexpression of CYLD caused downregulation of RIPK1 in Mel-CV and ME1007 cells, which was nevertheless reversed by the treatment with the proteasome inhibitor MG132 (XREF_FIG), substantiating that downregulation of RIPK1 expression by CYLD is mediated by the proteasomal degradation XREF_BIBR.

32252875

➶

reach

CYLD can also negatively regulate the expression of receptor interacting protein kinase 1 (RIPK1) that is emerging as an important determinant of cell fate in response to cellular stress through its deubiquitinase activity XREF_BIBR.

32252875

CYLD inhibits RIPK1.

| 2 8

CYLD inhibits RIPK1. 10 / 11

| 2 8

➶

reach

Then, we found that RIP3 accounts for shikonin induced activation of MLKL, and activated MLKL reversely up-regulates the protein level of CYLD and promotes the activation of RIP1 and RIP3.

31560934

➶

reach

In support, overexpression of Snail1 reduced CYLD expression and upregulated RIP1 in Mel-CV.

29880840

➶

reach

Caspase-8 also targets the deubquitinase CYLD preventing RIPK1 initiation of necroptosis [XREF_BIBR, XREF_BIBR].

27710879

➶

eidos

This was demonstrated by the findings that knockdown of CYLD resulted in upregulation of RIPK1 that was associated with enhancement in K63-linked polyubiquitination of the protein and that co-knockdown of RIPK1 diminished CYLD knockdown-induced apoptosis in sensitive cells .

32252875

➶

reach

Formation of the secondary, receptor-free cytoplasmic complex II is largely dependent on the activity of DUBs, specifically cylindromatosis (CYLD), A20 (also known as TNFAIP3) and ubiquitin thioesterase OTULIN, which destabilize complex I, abrogate NF-kappaB activation and release RIPK1 from complex I, which then forms the cytosolic complex II XREF_BIBR, XREF_BIBR.

29242641

➶

reach

Silencing of CYLD caused upregulation of RIPK1 in Mel-CV, ME1007, Mel-FH, and ME4405 cells regardless of their differential apoptotic responses (XREF_FIG).

32252875

➶

reach

Thus, CYLD inhibits MyD88, RIP1 (receptor interacting serine/threonine protein kinase 1), TRAF2, TRAF6, TRAF7 and NEMO downstream to TLR signaling and regulates exaggerated inflammation which can lead to the development of severe infection causing sepsis and associated organ damage.

| DOI

➶

reach

32252875

➶

reach

Rather than inhibiting RipK1 degradation, knock-down of CYLD and/or A20 appeared to enhance the degradation of RipK1, suggesting that CYLD and A20 promote maintenance of RipK1.

29789521

➶

eidos

In contrast , overexpression of CYLD caused downregulation of RIPK1 in Mel-CV and ME1007 cells , which was nevertheless reversed by the treatment with the proteasome inhibitor MG132 ( Fig. 4C ) , substantiating that downregulation of RIPK1 expression by CYLD is mediated by the proteasomal degradation20 ,30,32,33 .

32252875

CYLD activates RIPK1.

| 10

CYLD activates RIPK1. 10 / 11

| 10

➶

reach

Then, we found that RIP3 accounts for shikonin induced activation of MLKL, and activated MLKL reversely up-regulates the protein level of CYLD and promotes the activation of RIP1 and RIP3.

31560934

➶

reach

CYLD destabilizes complex I and allows RIP1 to dissociate from the plasma membrane.

25042848

➶

reach

CYLD Is Critical for Protection Against the Apoptosis Inducing Potential of RIPK1 in a Subset of Melanoma Cells.

32252875

➶

reach

An alternative explanation for the embellished necroptotic sensitivity observed in casp8 deficient cells has been raised by Ting and colleagues, observing that casp8 mediated cleavage of the E3 ubiquitin ligase CYLD enhances RIP1 and RIP3 dependent necroptosis [XREF_BIBR].

24856110

➶

reach

In addition we show that optineurin is required for CYLD mediated deubiquitnation of RIP.

21408173

➶

reach

32252875

➶

reach

32252875

➶

reach

Rather than inhibiting RipK1 degradation, knock-down of CYLD and/or A20 appeared to enhance the degradation of RipK1, suggesting that CYLD and A20 promote maintenance of RipK1.

29789521

➶

reach

CYLD and A20 function as deubiquitination enzymes to inhibit IKK by targeting RIP1 upstream of IKK, while CUEDC2 acts as an adaptor protein to keep IKK in an inactivated status by recruiting a phospha[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

28499869

➶

reach

Mouse RIP3, RIP1, MLKL, and CYLD siRNAs were synthesized by GenePharma : RIP3-1 (cccgacgaugucuucugucaa), RIP3-2 (cuccuuaaagucaauaaacau), RIP1-1 (ccacuagucugacugauga), RIP1-2 (ucaccaauguugcaggaua), CYLD-1 (uccauugaggauguaaauaaa), CYLD-2 (aaggguugaaccauuguuaaa), MLKL-1 (gagauccaguucaacgaua), and MLKL-2 (uaccaucaaaguauucaacaa).

25093162

CYLD increases the amount of RIPK1.

| 2

CYLD increases the amount of RIPK1. 2 / 2

| 2

➶

reach

32252875

➶

reach

Furthermore, we demonstrate FMRP to be critically important for regulating key molecules in TNF receptor 1 (TNFR1)-dependent apoptosis and necroptosis including CYLD, c-FLIP S and JNK, which contribute to prolonged RIPK1 expression.

31409605

CASP8 affects CYLD

2 | 3 20

CASP8 inhibits CYLD.

2 | 3 9

CASP8 inhibits CYLD. 10 / 16

| 3 9

➶

reach

We identified cFLIP upregulation that may promote caspase 8 mediated degradation of CYLD, and other necrosome components, as a possible mechanism abrogating Mtb 's capacity to coopt necroptotic signaling.

29229989

➶

reach

Co-transfection of HEK 293 cells revealed that over-expression of wild-type CASPASE 8, but not the catalytically inactive mutant CASPASE 8-C360S, causes degradation of CYLD protein (XREF_FIG).

22037414

➶

reach

Neither RIPK1 nor RIPK3 was required for the processing of CYLD to CYLDp25 in MEFs (XREF_SUPPLEMENTARY), indicating that CASPASE 8 inactivation of CYLD occurs upstream of these necrosome components.

22037414

➶

reach

Neither RIPK1 nor RIPK3 were required for CYLD cleavage, and CYLD inactivation by casp8 is proposed to occur upstream of RIPK activity.

22889224

➶

sparser

Neither RIPK1 nor RIPK3 were required for CYLD cleavage, and CYLD inactivation by casp8 is proposed to occur upstream of RIPK activity.

22889224

➶

reach

Active caspase-8 has been reported to inhibit necroptosis by cleaving RIPK1, RIPK3, and CYLD XREF_BIBR - XREF_BIBR.

26924060

➶

reach

In contrast, loss of CASPASE 8 prevented CYLD degradation resulting in necrotic death.

22037414

➶

sparser

Neither RIPK1 nor RIPK3 was required for the processing of CYLD to CYLDp25 in MEFs ( xref ), indicating that CASPASE 8 inactivation of CYLD occurs upstream of these necrosome components.

22037414

➶

reach

Caspase 8 then cleaves and inactivates RIPK1, RIPK3 and CYLD and stimulates apoptosis.

25015821

➶

sparser

Since caspase 8 is not recruited to the membrane-anchored TNFR-1 complex where CYLD is supposed to exert its effect [ xref , xref ], caspase 8 should not be able to cleave and inhibit CYLD at this complex.

24098568

Catalytically active CASP8 inhibits CYLD. 2 / 2

2 |

➶

bel

Therefore, removal of CYLD-WT by CASPASE 8 prolongs the ubiquitination state of RIPK1 and maintains RIPK1 in a pro-survival complex with NEMO. In contrast, the resistance of CYLD-D215A to proteolytic cleavage by CASPASE 8 resulted in less ubiquitination of RIPK1 (Figure 5), which enhanced RIPK1 interaction with the necrosome to initiate death (Figure 4). These observations demonstrate that CASPASE 8 cleavage of CYLD functions as a pro-survival event by preventing CYLD from deubiquitinating RIPK1

22037414

➶

bel

CASP8 activates CYLD.

| 9

CASP8 activates CYLD. 9 / 9

| 9

➶

reach

Following TNF stimulation, aberrant CYLD necroptotic activity is held in check by caspase-8 mediated CYLD processing and inactivation 74.

27158445

➶

reach

24856110

➶

reach

Thus, caspase-8 can target CYLD (the cylindromatosis tumor suppressor protein) XREF_BIBR, XREF_BIBR, a deubiquinating enzyme participant of necroptosis, and infection of HeLa cells with L - MV results in some activation of this caspase XREF_BIBR.

23072900

➶

reach

Necroptotic signaling is also suppressed by caspase 8 mediated cleavage of RIPK1 and/or CYLD.

23720337

➶

reach

XREF_BIBR, XREF_BIBR Second, caspase 8 mediated cleavage of CYLD generates a survival signal, whereas the mutation of caspase 8 mediated cleavage site on CYLD switches cell survival to necrotic cell death in response to TNFalpha.

27383048

➶

reach

24098568

➶

reach

In normal circumstances, caspase-8 molecule activates apoptosis by blocking the necroptosis and by cleaving RIPK1 and CYLD [XREF_BIBR - XREF_BIBR].

29980212

➶

reach

Caspase-8 and FADD in tandem inhibit necroptosis by inhibiting the activity of RIPK1 and RIPK3 and CYLD and promote the advent of apoptosis via the cleavage of PARP-1 [XREF_BIBR, XREF_BIBR].

29052145

➶

reach

Caspase-8 also targets the deubquitinase CYLD preventing RIPK1 initiation of necroptosis [XREF_BIBR, XREF_BIBR].

27710879

CASP8 decreases the amount of CYLD.

| 2

CASP8 decreases the amount of CYLD. 2 / 6

| 2

➶

reach

Levels of CYLD may be indirectly increased by allosteric inhibition of caspase 8 (which cleaves CYLD) by zVAD-FMK [XREF_BIBR].

25342597

➶

reach

Blockade of Caspase 8 activity with the pharmacological inhibitor IETD prevents the loss of full-length CYLD and this correlates with the entry of the NEMO deficient cells into cell death by programmed necrosis.

22848449

CYLD affects CYLD

| 1 23

CYLD inhibits CYLD.

| 9

CYLD inhibits CYLD. 8 / 9

| 8

➶

reach

Additionally, phosphorylation of CYLD was found to downregulate CYLD activity : transient phosphorylation by IKK in a serine cluster just upstream of the TRAF2 binding site, attenuates DUB function XREF_BIBR.

23335970

➶

reach

These results demonstrate that phosphorylation of CYLD at Ser418 suppresses CYLD activity, resulting in increased NF-kappaB transcriptional activation.

19481526

➶

reach

The CYLD staining and protein expression were lower in the OX-LDL+ Sal A group than OX-LDL group after culturing for 48 hours (P < 0.01, Figures XREF_FIG - XREF_FIG and XREF_FIG), revealing that OX-LDL increases CYLD level and Sal A antagonizes OX-LDL by downregulating CYLD.

29081889

➶

reach

Together, these observations demonstrate that IKKepsilon mediated phosphorylation of CYLD at Ser418 inhibits CYLD deubiquitinase activity.

19481526

➶

reach

As IKK mediated phosphorylation of CYLD has been reported to negatively regulate CYLD enzymatic activity [XREF_BIBR], we further explored whether IKK is also involved in regulating the degradation of CYLD by SCF beta-TRCP.

24961988

➶

reach

Interestingly, recent findings also suggest that OTULIN deficiency results in spontaneous inhibitory phosphorylation of CYLD, thereby limiting CYLD activity, which can be rescued by LUBAC inhibition [XREF_BIBR].

33288901

➶

reach

Phosphorylation of CYLD at Ser418 decreases CYLD activity.

19481526

➶

reach

However, constitutive phosphorylation of CYLD by IKK inactivates CYLD in HTLV-1-induced leukemia to promote heightened NF-kappaB activation.

22435550

CYLD bound to CEP350 inhibits CYLD. 1 / 1

| 1

➶

reach

In transgenic mice engineered to mimic the smallest truncation found in cylindromatosis patients, CYLD interaction with CAP350 is lost disrupting CYLD centrosome localization, which results in cilia formation defects due to impairment of basal body migration and docking.

25134987

CYLD decreases the amount of CYLD.

| 7

CYLD decreases the amount of CYLD. 6 / 8

| 6

➶

reach

An adeno associated virus (AAV) vector encoding CYLD was used to suppress CYLD expression by being intratracheally instilled in rats 7 days before MCT-AV treatment.

33507567

➶

reach

Adenoviral over-expression of CYLD shRNA (20 MOI) completely inhibited CYLD protein expression.

19800320

➶

reach

In vitro cell proliferation was measured and the result shows that CYLD knockout causes cell proliferation enhancement and CYLD overexpression causes cell proliferation suppression (XREF_FIG C, D).

32708712

➶

reach

Western blotting and a dual-luciferase reporter assay were used to verify that miR-1288 targets CYLD by interacting with the 3 ' UTR of CYLD to reduce CYLD expression.

28901464

➶

reach

To further confirm CYLD as a target for human melanoma, specific si-RNAs of CYLD were used to inhibit CYLD expression in both melanoma cells A375 and WM35, respectively.

29054757

➶

reach

Adenoviral over-expression of CYLD shRNA dose-dependently inhibited CYLD mRNA expression with an efficacy of> 90% knockdown of endogenous CYLD at dose of 10 multiplicity of infection (MOI) in HK-2 cel[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

19800320

CYLD bound to LEF1 decreases the amount of CYLD. 1 / 1

| 1

➶

reach

Our study showed that LEF1 binds the CYLD promoter and suppresses endogenous CYLD levels, whereas selenite caused LEF1 to dissociate from the CYLD promoter.

24577083

CYLD increases the amount of CYLD.

| 4

CYLD increases the amount of CYLD. 4 / 8

| 4

➶

reach

The relative expression levels of CYLD following CYLD overexpression in A549 cells and H460 cells were significantly higher (3.37 +/- 0.16 and 2.67 +/- 0.17 times), compared with that in pcDNA3.1 plasmid transfected A549 and H460 cells.

27738385

➶

reach

The p38 and CYLD pathway is involved in neuronal necroptosis induced by OGD injury and the p38 and CYLD pathway can be activated to increase CYLD protein expression.

29163038

➶

reach

BCL3 was identified as a CYLD specific substrate in BCC and treatment of BCC cell lines with cyclopamine rescued the expression of CYLD.

22235375

➶

reach

That is, inhibition of endogenous CYLD expression by CYLD siRNA in C33A cells (XREF_FIG) abrogated the hypoxia induced NF-kappaB activation associated with ectopic E6 expression (XREF_FIG).

18977328

CYLD activates CYLD.

| 1 3

CYLD activates CYLD. 4 / 5

| 1 3

➶

reach

IKKɛ also phosphorylates and inactivates the tumor suppressor CYLD, preventing CYLD from deubiquitinating specific substrates in the NF-κB signaling pathway.

23333767

➶

reach

33827598

➶

eidos

Knockdown of CYLD leads to diminished CYLD and p18 fluorescence and consequent reduction in co-localization ( Fig. 5d ) .

33654169

➶

reach

IKKe also phosphorylates and inactivates the tumor suppressor CYLD, preventing CYLD from deubiquitinating specific substrates in the NF-kB signaling pathway.

23333767

CYLD affects IKK_complex

| 2 27

CYLD inhibits IKK_complex.

| 2 26

CYLD inhibits IKK_complex. 10 / 29

| 2 26

➶

reach

Cyld -deficient mice have been generated by different groups, and these mice display a myriad of phenotypes that overall support the conclusion that CYLD inhibits IKK and NF-kappaB and contributes, at[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

19217402

➶

reach

28499869

➶

reach

These observations suggest that suppression of CYLD enhances the activity of the IKK kinase and the nuclear localization of NF-kappaB transcription factors.

20832754

➶

reach

Notch is capable of enhancing NF-kappaB activity by a Hes1 dependent mechanism (Hes1 mediated suppression of Cyld, a deubiquitinase that negatively regulates the IKK complex) 53 and Hes1 independent mechanisms (NICD induced expression of NF-kappaB, NICD enhanced IKKalpha activity, or NICD mediated NF-kappaB nuclear retention) XREF_BIBR - XREF_BIBR.

25048699

➶

reach

The effect of CYLD was not specific to RIG-I, as CYLD also deubiquitinated and inhibited the signaling activities of TBK1 and IKKɛ.

25023063

➶

sparser

CYLD inhibits IKK by cleaving K63-linked polyubiquitin chains on TRAF2, TRAF6 and NEMO xref , xref Interestingly, in patients with the cylindromas (a type of tumor), a mutation in the DUB domains of CYLD has been reported, suggesting its role of tumorgenesis xref .

23743222

➶

reach

We further demonstrate that CYLD also negatively regulates IkappaB kinase, although this function of CYLD is seen in a receptor dependent manner.

15496400

➶

reach

CYLD inhibits Tax stimulated activation of IKK but not that of Tak1.

21824392

➶

sparser

These include the deubiquitination enzymes CYLD and A20 that inhibit IKK, and the ubiquitin binding proteins NEMO and TAB2 which are the regulatory subunits of IKK and TAK1 kinase complexes, respectively.

22435549

➶

reach

Conversely, loss of the K63 specific deubiquitinase CYLD causes spontaneous activation of IKK and JNK as well as their upstream kinase Tak1.

26260210

CYLD activates IKK_complex.

| 1

CYLD activates IKK_complex. 1 / 2

| 1

➶

reach

CYLD deficiency causes spontaneous IKK and NF-kappaB activation, associated with aberrant T cell activation and development of intestinal inflammation.

33436547

CYLD affects cell death

| 3 24

CYLD activates cell death.

| 3 18

CYLD activates cell death. 10 / 24

| 3 18

➶

reach

Genetic manipulation of Cyld in combination with pharmacological modulation of autophagic functional status revealed that CYLD suppressed autolysosomal degradation and promoted cell death in cardiomyocytes.

32553594

➶

reach

21 Previously, it was reported that CYLD promotes induction of cell death by TNF-alpha.

22297296

➶

reach

XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR In cell death assays, overexpression of CYLD significantly enhanced induction of cell death stimulated by TNF-alpha, but this effect was abolished in CLIPR-59 knock-down cells (XREF_FIG).

22297296

➶

reach

Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death.

34887354

➶

eidos

32553594

➶

reach

We showed that CYLD dependent RIPK1 and RIPK3 necrosome formation occurred in neuronal cells exposed to ferroptosis activators and knockdown of the necroptosis-mediators CYLD, RIPK1 or RIPK3 attenuated cell death.

| PMC

➶

reach

CYLD Limits Gene Activation and Enhances Cell Death in Response to TNF.

26670046

➶

eidos

CYLD can limit TNF-induced prosurvival signaling and promote cell death [ 76 ] [ 77 ] [ 78 ] .

33432113

➶

eidos

CYLD can limit TNF-induced prosurvival signaling and promote cell death [ 76-78 ] .

33432113

➶

reach

In control non targeting siRNA transfected cells, the treatment with TNFalpha induced at least 60-70% cell death, which is blocked by knockdown of cyld and tnfr1 but not by that of rip1 (XREF_FIG).

19109899

CYLD inhibits cell death.

| 6

CYLD inhibits cell death. 5 / 6

| 5

➶

reach

Consistent with the data above, silencing CYLD largely abolished caspase 8 activation and necroptotic cell death induced by 5z-7 plus TNFalpha (XREF_FIG).

27685625

➶

reach

Ablation of the RIP1 deubiquitinase CYLD largely blocked apoptotic and necroptotic cell death induced by TAK1 inhibition.

27685625

➶

reach

SMAC mimetics can similarly disrupt CYLD phosphorylation and lead to ATLL cell death through reduction of RIPK1 ubiquitination, which is CYLD dependent.

32024820

➶

reach

Our studies reveal that under physiological conditions, TNF- and RIPK1-dependent cell death is suppressed by the linear ubiquitin-dependent inhibition of CYLD.

34887354

➶

reach

However, prolonged ATRA treatment reduced CYLD SUMOylation and promoted cell death instead.

26973854

Modified mutated CYLD inhibits cell death. 1 / 1

| 1

➶

reach

Overexpression of non SUMOylatable mutant CYLD in neuroblastoma cells reduced retinoic acid induced NF-kappaB activation and differentiation of cells, but instead promoted cell death.

24909169

NFkappaB affects CYLD

| 2 27

NFkappaB activates CYLD.

| 1 18

NFkappaB activates CYLD. 10 / 20

| 1 18

➶

reach

The NF-kappaB activation in CYLD deficient thymocytes is independent of CARMA1, because the NF-kappaB activation was also detected in CYLD and CARMA1 double knock-out thymocytes.

20233721

➶

reach

9 These data suggest that CYLD controls inflammation through TRAF signaling and NF-kappaB p65 and p50 activation or cellular proliferation through Bcl-3 activation and NF-kappaB p50 and p52 binding.Re[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

18245814

➶

reach

On the other hand, activated NF-kappaB stimulates transcriptional upregulation of CYLD to antagonize TRAF6 by promoting its K63 linked deubiquitination, presenting a negative feedback loop of NF-kappaB activation [XREF_BIBR].

24961988

➶

reach

Of the 128 screened siRNA pools, 15 matched these criteria including those targeting the known negative regulators of NF-kappaB signalling CYLD and A20.

22212761

➶

reach

As such, RIPK1 deubiquitination is mediated by a range of multiple deubiquitinating enzymes (DUBs) such as A20 and cylindromatosis (CYLD), which are upregulated by NF-kappaB at excessive intracellular concentrations of TNF-alpha [XREF_BIBR, XREF_BIBR].

29052145

➶

reach

On the other hand, mice that express overactive NF-kappaB or lack the negative regulator of NF-kappaB signaling CYLD, develop NKT cells but fail to mature and populate the lymphoid organs and peripheral tissues.

29312339

➶

reach

Supporting evidence for NF-kappaB- dependent upregulation of CYLD was provided by genomic sequence analysis that revealed NF-kappaB binding sites within the CYLD promoter region [37].

20347313

➶

reach

NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB : evidence for a novel inducible autoregulatory feedback pathway.

15226292

➶

sparser

This results in inhibition of NF-κB activation and loss of CYLD is shown to inhibit apoptosis (Trompouki et al., xref ; Figure xref ).

29479529

➶

reach

These data suggest that activation of Notch signaling in myeloid cells aggravates I/R injury, by enhancing the inflammation response by NF-kappaB through down regulation of CYLD.

27680285

NFkappaB inhibits CYLD.

| 1 3

NFkappaB inhibits CYLD. 4 / 5

| 1 3

➶

reach

This is also illustrated by the more than 100-fold increase of CFU in both NF-kappaB inhibited WT and Cyld -/- BMDM as compared to a < 10-fold increase in macrophages with ERK1/2 inhibition.

26834734

➶

sparser

These findings suggested that, by upregulating the expression of miR-130b and consequently inhibiting CYLD, NF-κB sustained its persistent activation and stimulated the progression of bladder cancer.

27391066

➶

reach

If NFkappaB upregulates miR-19, relative to CYLD, this pathway ultimately allows for the sustained activation of NFkappaB in T-ALL through the miR-19 mediated inhibition of CYLD [XREF_BIBR].

29137387

➶

reach

Similar to A20, the UCH-type deubiquitylating enzyme CYLD limits NF-kappaB activation by deubiquitylation.

26732666

NFkappaB increases the amount of CYLD.

| 3

NFkappaB increases the amount of CYLD. 3 / 3

| 3

➶

reach

Whether CYLD expression can be induced by NF-kappaB specifically following DNA damage as a means of feedback inhibition remains to be determined.

22435563

➶

reach

To determine the role of CYLD in NF-kappaB signaling of cholesteatoma, CYLD and NF-kappaB expression levels in middle ear cholesteatoma epithelium were examined by immunohistochemical analysis to determine protein level and localization and compared to those of normal retroauricular (RA) skin.

20414373

➶

reach

For instance, the transcription of CYLD is induced by activation of the NF-kappaB and MKK3/6-p 38 pathways Post-translational covalent modifications.

19489724

NFkappaB decreases the amount of CYLD.

| 3

NFkappaB decreases the amount of CYLD. 3 / 3

| 3

➶

reach

However, a recent report showed that the loss of CYLD in keratinocytes of mice did not affect transcription induced by the classical p65-p50 NF-kappaB dimers but had clear effects on Bcl-3-linked p50- or p52 dependent gene regulation [XREF_BIBR].

20414373

➶

reach

Thus, the present study revealed that, in bladder cancer, NF-kappaB can maintain its activity by establishing a feedback loop, in which NF-kappaB induced the expression of miR-130b, which consequently inhibited the expression of CYLD, which in turn was an endogenous inhibitor of NF-kappaB activation.

27391066

➶

reach

Interestingly, the reduced NF-kappaB activation in CYLD expressing macrophages limited the protective effect of IFN-gamma by reducing NF-kappaB-dependent signal transducers and activators of transcription-1 (STAT1) activation.

26834734

CYLD affects AKT

| 13

CYLD inhibits AKT.

| 9

CYLD inhibits AKT. 9 / 23

| 9

➶

reach

Overexpression of CYLD, a DUB for K63 linked ubiquitination of AKT, decreases AKT activity mediated by TRAF6 [XREF_BIBR].

25734985

➶

reach

Thus, we next explored the possibility that CYLD may inhibit Akt mediated fibrotic response via deubiquitinating TRAF6.

22491319

➶

reach

To further determine how CYLD negatively regulates Akt, we first examined whether CYLD physically interacts with Akt by performing co-immunoprecipitation experiments.

22491319

➶

reach

Furthermore, the results indicated that CRAL mainly resided in the cytoplasm and could sponge endogenous miR-505 to upregulate cylindromatosis (CYLD) expression, which further suppressed AKT activation and led to an increase in the sensitivity of gastric cancer cells to cisplatin in vitro and in preclinical models.

31885317

➶

reach

These results suggest that CYLD suppresses Akt activation to inhibit prostate cancer cells growth and development.

23300340

➶

reach

Nonetheless, these data demonstrate that CYLD indeed inhibits Akt mediated fibrotic response by at least in part directly interacting with and deubiquitinating Akt.

22491319

➶

reach

It is possible that CYLD may inhibit Akt mediated fibrotic response by actually deubiquitinating TRAF6.

22491319

➶

reach

As shown in XREF_SUPPLEMENTARY, CYLD knockdown, using siCYLD, still enhanced TGF-beta-induced fibrotic response in TRAF6 depleted cells, thereby suggesting that CYLD inhibits Akt mediated fibrotic response at least in part by directly interacting with and deubiquitinating Akt.

22491319

➶

reach

Taken together, these data provide strong evidence that CYLD negatively regulates Akt by directly interacting with and deubiquitinating K63 polyubiquitinated Akt, both in vitro in a cell-free system and in vivo under endogenous condition.

22491319

CYLD activates AKT.

| 4

CYLD activates AKT. 4 / 6

| 4

➶

reach

Lim and co-workers showed that CYLD suppresses TGF-beta signalling and prevents lung fibrosis by (indirectly) reducing the stability of Smad3, in an AKT, GSK3beta and E3 ligase carboxy terminus of Hsc[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

27155333

➶

reach

To determine whether CYLD inhibits cell proliferation and survival by suppressing activation of Akt, we performed cell proliferation and apoptosis assays on control and CYLD-knockdown prostate cancer cells treated with or without the PI3K inhibitors LY294002 or wortmannin.

23300340

➶

reach

CYLD decreases Smad3 stability by inhibiting Akt.

22491319

➶

reach

Together, these data suggest that CYLD decreases Smad3 stability and TGF-beta-signalling by inhibiting Akt.

22491319

CYLD affects TNF

| 18

CYLD activates TNF.

| 9

CYLD activates TNF. 9 / 13

| 9

➶

reach

CYLD Limits Gene Activation and Enhances Cell Death in Response to TNF.

26670046

➶

reach

Hence, the deubiquitinase function of CYLD is required to promote TNF induced programmed necrosis.

24098568

➶

reach

CYLD Promotes TNF-

27738385

➶

reach

CYLD induction mediated, at least in part, the TZD mediated downregulation of tumor necrosis factor alpha (TNFalpha)-induced interleukin 8 (IL-8).

27865894

➶

reach

In addition, CD11c-Cre Cyld (ex7/8 fl/fl) DCs produced more TNF, IL-10, and IL-12 upon infection, which led to enhanced stimulation of IFN-gamma-producing NK cells.

25675948

➶

reach

RNAi mediated silencing of CYLD attenuates ROS production and TNF induced programmed necrosis [XREF_BIBR].

24098568

➶

reach

Moreover, overexpression of CYLD increased TNF-alpha induced cell apoptosis in A549 cells.

27738385

➶

reach

CYLD deficient cells are protected from RIPK1 mediated necroptosis in response to TNF plus caspase inhibition with or without Smac mimetic.

25459879

➶

reach

Consistent with a role in programmed necrosis, CYLD promotes the assembly of the RIP1-FADD-caspase 8 complex in response to TNF, IAP antagonist, and zVAD-fmk treatment [XREF_BIBR].

20346680

CYLD inhibits TNF.

| 4

CYLD inhibits TNF. 4 / 10

| 4

➶

reach

OPTN is required for CYLD dependent deubiquitination of RIP and also for CYLD dependent inhibition of TNFalpha induced by NF-kappaB activity.

29951055

➶

reach

The tumor suppressor cylindromatosis (CYLD) inhibits the NF-kappaB pathway by deubiquinating the IKKgamma subunit, as well as TNF receptor associated factor (TRAF) 2, TRAF6, and B-Cell CLL and Lymphoma 3 (BCL3) that are required for maintaining NF-kB activity.

27422962

➶

reach

CYLD can limit TNF induced prosurvival signaling and promote cell death [XREF_BIBR - XREF_BIBR].

33432113

➶

reach

Concomitant Loss of OTULIN and CYLD Interaction with HOIP Increases M1Ubiquitination at the TNF-RSC and Enhances TNF Induced Gene Activation.

26670046

CYLD increases the amount of TNF.

| 5

CYLD increases the amount of TNF. 5 / 5

| 5

➶

reach

Adenoviral knockdown of Cyld inhibited basal and the tumor necrosis factor alpha (TNFalpha)-induced mRNA expression of pro inflammatory cytokines including monocyte chemotactic protein-1 (Mcp-1), intercellular adhesion molecule (Icam-1) and interleukin-6 (Il-6) in rat adult aortic SMCs (RASMCs).

22406061

➶

reach

22406061

➶

reach

Knockdown of CYLD rescued the expression of TNF-alpha and IL-1beta at both the mRNA and protein levels in RBP-J cKO BMDMs (XREF_FIG).

27680285

➶

reach

22406061

➶

reach

22406061

CYLD affects SMAD3

| 22

CYLD inhibits SMAD3.

| 15

CYLD inhibits SMAD3. 10 / 21

| 15

➶

reach

We thus determined whether GSK3beta is involved in mediating CYLD induced Smad3 degradation.

22491319

➶

reach

Because Akt is known as the major upstream regulator of GSK3beta XREF_BIBR XREF_BIBR, we investigated whether Akt mediates CYLD induced degradation of Smad3.

22491319

➶

reach

Nonetheless, these data suggest that CYLD decreases Smad3 protein stability via negatively regulating Akt.

22491319

➶

reach

These data suggest that CYLD decreases Smad3 stability in a DUB activity dependent manner.

22491319

➶

reach

This interesting result thus led us to determine whether Akt is critically involved in mediating CYLD induced degradation of Smad3 by first examining the effect of Akt knockdown on Smad3 protein stability.

22491319

➶

reach

Interestingly, CYLD decreases Smad3 stability by directly deubiquitinating K63 polyubiquitinated Akt.

22491319

➶

reach

CYLD decreases Smad3 stability via Akt-GSK3beta-CHIP pathway.

22491319

➶

reach

CYLD decreases Smad3 stability by inhibiting Akt.

22491319

➶

reach

On the basis that carboxy terminus of CHIP has been shown to mediate Smad3 degradation XREF_BIBR XREF_BIBR, we first determined whether CHIP mediates CYLD induced Smad3 degradation by using siCHIP.

22491319

➶

reach

Moreover, CYLD decreases Smad3 stability by deubiquitinating K63 polyubiquitinated Akt.

22491319

CYLD activates SMAD3.

| 5

CYLD activates SMAD3. 5 / 5

| 5

➶

reach

To further determine whether CYLD inhibits TGF-beta-signalling by likely targeting Smad3, we next evaluated the effect of CYLD knockdown in Smad3 deficient MEF cells.

22491319

➶

reach

27155333

➶

reach

This study proposes that CYLD inhibits TGFbeta signalling by decreasing the stability of SMAD3 via the AKT-GSK3-CHIP pathway.

25007997

➶

reach

CYLD inhibited transforming growth factor-beta-signalling and prevented lung fibrosis by decreasing the stability of Smad3 in an E3 ligase carboxy terminus of Hsc70 interacting protein dependent manner.

| 19

CYLD inhibits JNK. 10 / 19

| 19

➶

reach

Expression of a non cleavable form of CYLD inhibited activation of the JNK pathway and expression of AP-1 target genes in a T-cell line, although CYLD silencing only minimally increased JNK activation [XREF_BIBR], possibly because of redundancy with other deubiquitinating enzymes.

26507244

➶

reach

CYLD, a tumor suppressor and a target gene of NF-κB, negatively regulates NF-κB and JNK activation by removing K63-linked polyubiquitin chains from TRAF2 and TRAF6 as well as several other signaling proteins [214,215].

23758787

➶

reach

The loss of CYLD in both primary T cells and the Jurkat T cell line causes the constitutive activation of Tak1 as well as its downstream targets JNK and IKK.

17548520

➶

reach

On the contrary, CYLD WT overexpression leads to a diminished JNK activation both in non stimulated and in TNF-alpha-stimulated A-CYLD WT cells (XREF_FIG).

21900959

➶

reach

Recent evidence demonstrates that CYLD negatively regulates the c-Jun N-terminal kinase (JNK) signaling pathway, a critical mediator of cell survival.

20347313

➶

reach

Conversely, loss of the K63 specific deubiquitinase CYLD causes spontaneous activation of IKK and JNK as well as their upstream kinase Tak1.

26260210

➶

reach

CYLD negatively regulates the activation of IKK and JNK, and its expression is markedly upregulated under conditions of RANKL induced osteoclastogenesis [XREF_BIBR].

22216904

➶

reach

C-Jun N-terminal kinase (JNK) signaling pathway activated by TNF alpha, anti-CD40 antibody, IL-1 beta, and lipopolysaccharide is repressed by CYLD by reducing the activity of MKK7 and JNKK2, which is [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

17851586

➶

reach

The tumor suppressor CYLD antagonizes NF-kappaB and JNK signaling by disassembly of Lys63 linked ubiquitin chains synthesized in response to cytokine stimulation.

18313383

➶

reach

Depending on the cellular context CYLD has been shown to negatively regulate NF-kappaB and/or JNK signalling pathways resulting in suppression of cell proliferation and survival.

19893491

CYLD activates JNK.

| 1 6

CYLD activates JNK. 7 / 7

| 1 6

➶

reach

2 The inhibition of CYLD function in keratinocytes enhances the activation of the JNK pathway.

21900959

➶

sparser

In agreement with the reported negative regulation of JNK and c-Myc activation by CYLD [ xref ], WB analysis of these molecules showed increased Akt, JNK and c-Myc activation (measured as levels of P-Akt, P-JNK and P-c-Myc respectively) in the skin of transgenic mice lacking the DUB function ( xref ).

30631004

➶

reach

In agreement with the reported negative regulation of JNK and c-Myc activation by CYLD [XREF_BIBR], WB analysis of these molecules showed increased Akt, JNK and c-Myc activation (measured as levels of P-Akt, P-JNK and P-c-Myc respectively) in the skin of transgenic mice lacking the DUB function (XREF_FIG).

30631004

➶

reach

Moreover, we found that CYLD m not only increased JNK activity but also increased K63 ubiqutination on both c-Jun and c-Fos, and ultimately potentiated AP1 transcriptional activity.

21478324

➶

reach

Curiously, in CD3+ CD28 stimulated Jurkat T cells, MALT1 cleaves CYLD increasing activation of JNK, but not NF-kappaB [XREF_BIBR].

23474202

➶

reach

In support of this view, MALT1 proteolysis of the inhibitory deubiquitinases A20 and CYLD potentiates NF-kappaB and JNK, respectively [XREF_BIBR, XREF_BIBR], while cleavage of the RNase Regnase-1 prolongs mRNA stability of T cell effector genes [XREF_BIBR].

25965667

➶

reach

CYLD Inhibits Tumorigenesis and Metastasis by Blocking JNK and AP1 Signaling at Multiple Levels.

21478324

CYLD affects TRAF6

1 | 1 2 14

CYLD inhibits TRAF6.

1 | 1 2 7

CYLD inhibits TRAF6. 10 / 18

1 | 1 2 7

➶

reach

22491319

➶

sparser

The ubiquitin-editing enzyme CYLD inhibits TRAF6 and -7 and TLR2 [ xref ].

24009023

➶

reach

As we described here for YOD1, CYLD is acting on TRAF6 and p62 complexes, but - in contrast to YOD1 - CYLD is not preventing the formation of TRAF6 and p62 aggregates, but is recruited to TRAF6 by p62.

28244869

➶

sparser

TRAF6 are inhibited by A20, CYLD and OTUB2 that specially remove TRAF6 K63‐linked ubiquitination.

28744851

➶

eidos

TRAF6 are inhibited by A20 , CYLD and OTUB2 that specially remove TRAF6 K63-linked ubiquitination .

28744851

➶

reach

Similarly, de-ubiquitinating enzyme cylindromatosis (CYLD) inhibits NF-kappaB signaling via de-ubiquitination and inactivation of TNFR associated factor 2 (TRAF2) and TRAF6 [XREF_BIBR, XREF_BIBR]; de-ubiquitinating protease A20 inhibits NF-kappaB activation induced by Toll like receptor 4 (TLR4) via removing K63 linked polyubiquitin chains of TRAF6 [XREF_BIBR].

27164085

➶

signor

The nf-kappab activation by cyld is mediated, at least in part, by the deubiquitination and inactivation of tnfr-associated factor 2 (traf2) and, to a lesser extent, traf6.

12917689

➶

reach

Thus, it is possible that CYLD functions in diverse pathways and loss of CYLD activity contributes to tumorigenesis via multiple mechanisms.Lys63-linked ubiquitin chains, synthesized in response to cy[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

18313383

➶

reach

TRAF6 are inhibited by A20, CYLD and OTUB2 that specially remove TRAF6 K63‐linked ubiquitination.

28744851

➶

reach

Further, the de-ubiquitinase CYLD has been shown to inactivate TRAF6 downstream of RANK in osteoclasts, as evidenced by removal of polyubiquitin chains, and the physiologic relevance of this mechanism is supported by the phenotype of CYLD deficient osteoclasts, which exhibit hyper-responsiveness to RANK.

26085208

CYLD activates TRAF6.

| 7

CYLD activates TRAF6. 7 / 7

| 7

➶

reach

CYLD has been shown to target TRAF6, TRAF2, and NEMO for deubiquitination, thus presumably reduced their activities in NF-kappaB activation.

22649774

➶

reach

40 RANKL stimulated osteoclastogenesis potently induces the expression of CYLD, and the accumulated CYLD targets TRAF6 by interacting with the adaptor protein, p62.

19373246

➶

reach

More importantly, we showed that TRAF-6-mediated over-expression of PAI-1 was inhibited by co-expression of wt-CYLD in S. p -infected A549 cells, suggesting that CYLD may target TRAF-6 in inhibiting P[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

26056944

➶

reach

It has been shown that the tumor suppressor CYLD targets TRAF6 for deubiquitination to terminate TLR triggered activation of NF-kappaB XREF_BIBR XREF_BIBR.

27586056

➶

reach

The deubiquitinating enzymes A20 and CYLD inhibit NF-kappaB signaling by targeting TRAF6 upstream of IKK, while a recent report shows that CUEDC2 inhibits IKK activity by recruiting a phosphatase PP1 and keeps IKK in an inactivated status.

21703539

➶

reach

It has been demonstrated that the deubiquitinating enzymes A20 and CYLD inhibit NF-kappaB signaling by targeting TRAF6 upstream of IKK, while the deubiquitinating protein DUBA inhibits type I interferon activity by targeting TRAF3.

20434986

➶

reach

18313383

CYLD affects ERK

| 2 18

CYLD inhibits ERK.

| 1 13

CYLD inhibits ERK. 10 / 19

| 1 13

➶

reach

CYLD Impairs Production of Cytokines, ROS, and NO and Reduces Activation of NF-kappaB, ERK1/2, and p38MAPK in Lm Infected BMDM.

26834734

➶

reach

As shown in XREF_FIG, CYLD WT inhibited ERK phosphorylation, while CYLD knockdown, via siCYLD, markedly enhanced ERK activation by NTHi (XREF_FIG).

25389768

➶

reach

However, it remains unknown if CYLD also suppresses ERK activation induced by bacterial pathogens.

25389768

➶

reach

Here we provide clear evidence that CYLD inhibits NTHi induced activation of ERK (XREF_FIG), and we also demonstrate that CYLD controls IL-8 expression via specifically targeting ERK phosphorylation by activating the ERK pathway with a constitutively active form of MEK (XREF_FIG).

25389768

➶

reach

Future studies will focus on using DUB activity deficient CYLD mutant constructs to determine whether DUB activity is essential for the CYLD mediated suppression of ERK signaling pathway induced by bacterial pathogens.

25389768

➶

reach

Taken together, the CYLD suppression of ERK dependent IL-8 via MKP-1 may bring novel insights into the tight regulation of inflammatory responses and also lead to innovative therapeutic strategies for controlling these responses by targeting key negative regulators of inflammation.

25389768

➶

reach

We next sought to determine how CYLD negatively regulates the ERK signaling pathway in order to mediate NTHi induced IL-8 expression.

25389768

➶

reach

We thus asked whether CYLD inhibited ERK activation.

25389768

➶

reach

In addition, we further investigated the detailed mechanism by which CYLD negatively regulates the ERK signaling pathway in a DUB activity dependent or independent manner.

25389768

➶

reach

CYLD also enhances oxidative stress by inhibiting the activation of the extracellular signal regulated kinase (ERK), p38/AP -1 and c-Myc pathways, ensuring Nrf2 downregulation.

30186311

CYLD activates ERK.

| 1 5

CYLD activates ERK. 6 / 6

| 1 5

➶

reach

57 They reported that in human lung A549 cells and lungs of Cyld -/- mice, CYLD targets the activation of ERK.

28372529

➶

reach

However, because Cyld deficiency did not cause the activation of ERK, the target of CYLD might be an intermediate signaling factor specifically mediating the activation of JNK and IKKbeta.

17548520

➶

reach

Here, we examine both human lung epithelial A549 cells and lung of Cyld -/- mice to show that CYLD specifically targets the activation of ERK.

25389768

➶

reach

The finding that CYLD may target the ERK pathway in negatively controlling IL-8 expression is particularly significant.

25389768

➶

sparser

Autophagy is an intrinsic defense mechanism against Lm and, therefore, we further investigated whether CYLD-dependent RIPK2 and ERK1/2 activation influences the formation of autophagosomes.

26834734

➶

reach

However, it remained largely unknown whether or how CYLD modulated ERK signaling, when induced by bacterial pathogens.

25389768

CYLD affects Neoplasm Invasiveness

| 1 1 20

CYLD inhibits Neoplasm Invasiveness.

| 1 1 14

CYLD inhibits Neoplasm Invasiveness. 10 / 13

| 1 1 10

➶

reach

Histologically, CYLD clearly prevented massive immune cell infiltration surrounding necrotic regions, and pseudopalisades appeared in bevacizumab treated control tumors.

25071012

➶

reach

For example, inhibition of CYLD expression enhanced human malignant melanoma growth and invasion [XREF_BIBR].

29808164

➶

reach

XREF_BIBR Additionally, Sanches et al XREF_BIBR showed that CYLD suppresses cell migration and invasion in cervical cancer, and Suenaga et al XREF_BIBR reported that CYLD downregulates induction of cisplatin resistance in oral squamous cell carcinoma.

33149672

➶

reach

Together, these findings suggest that CYLD restricts infiltration of inflammatory cells and invasion enhanced by increased hypoxia after anti-VEGF therapy in GBM.

25071012

➶

reach

Loss of CYLD stimulates cellular proliferation, migration, and invasion by triggering BCL-3 nucleus translocation and activation of cyclin D1 and N-cadherin [XREF_BIBR].

| PMC

➶

reach

Furthermore, CYLD overexpression inhibited SMAD7 mediated cell invasion, while CYLD depletion increased SMAD7 mediated cell invasion in OSCC cells.

26982322

➶

reach

These clinical findings support a link between the known tumor promoter Snail1 and its transcriptional target CYLD, indicating an important role for Snail1 to suppress CYLD during progression of melanoma and for CYLD to suppress melanoma cell proliferation and invasion.

19124656

➶

reach

Rescue of CYLD expression in melanoma cells reduced proliferation and invasion in vitro and tumor growth and metastasis in vivo.

19124656

➶

reach

Compared with the control group, miR-181 silencing or CYLD overexpression significantly attenuated cell proliferation, invasion and migration, and notably increased the proportion of apoptotic cells.

32901872

➶

eidos

Loss of CYLD stimulates cellular proliferation , migration , and invasion by triggering BCL-3 nucleus translocation and activation of cyclin D1 and N-cadherin [ 99 ] .

| PMC

CYLD inhibits Neoplasm Invasiveness. 4 / 4

| 4

➶

reach

These findings suggest that CYLD inhibits NPC development and provides strong evidence supporting a role for CYLD inhibiting fibroblast and endothelial stromal cell infiltration into NPC via suppressing the NF-kB pathway.

32708712

➶

reach

Additionally, CYLD was able to inhibit fibroblast and endothelial stromal cell infiltration into the NPC tumor microenvironment.

32708712

➶

reach

CYLD Suppresses Fibroblast and Endothelial Cell Infiltration in NPC TME.

32708712

➶

reach

Single Cell Analysis Shows CYLD Suppresses Specific Stromal Cell Infiltration in the TME.

32708712

CYLD activates Neoplasm Invasiveness.

| 6

CYLD activates Neoplasm Invasiveness. 4 / 4

| 4

➶

reach

The TGF-beta gene also activates miR-182, which can affect the CYLD gene, which can further contribute to the activation of NF-kappaB, which was demonstrated in the case of glioblastoma, and subsequently lead to angiogenesis and tumor invasion [XREF_BIBR].

| PMC

➶

reach

These findings suggest that downregulation of CYLD promotes invasion with mesenchymal transition via ALK5 stabilization in OSCC cells.

29235674

➶

reach

Poor CYLD expression enhanced OSCC tumor invasion, suggesting low patient survival rates.

32821162

➶

reach

Furthermore, CYLD overexpression inhibited SMAD7 mediated cell invasion, while CYLD depletion increased SMAD7 mediated cell invasion in OSCC cells.

26982322

CYLD activates Neoplasm Invasiveness. 2 / 2

| 2

➶

reach

Our study is the first to demonstrate CYLD modulates fibroblast and endothelial cell infiltration in the NPC tumor microenvironment in addition to inhibiting tumorigenicity and metastasis.

32708712

➶

reach

In conclusion, the findings that CYLD regulates three cancer hallmarks and mediates stromal cell infiltration in TME in NPC indicate it plays a major tumor-suppressive role in NPC tumorigenesis and metastasis by negatively regulating the NF-kB signaling pathway.

32708712

CYLD affects CXCL8

| 1 22

CYLD decreases the amount of CXCL8.

| 12

CYLD decreases the amount of CXCL8. 10 / 10

| 10

➶

reach

Addition of CYLD siRNA to A20 siRNA further increased the IL-8 mRNA expression suggesting additive effects of CYLD and A20.

28629782

➶

reach

Addition of CYLD siRNA to A20 siRNA further increased the IL-8 mRNA expression in tolerant cells suggesting additive effects of CYLD and A20.

28629782

➶

reach

Together, these data suggest that CYLD negatively regulates IL-8 expression by specifically targeting the ERK signaling pathway.

25389768

➶

reach

CYLD negatively regulates nontypeable Haemophilus influenzae induced IL-8 expression via phosphatase MKP-1-dependent inhibition of ERK.

25389768

➶

reach

Having demonstrated that CYLD suppresses NTHi induced IL-8 expression, we next aimed to investigate the mechanism through which this regulation occurs.

25389768

➶

reach

We next sought to determine whether CYLD inhibits upregulation of IL-8 expression induced by direct activation of ERK using a constitutively active form of MEK (MEK-CA).

25389768

➶

reach

In this study, we demonstrated that CYLD strongly suppressed NTHi induced IL-8 expression in human lung epithelial cells.

25389768

➶

reach

Importantly, we determined that CYLD negatively regulates ERK dependent IL-8 expression specifically by inducing MKP-1 expression.

25389768

➶

reach

Here, we show that CYLD suppresses NTHi induced IL-8 expression by specifically targeting the activation of ERK.

25389768

➶

reach

We further demonstrated that CYLD decreased IL-8 levels via inactivation of the ERK signaling pathway.

25389768

Modified CYLD decreases the amount of CXCL8. 2 / 2

| 2

➶

reach

As shown in XREF_FIG, DUB activity deficient CYLD mutant (CYLD H/N) had no effect on NTHi induced MKP-1 and IL-8 expression, whereas overexpression of CYLD WT enhanced MKP-1 induction and suppressed IL-8 expression.

25389768

➶

reach

Moreover, overexpression of CYLD WT suppressed, whereas CYLD knockdown by siCYLD enhanced, MEK-CA-induced IL-8 expression (XREF_FIG and XREF_SUPPLEMENTARY).

25389768

CYLD inhibits CXCL8.

| 1 6

CYLD inhibits CXCL8. 7 / 7

| 1 6

➶

reach

Additionally, similar result was also observed in human cervical epithelial HeLa cells (XREF_SUPPLEMENTARY), which further suggests the generalizability of inhibition of IL-8 by CYLD.

25389768

➶

reach

As shown in XREF_FIG, IL-8 induction is markedly inhibited by CYLD WT.

25389768

➶

sparser

Additionally, similar result was also observed in human cervical epithelial HeLa cells ( xref ), which further suggests the generalizability of inhibition of IL-8 by CYLD.

25389768

➶

reach

MKP-1 and CYLD can synergistically inhibit production of neutrophil chemoattractant IL-8 from airway epithelial cells.

32477341

➶

reach

1 | 1 10

CYLD inhibits BCL3. 10 / 11

1 | 1 8

➶

reach

Interestingly, the ubiquitin ligase CYLD, which negatively regulates bcl3 nuclear localization, was increased 2.7-fold in the RNA-Seq analysis (XREF_SUPPLEMENTARY).

25873381

➶

reach

CYLD prevents nuclear accumulation of BCL-3 and hence reduces Cyclin D1 expression and proliferation of keratinocytes.

19124656

➶

sparser

CYLD inhibits Bcl3 by antagonizing the K63-linked polyubiquitination of Bcl3 thus preventing its nuclear translocation.

22435550

➶

signor

Cyld binds and deubiquitinates bcl-3in cyld+/+ keratinocytes, tpa or uv light triggers the translocation of cyld from the cytoplasm to the perinuclear region, where cyld binds and deubiquitinates bcl-3, thereby preventing nuclear accumulation of bcl-3 and p50/bcl-3- or p52/bcl-3-dependent proliferation.

16713561

➶

reach

CYLD, but not C/S-CYLD, abrogated BCL-3 binding of IL-10 promoter, confirming the important role of CYLD in the regulation of BCL-3.

19124656

➶

reach

Furthermore, siRNA against Snail1, which up-regulated CYLD expression (XREF_FIG), reduced nuclear BCL-3 levels, confirming that reexpression of CYLD blocks nuclear translocation of BCL-3 in melanoma (XREF_FIG).

19124656

➶

reach

Here, decreasing CYLD levels activated BCL3 accumulation followed by its import into the nucleus, probably mediated by an interaction between the polyubiquitin chains of BCL-3 and importins.

26652480

➶

reach

It was observed in malignant melanoma that loss of CYLD also induces nuclear accumulation of BCL-3 and NF-kappaB activation, with the consequence of induced N-cadherin (migration) and cyclin D1 (proliferation) activity.

29344161

➶

reach

CYLD negatively regulates BCL3, preventing nuclear entry where it forms a dimer with p50 and p52, resulting in transcription of genes involved in proliferation including cyclin D1.

21552290

➶

reach

CYLD inhibits Bcl3 by antagonizing the K63 linked polyubiquitination of Bcl3 thus preventing its nuclear translocation.

22435550

CYLD inhibits ubiquitinated BCL3. 1 / 1

| 1

➶

| 14

CYLD activates necroptotic process. 10 / 14

| 14

➶

reach

CYLD is required for TLR3 or TLR4 receptor induced necroptosis.

26491219

➶

reach

The deubiquitinase CYLD has been identified to be involved in TLR induced necroptosis in macrophages from wild derived MOLF mice.

25714887

➶

reach

CYLD deficient cells are protected from RIPK1 mediated necroptosis in response to TNF plus caspase inhibition with or without Smac mimetic.

25459879

➶

reach

We found that inhibition of cyld expression in Jurkat cells also attenuated necroptosis (XREF_FIG).

19109899

➶

reach

Active caspase 8 in Complex IIa not only initiates the caspase cascade and the apoptotic program, but also cleaves and inactivates essential necroptosis mediators such as RIPK1, RIPK3 and CYLD.

25493335

➶

reach

10 Active Caspase-8 not only initiates the apoptotic program but also cleaves and inactivates essential necroptosis mediators such as RIPK1, RIPK3 and CYLD.

27560715

➶

reach

Knockdown of the RNA sensing molecule RIG-I or the RIP1 deubiquitin protein, CYLD, but not STING, rescued cells from SeV induced necroptosis.

28060376

➶

reach

As a consequence of inhibiting RIPK1 ubiquitylation, the requirement of CYLD to initiate necroptosis was greatly reduced, and therefore, we moved to an MLKL dependent model (data not shown).

31564612

➶

reach

Specifically, CYLD removed lysine 63 and linear ubiquitin chains from RIP1 and promoted necroptosis in TNF receptor signaling, which was involved in the regulation of different cellular processes including inflammation, fibrosis, and cancer.

27738385

➶

reach

However, loss of CYLD in vivo was shown to delay, but not prevent necroptosis during skin inflammation [XREF_BIBR].

29229989

CYLD inhibits necroptotic process.

| 6

CYLD inhibits necroptotic process. 6 / 6

| 6

➶

reach

Recently, CYLD was shown to negatively regulate necroptosis induced by oxygen-glucose-deprivation (OGD) in primary cortical neurons.

29163038

➶

reach

The inhibition of cIAP and activation of CYLD could also promote necroptosis XREF_BIBR, XREF_BIBR.

23835476

➶

reach

Furthermore, KIAA1191 high expression suppressed the proliferation and migration of MM cells; upregulated the expression of RIP1, RIP3, and CYLD, and restored the TNF-α/z-VAD-induced necroptosis.

34989828

➶

reach

Caspase-8 also targets the deubquitinase CYLD preventing RIPK1 initiation of necroptosis [XREF_BIBR, XREF_BIBR].

27710879

➶

reach

In apoptotic signaling, caspase-8 may cleave de-ubiquitinase CYLD, RIP1 and RIP3, blocking initiation of necroptosis.

22658960

➶

reach

Thus, in the case of KP35 infection, induction of necroptosis is not due to increased CYLD, but rather the previously observed inhibition of necroptosis by CYLD was not detected.

28125817

MALT1 affects CYLD

| 3 12

MALT1 inhibits CYLD.

| 3 6

MALT1 inhibits CYLD. 9 / 10

| 3 6

➶

sparser

Human paracaspase MALT1 is central to plasticity of lymphocytes as MALT1 proteolytic inactivation of CYLD ensures sustained activation of NFκB as well as RIG1 for providing innate immune response ( Be[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

25500259

➶

reach

T-cell receptor induced JNK activation requires proteolytic inactivation of CYLD by MALT1.

21448133

➶

reach

CYLD but Not RelB Nor Regnase-1 Is Reduced by MALT1 Activity in Macrophages.

29018444

➶

reach

In summary, our study demonstrates for the first time that (i) MALT1 modulates TLR7 agonist- and IAV induced MMP-9 response in alveolar macrophages; (ii) MALT1 mediates CYLD reduction in macrophages upon TLR7 stimulation; (iii) MMP-9 production in alveolar macrophages is through NF-kappaB but not AP-1; and that (iv) MALT1 deficiency results in reduced IAV induced disease severity.

29018444

➶

reach

Human paracaspase MALT1 is central to plasticity of lymphocytes as MALT1 proteolytic inactivation of CYLD ensures sustained activation of NFkappaB as well as RIG1 for providing innate immune response [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

25500259

➶

reach

Inhibition of MALT1 activity by z-VRPR-fmk reversed CYLD degradation slightly but the difference did not reach statistical significance.

29018444

➶

sparser

Here, we show that T-cell receptors (TCR) activation, as well as overexpression of the oncogenic API2-MALT1 fusion protein, results in proteolytic inactivation of CYLD by MALT1, which is specifically required for c-jun N-terminal kinase (JNK) activation and the inducible expression of a subset of genes.

21448133

➶

reach

21448133

➶

sparser

MALT1 proteolytically cleaves and inactivates A20 as well as CYLD, two negative regulators of NF-κB signaling ( xref , xref ).

22224767

MALT1 activates CYLD.

| 5

MALT1 activates CYLD. 5 / 6

| 5

➶

reach

At the same time, MALT1 could function as a protease activity upon TCR and CD28 co-stimulation to inactivate negative regulators of NF-kappaB signaling such as the A20 (also known as TNFAIP3), CYLD (cylindromatosis), RNase Regnase-1 as well as RelB and HOIL1 [XREF_BIBR - XREF_BIBR].

27105502

➶

reach

The requirement for MALT1 mediated CYLD cleavage for intact JNK signaling downstream of the TCR has been previously described XREF_BIBR.

23335970

➶

reach

JNK activation has been connected to MALT1 catalysed CYLD cleavage XREF_BIBR.

27068814

➶

reach

In addition, MALT1 promotes lymphocyte activation by cleaving A20 and CYLD, deubiquitinating enzymes that have inhibitory roles in the NF-kappaB and JNK pathway, respectively XREF_BIBR, XREF_BIBR, and by cleavage of BCL10, which promotes lymphocyte adhesion XREF_BIBR.

23977204

➶

reach

To further confirm that MALT1 protease mediated the cleavage of MCPIP1 in macrophages, we used siRNA to knockdown MALT1 expression in macrophages, confirming that MALT1 promoted MCPIP1, but not A20, CYLD, BCL10 or RelB, degradation.

29263935

MALT1 decreases the amount of CYLD.

| 1

MALT1 decreases the amount of CYLD. 1 / 4

| 1

➶

reach

Our results indicate that MALT1 activation by either imiquimod or IAV reduces the levels of CYLD and that imiquimod induced reduction is MALT1 activity dependent.

29018444

SNAI1 affects CYLD

| 13

SNAI1 decreases the amount of CYLD.

| 7

SNAI1 decreases the amount of CYLD. 6 / 8

| 6

➶

reach

Snail can inhibit CYLD expression in melanoma [XREF_BIBR].

23644884

➶

reach

CYLD expression is downregulated by the transcriptional repressor Snail in both basal cell carcinoma and melanoma.

22435550

➶

reach

Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma.

19124656

➶

reach

Snail also promotes proliferation in a melanoma model by repressing expression of CYLD, a tumor suppressor gene that functions as a deubiquitination enzyme.

23761168

➶

reach

Reduced CYLD expression in basal cell carcinoma was mediated by GLI1 dependent activation of the transcriptional repressor Snail.

21577203

➶

reach

However, CYLD mRNA transcription is directly inhibited by Snail [XREF_BIBR] and the Notch target Hes1 [XREF_BIBR], both of which are up-regulated and activated under hypoxic conditions [XREF_BIBR, XREF_BIBR].

reach

Now, Massoumi et al. show that Snail also promotes tumor cell division by shutting off the tumor suppressor CYLD.

| PMC

CYLD affects necrotic cell death

| 17

CYLD activates necrotic cell death.

| 15

CYLD activates necrotic cell death. 10 / 16

| 15

➶

reach

They inhibit programmed necrosis by cleavage and inactivation of essential necrosis mediators including RIP1, RIP3 and CYLD [XREF_BIBR - XREF_BIBR].

24059293

➶

reach

Overexpression of CYLD Enhances TNF-alpha-Induced Cell Necrosis of Lung Cancer Cells.

27738385

➶

reach

In addition, knockdown of CYLD, a deubiquitinase of RIP1, blocked TNF-alpha-induced necrosis of HT-22 cells.

25093162

➶

reach

Hence, CYLD was thought to promote necrosis by de-ubiquitination of RIP1 at the TNFR-1 membrane complex.

24098568

➶

reach

In addition, Patrick et al. found that CYLD’s deubiquitase catalytic activity was necessary for the necrosis of colonic epithelial cells and the occurrence of colitis in FADD mice (135).

| PMC

➶

reach

Inhibition of CYLD expression inhibits TNF-alpha-induced Jurkat cell program necrosis, indicating that CYLD is a critical regulator of procedural necrosis.

30034339

➶

reach

When Caspase 8 activity was inhibited, L929 cells died by necrosis, which was blocked by knockdown of either CYLD or RIPK3 (XREF_SUPPLEMENTARY).

22037414

➶

reach

In support of caspase 8 's role in necrosis, cleavage resistant mutants of RIP1, RIP3 and CYLD promote necrosis without an obligate need to inhibit caspases.

24766891

➶

reach

All of the data revealed that overexpression of CYLD promoted cell necrosis in lung cancer cells.

27738385

➶

reach

22 Therefore, we propose that CYLD protein levels decrease to evade the necrosis elicited by sustained high CYLD levels.

24577083

CYLD inhibits necrotic cell death.

| 2

CYLD inhibits necrotic cell death. 2 / 2

| 2

➶

reach

Interestingly, CYLD protein levels decreased in late-phase apoptosis, despite consistently upregulated mRNA levels (XREF_FIG), likely due to CYLD cleavage by caspase-8 to prevent necrosis.

24577083

➶

reach

22 Therefore, we propose that CYLD protein levels decrease to evade the necrosis elicited by sustained high CYLD levels.

24577083

CYLD affects TBK1

| 2 15

CYLD activates TBK1.

| 2 8

CYLD activates TBK1. 10 / 10

| 2 8

➶

reach

Together, these results suggest that CYLD targets TBK1 or its downstream molecules to negatively regulate antiviral response.

24493797

➶

sparser

CYLD deficiency causes constitutive activation of TBK1 and IKKε in DCs, and the CYLD-deficient DCs and MEFs are hyper-responsive to VSV in IFNβ induction xref .

27012466

➶

reach

As expected, expression of CYLD resulted in reduction of the ubiquitination levels of overexpressed TBK1, further indicating that CYLD activity targeted TBK1 (XREF_FIG).

25923723

➶

reach

Although this phenotype may involve ubiquitin dependent activation of RIG-I, CYLD also directly targets TBK1 and IKKepsilon to inhibit their ubiquitination 79.

27012466

➶

reach

Genetic deficiency in the DUB CYLD causes constitutive activation of TBK1 and IKKepsilon in DCs, rendering the cells hyperresponsive to VSV induced type I IFN expression XREF_BIBR, XREF_BIBR.

27012466

➶

reach

MIB1/2, Nrdp1, CYLD, A20-TAX1BP1-ABIN1 complex and RNF11-TAX1BP1 complex modulate K63-linked ubquitination of TBK1.

23395611

➶

sparser

Because CYLD deficiency causes constitutive activation of IKKε and TBK1, this DUB has been suggested to play an essential role in preventing the aberrant activation of these kinases during the induction of type1 interferon that occurs during viral infection ( xref ).

19489724

➶

reach

CYLD deficiency causes constitutive activation of TBK1 and IKKepsilon in DCs, and the CYLD deficient DCs and MEFs are hyper-responsive to VSV in IFNbeta induction 80.

27012466

➶

reach

CYLD deficiency causes constitutive activation of IKKepsilon and TBK1, which is associated with hyper-induction of IFNs in virus infected cells.

18467330

➶

reach

Because CYLD deficiency causes constitutive activation of IKKepsilon and TBK1, this DUB has been suggested to play an essential role in preventing the aberrant activation of these kinases during the induction of type1 interferon that occurs during viral infection.

19489724

CYLD inhibits TBK1.

| 7

CYLD inhibits TBK1. 7 / 7

| 7

➶

reach

Our previous studies as well as others have demonstrated that A20, TAX1BP1, ABIN1 and CYLD inhibit TBK1 and IKKi by antagonizing their Lys63 linked polyubiquitation XREF_BIBR, XREF_BIBR, XREF_BIBR.

23308279

➶

reach

CYLD also negatively regulates the IKK related kinases, IKKepsilon and TBK1, by the same mechanisms.

19489724

➶

reach

Since we have previously shown that Optn accumulates in the nucleus during the G2/M transition [XREF_BIBR], we speculated that this Optn relocation could prevent Optn and CYLD mediated inhibition of TBK1 activity.

25923723

➶

reach

The effect of CYLD was not specific to RIG-I, as CYLD also deubiquitinated and inhibited the signaling activities of TBK1 and IKKɛ.

25023063

➶

reach

The effect of CYLD was not specific to RIG-I, as CYLD also deubiquitinated and inhibited the signaling activities of TBK1 and IKKepsilon.

25023063

➶

reach

TBK1 signaling was active in these tumors as measured by elevated pCYLD and pTBK1 levels, and, in consonance with our findings in vitro, CYT387 treatment blocked CYLD phosphorylation and paradoxically increased pTBK1 (XREF_FIG).

24444711

➶

reach

The effect of CYLD was not specific to RIG-I, as CYLD also deubiquitinated and inhibited the signaling activities of TBK1 and IKKe.

25023063

CYLD affects Cell Survival

| 2 12

CYLD inhibits Cell Survival.

| 2 5

CYLD inhibits Cell Survival. 7 / 10

| 2 5

➶

sparser

Overexpressed CYLD also significantly inhibited cell viability.

18245814

➶

reach

In T cell acute lymphoblastic leukemia (T-ALL), CYLD expression is repressed by the Notch and Hes1 pathway to promote persistent IKK activation and cell survival [XREF_BIBR].

21119682

➶

sparser

The results indicated that cell viability of Huh-7 and HepG2 cells was inhibited by EAC and EACG (Figures xref ).

30072899

➶

reach

In various tumor types, CYLD loss can lead to cell survival or cell proliferation.

20347313

➶

reach

Loss of CYLD in different types of tumors leads to either cell survival or proliferation.

21573132

➶

reach

Reduced expression of CYLD promotes cell survival and inflammation in gefitinib treated NSCLC PC-9 cells : targeting CYLD may be beneficial for acquired resistance to gefitinib therapy.

32441799

➶

reach

Furthermore, cell viability assessed by MTS assay was also suppressed by overexpressed CYLD (20% inhibition; P < 0.05, compared with control), but not by catalytically inactive CYLD.

18245814

CYLD activates Cell Survival.

| 7

CYLD activates Cell Survival. 7 / 7

| 7

➶

reach

We focused on investigation of the mechanism by which CYLD promotes cell survival in Mel-CV and ME1007 cells.

32252875

➶

reach

CYLD is among the most frequently mutated genes in multiple myeloma and likely contributes to the persistent NF-kappaB activation and enhanced cell survival in these tumors.

22435550

➶

reach

Downregulation of CYLD promoted cell survival and migratory activities through NF-kappaB activation, whereas CYLD overexpression inhibited those activities in MDA-MB-231 cells.

24398777

➶

reach

The decrease in cell viability caused by CYLD knockdown was due to induction of apoptosis, as it was associated with activation of the caspase cascade and was abolished by treatment with a general caspase inhibitor.

32252875

➶

reach

Strikingly, while CYLD silencing decreased cell viability as measured using CellTiter-Glo assays in Mel-CV and ME1007 cells, it resulted in a moderate yet statistically significant increase in cell viability in ME4405 cells and had no effect on the viability of Mel-FH cells (XREF_FIG).

32252875

➶

reach

miR-19a is a member of the miR-17-92 cluster and has been shown to be overexpressed in T-cell acute lymphoblastic leukemia and multiple myeloma where it was revealed that miR-19a negatively regulates the expression of CYLD and SOCS-1 respectively to promote cell survival and pathogenesis [XREF_BIBR, XREF_BIBR].

25886994

➶

reach

CYLD deficiency promotes cancer cell proliferation, cell survival and tumorigenesis.

23300340

CYLD affects cell differentiation

| 13

CYLD activates cell differentiation.

| 10

CYLD activates cell differentiation. 10 / 12

| 10

➶

reach

In addition, CYLD modulates dendritic growth and postsynaptic differentiation in mouse hippocampal neurons [XREF_BIBR].

33318303

➶

reach

Increased CYLD expression enhances the differentiation of keratinocytes in human skin equivalents.

21900959

➶

reach

Importantly, we have discovered that CYLD WT also promotes the differentiation of A431 tumoral keratinocytes through inhibition of JNK activation.

21900959

➶

reach

The decreased JNK pathway activation in the H-CYLD WT cells appears as a plausible mechanism for CYLD induction of keratinocytes differentiation.

21900959

➶

reach

We show that CYLD overexpression increases keratinocyte differentiation while CYLD loss of function impairs epidermal differentiation.

21900959

➶

reach

Furthermore, depletion of beta-TRCP induced CYLD accumulation and TRAF6 deubiquitination in osteoclast precursor cells, leading to suppression of RANKL induced osteoclast differentiation.

24961988

➶

reach

As a result, we have found that forced expression of wild-type CYLD (CYLD WT) both in HaCaT keratinocytes and in the skin equivalents enhances keratinocyte differentiation, while the inhibition of CYLD function by expression of a catalytically inactive form of CYLD impairs epidermal differentiation.

21900959

➶

reach

In addition to the skin appendages changes, the K5-CYLD C/S mice show epidermal alterations, mainly impaired keratinocyte differentiation, thus confirming in vivo the results that our group have previously described using a model of skin equivalents of human HaCaT keratinocytes [XREF_BIBR], in which we demonstrated that the overexpression of the wild-type CYLD (CYLD wt) promoted keratinocyte differentiation, whereas the expression of the mutant CYLD C/S prevented, through the activation of the JNK pathway, the epidermal differentiation [XREF_BIBR].

30631004

➶

reach

The diminished function of CYLD impairs the differentiation of keratinocytes in human HaCaT skin equivalents.

| 2 14

CYLD inhibits DDX58.

| 10

CYLD inhibits DDX58. 7 / 8

| 7

➶

reach

Conversely, the removal of Lys63 linked ubiquitylation by the cellular deubiquitylating enzymes (DUBs) ubiquitin C-terminal hydrolase 3 (USP3), USP21 and CYLD, represses RIG-I signalling.

27174148

➶

reach

XREF_BIBR, XREF_BIBR Conversely, CYLD, a tumor suppressor gene expressed in cylindromatosis, negatively regulates RIG-I activation by deubiquitinating the K63 linked ubiquitin chains on RIG-I.

33462384

➶

reach

The tumor suppressor CYLD (cylindromatosis), another OTU de-ubiquitinating enzyme that removes Lys 63 linked polyubiquitin chains, was also recently shown to negatively regulate RIG-I.

19615405

➶

reach

USP3, USP21 and CYLD inhibit RIG-I K63-linked ubiquitination and activation.

28744851

➶

reach

For example, the 3C protein of enterovirus 71 (EV71), a member of the Picornaviridae family that causes hand, foot and mouth disease, and occasionally severe central nervous system diseases, downregulates the host microRNA miR-526a to increase the expression of the cellular DUB enzyme CYLD, thus inhibiting the activation of RIG-I 74.

27174148

➶

reach

Conversely, the removal of Lys63-linked ubiquitylation by the cellular deubiquitylating enzymes (DUBs) ubiquitin C-terminal hydrolase 3 (USP3), USP21 and CYLD, represses RIG-I signalling (reviewed in REF.

27174148

➶

reach

Another ubiquitin ligase RNF135 (also known as Riplet) is similarly involved in the positive regulation of RIG-I signaling, while RNF125 and the deubiquitinase CYLD are known to negatively regulate RIG-I signaling.

24931123

CYLD bound to DDX58 inhibits DDX58. 2 / 2

| 2

➶

reach

CYLD binds to RIG1 and thereby inhibits ubiquitylation and signalling functions of RIG1.

28959952

➶

reach

CYLD binds to RIG-I and inhibits the ubiquitination and signaling function of RIG-I XREF_BIBR, XREF_BIBR.

27012466

CYLD inhibits ubiquitinated DDX58. 1 / 1

| 1

➶

reach

Loss of CYLD in DCs causes accumulation of ubiquitinated RIG-I.

32215003

CYLD activates DDX58.

| 2 3

CYLD activates DDX58. 5 / 5

| 2 3

➶

reach

Ubiquitylation events are reversible processes, and, accordingly, several deubiquitylating enzymes, in particular ubiquitin specific peptidase 3 (USP3), USP21 and CYLD lysine 63 deubiquitinase (CYLD), modulate RIG-I signalling by removing K63-polyubiquitin chains, although with unique kinetics.

31792373

➶

eidos

The effect of CYLD was not specific to RIG-I , as CYLD also deubiquitinated and inhibited the signaling activities of TBK1 and IKKepsilon .

25023063

➶

eidos

Ubiquitylation events are reversible processes , and , accordingly , severaldeubiquitylating enzymes , in particular ubiquitin specific peptidase 3 ( USP3 ) , USP21 and CYLD lysine 63 deubiquitinase ( CYLD ) , modulate RIG-I signalling by removing K63-polyubiquitin chains , although with unique kinetics ( reviewed elsewhere112 ,118 ) .

31792373

➶

reach

The data indicate that CYLD targets RIG-I as well as TBK1 for deubiquitination that leads to inactivation of the signaling.

18703349

➶

reach

miR-526a downregulates the expression of the deubiquitylating enzyme CYLD, which ultimately promotes RIG-I K63 linked ubiquitylation and interferon responses 152.

31792373

CYLD increases the amount of DDX58.

| 1

CYLD increases the amount of DDX58. 1 / 1

| 1

➶

reach

CYLD silencing resulted in an increase of poly IC induced RIG-I and MDA5 protein levels and increased CCL5 and CXCL10 mRNA and protein expression, but unexpectedly decreased mRNA expressions of RIG-I and MDA5.

29166644

SPATA2 affects CYLD

| 3 7

SPATA2 activates CYLD.

| 3 6

SPATA2 activates CYLD. 9 / 13

| 3 6

➶

reach

SPATA2 promotes CYLD activity and regulates TNF induced NF-kappaB signaling and cell death.

27458237

➶

sparser

Finally, the finding that SPATA2 activates CYLD adds SPATA2 to the growing list of allosteric DUB activators.

27591049

➶

sparser

The location of the SPATA2 binding site at the back of the palm domain suggests that SPATA2 activates CYLD in a distinct manner.

27591049

➶

reach

To directly address if SPATA2 mediates the ability of CYLD to regulate baseline NF-kappaB activity, we ectopically expressed CYLD in WT, CYLD KO, and SPATA2 KO cells.

27591049

➶

reach

The location of the SPATA2 binding site at the back of the palm domain suggests that SPATA2 activates CYLD in a distinct manner.

27591049

➶

sparser

SPATA2 Activates CYLD.

27591049

➶

reach

Finally, the finding that SPATA2 activates CYLD adds SPATA2 to the growing list of allosteric DUB activators.

27591049

➶

reach

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.

27591049

➶

reach

SPATA2 Activates CYLD.

27591049

SPATA2 inhibits CYLD.

| 1

SPATA2 inhibits CYLD. 1 / 3

| 1

➶

reach

The fact that KO of SPATA2 already prevents association of CYLD with the TNFR1 (XREF_FIG D) indicates that SPATA2L can not simply substitute for SPATA2, at least in the cellular systems tested.

27591049

CYLD affects (-)-noscapine

| 16

CYLD activates (-)-noscapine.

| 15

CYLD activates (-)-noscapine. 10 / 15

| 15

➶

reach

Flow cytometry and immunofluorescence microscopy reveal that CYLD increases the ability of noscapine to induce mitotic arrest and apoptosis.

25897332

➶

reach

CYLD enhances the effect of noscapine on microtubule polymerization.

25897332

➶

reach

Based on the data presented in this work, we propose the following model for how CYLD promotes noscapine activity in leukemia cells.

25897332

➶

reach

Thus, we examined whether CYLD modulates the ability of noscapine to cause mitotic arrest.

25897332

➶

reach

In addition, flow cytometric analysis of DNA content showed that CYLD and its C/S mutant, but not its DeltaCG1 mutant, promoted the ability of noscapine to induce the accumulation of G2/M cells.

25897332

➶

reach

To understand how CYLD modulates noscapine activity in leukemia cells, we transfected cells with GFP, GFP-CYLD, GFP-CYLD-DeltaCG1, in which the extreme N-terminal CAP-Gly domain of CYLD was deleted, or GFP-CYLD-C/S, in which cysteine 601 was mutated to serine to disrupt the deubiquitinase activity of CYLD.

25897332

➶

reach

We found that CYLD, but not its DeltaCG1 mutant, significantly promoted the effect of noscapine on microtubule assembly in vitro.

25897332

➶

reach

It is possible that CYLD may also exert on these pathways to stimulate noscapine activity.

25897332

➶

reach

CYLD enhances noscapine activity to induce mitotic arrest and apoptosis in a microtubule dependent manner.

25897332

➶

reach

Here we demonstrate that cylindromatosis (CYLD), a microtubule associated tumor suppressor protein, modulates the activity of noscapine both in cell lines and in primary cells of acute lymphoblastic leukemia (ALL).

25897332

CYLD inhibits (-)-noscapine.

| 1

CYLD inhibits (-)-noscapine. 1 / 1

| 1

➶

reach

CYLD siRNAs inhibit the ability of noscapine to induce mitotic arrest and apoptosis in leukemia cell lines.

25897332

E6 affects CYLD

| 16

E6 activates CYLD.

| 9

E6 activates CYLD. 9 / 9

| 9

➶

reach

For example, the E6 protein of human papillomavirus (HPV) targets CYLD for ubiquitination and proteasomal degradation, leading to persistent NF-kappaB activation by hypoxia in HPV infected cancer cells 130.

21135871

➶

reach

Under hypoxic conditions, the HPV encoded E6 protein inactivates the CYLD tumor suppressor, a negative regulator of the NF-kappaB pathway and thereby allows for unrestricted activation of NF-kappaB.

18977328

➶

reach

Interestingly, there is a precedent for E6 influencing signaling pathways involving K63 branching : HPV E6 targets the lysine 63 specific Deubiquitinase CYLD (a negative regulator of the NF-kB pathway), thereby causing prolongation of hypoxia induced NF-kB activation.

19587541

➶

reach

Therefore, E6 targeting of CYLD appears to be an essential step in HPV mediated tumorigenesis.

21119682

➶

reach

One study demonstrated that Cyld is targeted for degradation by HPV (human papillomavirus) E6 virus, to prolong NF-kappaB activation following hypoxia [XREF_BIBR].

24993778

➶

reach

Under hypoxic conditions, high-risk E6 also inactivates the CYLD tumor suppressor through interactions with CYLD deubiquitinase to allow unrestricted activation of NF-kappaB XREF_BIBR.

21152115

➶

reach

9 In cancers related to human papillomavirus (HPV), such as cervical cancer, CYLD is targeted by HPV E6 protein for degradation.

26370355

➶

reach

For these studies, we studied the state of CYLD ubiquitination in SiHa and HeLa cells that were treated with E6 specific siRNA or control siRNA.

18977328

➶

reach

Based on these results, we concluded that E6 targets CYLD for proteasome mediated degradation.

18977328

E6 inhibits CYLD.

| 4

E6 inhibits CYLD. 4 / 4

| 4

➶

reach

In preclinical models, under hypoxic conditions, the HPV encoded E6 protein promotes inactivation and degradation of the CYLD tumor suppressor, resulting in prolonged activation of NF-kappaB pathway [XREF_BIBR].

26933818

➶

reach

As HPV16 E6 inactivates CYLD XREF_BIBR and because defective CYLD causes enhanced nuclear import of BCL-3, we reasoned that HPV16 E6 may induce KIAA1199 expression through BCL-3 in transformed keratinocytes.

25366117

➶

reach

It is also plausible that post-translational hydroxylation may take place on a protein involved in formation of a protein complex that includes E6 and CYLD, whereby hydroxylation impairs complex formation and, by extension, the ability of E6 to target CYLD for ubiquitination.

18977328

➶

reach

Importantly, degradation of CYLD by E6 was prevented by treatment of cells with the proteasome inhibitor, MG132 (XREF_FIG).

18977328

E6 decreases the amount of CYLD.

| 3

E6 decreases the amount of CYLD. 3 / 3

| 3

➶

reach

Transient transfection studies involving E6 and Flag tagged CYLD constructs in HEK293 cells demonstrated that CYLD expression was reduced by E6 in a dose dependent manner (XREF_FIG).

18977328

➶

reach

E6 reduces CYLD expression through a proteasome dependent mechanism.

18977328

➶

reach

Thus, in ambient oxygen tension, E6 gene silencing in HPV positive cells led to NF-kappaB and IKKbeta activation and increased CYLD expression, whereas ectopic expression of E6 in HPV negative cells resulted in NF-kappaB activation and CYLD degradation.

18977328

CYLD affects Interferon

| 1 14

CYLD inhibits Interferon.

| 1 7

CYLD inhibits Interferon. 8 / 9

| 1 7

➶

eidos

However , as viral infection goes on , CYLD accumulates and cleaves the K63-linked ubiquitin chains of RIG-I , inhibiting virus-triggered type I IFN signaling .

32215003

➶

reach

Ectopic expression of CYLD antagonizes the IFN response whereas siRNA-mediated knockdown of CYLD expression allows for a more robust IFN response.

22312431

➶

reach

For example, CYLD removes polyubiquitin chains from TBK1 and RIG-I and thus inhibits the IRF3 signaling pathway and IFN production triggered by RIG-I; conversely, CYLD knockdown enhances this response (58).

34707613

➶

reach

Several DUBs were shown to have an inhibitory effect on the RIG-I signalling pathway (Fig XREF_FIG), as for example knockdown of CYLD enhanced type-I IFN production in response to SeV infection whereas ectopic CYLD expression inhibited it XREF_BIBR.

24375678

➶

reach

Since CYLD negatively regulates IFN induction, XREF_BIBR, XREF_BIBR we examined whether the loss of CYLD renders mice more resistant to viral infection.

21946435

➶

reach

Ectopic expression of CYLD inhibits the IRF3 signalling pathway and IFN production triggered by RIG-I; conversely, CYLD knockdown enhances the response.

18636086

➶

reach

The deubiquitinating enzyme CYLD cleaves K63 linked polyubiquitin chains from specific substrates, including tumor necrosis factor receptor associated factors (TRAF)-2, TRAF6, transforming growth factor beta activated kinase 1 (TAK1), B cell lymphoma 3 (BCL3), STAT3, nuclear factor kappa B essential modulator (NEMO), and retinoic acid inducible gene 1 (RIG-1), and negatively regulates the activation of NF-kappaB, MAPKs, and type I IFN production.

26834734

➶

reach

Strikingly, the CYLD and TRAF3 genetic alterations affected mutually exclusive HPV+ HNSCC tumor groups, suggesting that alterations in either TRAF3 or CYLD may function independently and sufficiently to deregulate the downstream NF-kappaB and IFN responses.

28295216

CYLD activates Interferon.

| 7

CYLD activates Interferon. 5 / 5

| 5

➶

reach

Release of the CYLD mediated inhibition of TBK1 during this phase results in enhanced IFN and ISG signaling pathway, independently of viral infection.

25923723

➶

reach

For example, the DUB enzyme cylindromatosis (CYLD) was shown to directly bind RIG-I and mediate the removal of K63-ub and limit IFN induction [XREF_BIBR].

21949557

➶

reach

It was initially believed that CYLD inhibited IFN signaling by deubiquitinating the PRR, RIG-1, and downstream kinases TANK binding kinase 1 (TBK-1) and inhibitor of NF-kappaB kinase Epsilon (IKKEpsilon) 44; but, surprisingly, IFN response to vesicular stomatitis virus in CYLD knockout mice or cells from these mice was abrogated.45 On the basis of these reports, TRAF3 and CYLD may serve similar functions after viral infection, namely, to inhibit NF-kappaB and activate IFN.

28295222

➶

reach

For example, the DUB enzyme cylindromatosis (CYLD) was shown to directly bind RIG-I and mediate the removal of K63-ub and limit IFN induction [45].

21949557

➶

reach

Based on these reports, TRAF3 and CYLD may serve similar functions after viral infection, namely to inhibit NF-kappaB and activate IFN.

28295222

CYLD bound to DDX58 activates Interferon. 1 / 1

| 1

➶

reach

CYLD physically interacts with both RIG-I and MAVS and preferentially inhibits the ubiquitination of RIG-I [XREF_BIBR] along with TBK1 and IKKepsilon, upregulating several IFN stimulating genes.

33138315

CYLD bound to MAVS activates Interferon. 1 / 1

| 1

➶

reach

CYLD physically interacts with both RIG-I and MAVS and preferentially inhibits the ubiquitination of RIG-I [XREF_BIBR] along with TBK1 and IKKepsilon, upregulating several IFN stimulating genes.

33138315

CYLD affects Ubiquitin

| 13

CYLD inhibits Ubiquitin.

| 9

CYLD inhibits Ubiquitin. 9 / 11

| 9

➶

reach

We further show that CYLD negatively regulates a ubiquitin dependent NF-kappaB activator, RIP1.

17981138

➶

reach

This suppression of CYLD promoted ubiquitin conjugation of NF-kappaB signaling pathway components and induction of an aggressive phenotype of glioma cells both in vitro and in vivo.

23006329

➶

reach

Consistent with the notion that NF-kappaB signalling could be turned off through negative feedback mechanism involving CYLD mediated ubiquitin (Ub) deconjugation [XREF_BIBR], the CYLD depletion compromised and CYLD overexpression potentiated cell apoptosis are separately overrided by NF-kappaB inhibitor BAY 11-7085 and IkappaBalpha siRNA.

29050336

➶

reach

Mechanistically, CYLD removes lysine-63-linked ubiquitin chains from TRAF2, TRAF6, and NEMO, whereas lysine-48-linked ubiquitin chains are not degraded by CYLD.

14676304

➶

reach

18313383

➶

reach

CYLD was shown to negatively regulate NF-kappaB and MAPK activation by removing ubiquitin chains from key signalling molecules including NEMO, TRAF2, TRAF6 and RIPK1.

27561390

➶

reach

CYLD and TNFAIP3 and A20 negatively regulate the NFkappaB pathway by removing ubiquitin chains from multiple signaling molecules including TRAFs and RIP.

19615732

➶

reach

XREF_BIBR Suppression of CYLD by miR-182 promoted ubiquitin conjugation of NFkappaB signaling components and led to sustained NFkappaB activation.

26273328

➶

reach

Deubiquitinating enzyme CYLD negatively regulates the ubiquitin dependent kinase Tak1 and prevents abnormal T cell responses.

17548520

CYLD activates Ubiquitin.

| 4

CYLD activates Ubiquitin. 4 / 4

| 4

➶

reach

18313383

➶

reach

MiR-182 can suppress cylindromatosis (CYLD), a deubiquitinase that mediates ubiquitin deconjugation and acts as an inhibitor of nuclear factor kappaB (NF-kappaB) activation, leading to overactivation of NF-kappaB signaling.

24202447

➶

reach

Both CYLD and TRAF2 phosphorylation thus increase ubiquitin-dependent NF-κB signaling.

23333767

➶

reach

Thus, CYLD mediated removal of ubiquitin chains, including of linear chains, from components of the TNF-RSC results in diminished TNF induced gene activation and, at the same time, enhanced cell death.

26670046

CYLD affects HDAC6

| 4 9

CYLD inhibits HDAC6. 10 / 14

| 4 9

➶

sparser

Moreover, CYLD is also able to inhibit HDAC6, a member of the HDAC family whose major substrate is α-tubulin, has become a target for drug development to treat cancer due to its major contribution in oncogenic cell transformation xref .

22911729

➶

reach

CYLD mediated HDAC6 inhibition was observed to enhance its association with the MTs, reduce the rate of cytokinesis, and delay cell cycle (XREF_FIG).

21076528

➶

reach

CYLD also inhibits HDAC6, leading to increased acetylated tubulin and less cellular motility, as we saw before [XREF_BIBR].

23644884

➶

reach

Moreover, CYLD is also able to inhibit HDAC6, a member of the HDAC family whose major substrate is alpha-tubulin, has become a target for drug development to treat cancer due to its major contribution in oncogenic cell transformation XREF_BIBR.

22911729

➶

sparser

CYLD interacts with p62 directly and CYLD can directly inactivate HDAC6, thereby controlling autophagy [ xref ].

25342597

➶

reach

In addition, CYLD inactivates HDAC6, which modulates cilia length [XREF_BIBR].

28900014

➶

reach

We further found by immunofluorescence microscopy a colocalization of CYLD and HDAC6 at the centrosome and basal body and, interestingly, loss of Cyld promoted the localization of HDAC6 at the centrosome and basal body.

27028867

➶

sparser

In addition, CYLD inactivates HDAC6, which modulates cilia length [ xref ].

28900014

➶

reach

CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin.

19893491

➶

reach

Taken together, these findings suggest that CYLD, TSA, and tubacin act within the same pathway to inhibit HDAC6, which results in elevated levels of acetylated alpha-tubulin.

19893491

CYLD affects Neoplasm Metastasis

| 1 12

CYLD inhibits Neoplasm Metastasis.

| 1 7

CYLD inhibits Neoplasm Metastasis. 7 / 8

| 1 6

➶

reach

CYLD inhibits proliferation and metastasis of melanoma cells in vivo.

19124656

➶

reach

Functional assays revealed CYLD inhibits NPC cell proliferation and migration in vitro and suppresses NPC tumorigenicity and metastasis in vivo by negatively regulating the NF-kB signaling pathway.

32708712

➶

reach

In summary, these data show that reduced CYLD expression induces tumorigenicity of melanoma, and that reexpression of CYLD reduces their tumor growth and metastasis in vivo.

19124656

➶

reach

CYLD Inhibits Tumorigenesis and Metastasis by Blocking JNK and AP1 Signaling at Multiple Levels.

21478324

➶

reach

Based on our results, loss of CYLD positively affects the formation of lymph vessels in melanoma and enhances metastasis, supporting the important role of CYLD especially in the early process of melanoma progression.

31591386

➶

reach

This mechanism plays an important role for the growth of melanoma cells because stable expression of CYLD in melanoma cells reduced tumor growth and metastasis in vivo in a xenograft model.

19124656

➶

eidos

Functional assays revealed CYLD inhibits NPC cell proliferation and migration in vitro and suppresses NPC tumorigenicity and metastasis in vivo by negatively regulating the NF-kB signaling pathway .

32708712

Modified CYLD inhibits Neoplasm Metastasis. 1 / 1

| 1

➶

reach

Re-expression of CYLD in melanoma cells with constitutively high Snail1 levels inhibited N-cadherin expression, leading to a reduced migratory and invasive potential in vitro and less pulmonary metastasis in a murine in vivo model.

19124656

CYLD activates Neoplasm Metastasis.

| 5

CYLD activates Neoplasm Metastasis. 5 / 5

| 5

➶

reach

It has been recently suggested that CYLD down-regulation could increase breast cancer metastasis through NFkappaB activation.

25605410

➶

reach

Hayashi et al. have found that CYLD downregulation promoted breast cancer metastasis via NF-kappaB activation, including RANKL signaling [XREF_BIBR].

27738385

➶

reach

Moreover, CYLD has also been reported to promote melanoma tumorigenesis and metastasis through suppression of JNK and activating protein 1 (AP-1), leading to decreased expression of cyclin D1 and N-cadherin XREF_BIBR.

32252875

➶

reach

In conclusion, PCDH-gamma-A12 and SLC19A1 promoters, but not CREB and CYLD promoters, are hypermethylated and contribute to the occurrence and metastasis of colorectal cancer.

29805555

➶

reach

CYLD downregulation may promote breast cancer metastasis via NF-kappaB activation, including RANKL signaling.

24398777

PDE4B affects CYLD

| 12

PDE4B inhibits CYLD.

| 4

PDE4B inhibits CYLD. 4 / 6

| 4

➶

reach

For example, inhibiting PDE4B in an HMEEC cell line caused an upregulation of CYLD and a concomitant reduction in inflammation [XREF_BIBR].

25342597

➶

reach

Moreover, PDE4B negatively regulates CYLD via selective activation of JNK2 but not JNK1.

23575688

➶

reach

PDE4B downregulates CYLD via activation of JNK2 pathway.

23575688

➶

reach

Moreover, PDE4B negatively regulates CYLD via specific activation of JNK2 but not JNK1.

23575688

PDE4B decreases the amount of CYLD.

| 6

PDE4B decreases the amount of CYLD. 6 / 6

| 6

➶

reach

In the present study, we identified PDE4B as a key negative regulator for CYLD via selective activation of c-jun N-terminal kinase 2 (JNK2), but not JNK1, and inhibition of PDE4B significantly enhanced NTHi induced CYLD expression and suppressed inflammation.

23575688

➶

reach

Taken together, it is evident that PDE4B negatively regulates CYLD expression and mediates NTHi induced inflammation via specific activation of JNK2 but not JNK1 pathway.

23575688

➶

reach

In the present study, we showed that inhibition of PDE4B markedly enhanced upregulation of CYLD expression by the bacterial pathogen NTHi, thereby suggesting that PDE4B acts as a negative regulator for CYLD.

23575688

➶

reach

Inhibition of PDE4B markedly increased the expression of CYLD and subsequently suppressed bacteria induced inflammation in well established models of both lung and middle ear inflammation.

23575688

➶

reach

As shown in XREF_FIG, PDE4B knockdown selectively inhibited activation of JNK2 but not JNK1, thereby confirming that PDE4B negatively regulates NTHi induced CYLD expression and mediates inflammation via specific activation of JNK2 but not JNK1.

| 11

CYLD decreases the amount of SERPINE1. 10 / 10

| 10

➶

reach

Together, these results indicate that TRAF-6 mediates S.p-induced PAI-1 expression, and CYLD inhibits PAI-1 expression probably through deubiquitinating TRAF-6.

26056944

➶

reach

CYLD was suggested to interfere with the NFAT signalling pathway by deubiquitylating transforming growth factor-β-activated kinase 1 (TAK1), and to negatively regulate KK3-p38 kinase-dependent expression of plasminogen activator inhibitor-1 [39], [40].

18817868

➶

reach

Pneumolysin (a virulence factor produced by S pneumonia) induces CYLD expression, which inhibits the expression of plasminogen activator inhibitor-1 (PAI-1) in the lung, they report, and CYLD deficiency protects mice against pneumolysin induced lung injury.

| PMC

➶

reach

The authors showed that CYLD inhibited S. p -induced PAI-1 expression in lung, thereby potentiating pulmonary damages [18].

26056944

➶

reach

In this study, we provided evidence to show that CYLD inhibits PAI-1 expression probably through directly interacting with and deubiquitinating TRAF-6.

26056944

➶

reach

In this issue of Immunity, Lim et al. (2007) demonstrate that CYLD, a deubiquinating enzyme, represses the expression of plasminogen activator inhibitor-1, which is critical in preventing tissue damage.

17723213

➶

reach

Results from the same study using the CYLD knockout cells have showed that CYLD negatively regulates PAI-1 expression via inhibition of MKK3-p38 MAPK signaling pathway [18].

26056944

➶

reach

Cylindromatosis (CYLD) inhibits Streptococcus pneumonia induced plasminogen activator inhibitor-1 expression via interacting with TRAF-6.

26056944

➶

reach

Our evidences here demonstrated that CYLD inhibited S. p -stimulated PAI-1 expression.

26056944

➶

reach

Based on these information, we propose that CYLD associates, deubiquinites and in-activates TRAF-6, thus inhibiting subsequent PAI-1 expression.

26056944

Modified CYLD decreases the amount of SERPINE1. 1 / 1

| 1

➶

reach

Over-expression of wt-CYLD dramatically inhibited PAI-1 mRNA expression in A549 cells with S. p infection.

26056944

CYLD inhibits SERPINE1.

| 1 1

CYLD inhibits SERPINE1. 2 / 2

| 1 1

➶

reach

Since PAI-1 inhibits plasminogen production and fibrinolysis, the indirect inhibition of PAI-1 by CYLD in combination with reduced lung hemorrhage and increased PAI-1 production of Cyld -/- mice indicate that CYLD caused augmented fibrinolysis.

23825949

➶

sparser

Since PAI-1 inhibits plasminogen production and fibrinolysis, the indirect inhibition of PAI-1 by CYLD in combination with reduced lung hemorrhage and increased PAI-1 production of Cyld −/− mice indicate that CYLD caused augmented fibrinolysis.

23825949

CYLD activates SERPINE1.

| 1

CYLD activates SERPINE1. 1 / 1

| 1

➶

reach

Interestingly, CYLD deficiency in the Cyld deficient mouse results in excessive production of PAI-1, thus providing efficient protection against lethality XREF_BIBR.

22491319

CYLD affects Cyclin

| 13

CYLD decreases the amount of Cyclin.

| 5

CYLD decreases the amount of Cyclin. 3 / 3

| 3

➶

reach

Indeed, CYLD is upregulated in injured carotid arteries of rats, reduces cyclin D1 levels, and is capable of suppressing vascular lesion formation.

25342597

➶

reach

19124656

➶

reach

Also supporting this line of evidence is the finding that the tumor suppressor CYLD blocks cyclin D1 expression by inhibiting Bcl-3 signaling [XREF_BIBR].

20731879

Modified CYLD decreases the amount of Cyclin. 2 / 2

| 2

➶

reach

10,73 CYLD expression is repressed by the transcription factor SNAI1 in melanoma, resulting in increased cyclin D1 expression.

26370355

➶

reach

CYLD overexpression also inhibited expression of cyclin D1 and activation of the E2F pathway through deubiquitination of the upstream molecule Bcl-3 and inhibition of its translocation into the nucleus.

18245814

CYLD inhibits Cyclin.

| 5

CYLD inhibits Cyclin. 3 / 3

| 3

➶

reach

These findings indicate that Bcl-3 is required for the inhibitory effect of Cyld on TPA- and UV induced cyclin D1 activation and proliferation.To test whether the retention of Bcl-3 is dependent on th[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

16713561

➶

reach

Moreover, regulation of JNK/AP -1 activation also plays a role in CYLD mediated suppression of cyclin D1 expression XREF_BIBR.

32252875

➶

reach

A potential area may be the downregulation of Cyclins by CYLD.

25342597

Modified CYLD inhibits Cyclin. 1 / 1

| 1

➶

reach

These results suggest that BCL-3-induced cyclin D1 and N-cadherin expression is blocked by the expression of CYLD.

19124656

Mutated CYLD inhibits Cyclin. 1 / 1

| 1

➶

reach

16713561

CYLD activates Cyclin.

| 2

CYLD activates Cyclin. 2 / 2

| 2

➶

reach

In agreement, down-regulation of CYLD in asSnail clones 1 and 2 resulted in up-regulation of Cyclin D1 and N-cadherin (XREF_FIG).

19124656

➶

reach

Importantly, TPA or UV-B failed to activate the Mut-CD1 promoter in Cyld +/+ as well as Cyld -/- keratinocytes, indicating that Cyld modulates TPA- or UV-B-mediated cyclin D1 promoter activation in an[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

16713561

CYLD increases the amount of Cyclin.

| 1

CYLD increases the amount of Cyclin. 1 / 1

| 1

➶

reach

To examine whether Cyld increases cyclin D1 expression in keratinocytes through activation of NF-kappaB, we compared the activity of wild-type and NF-kappaB binding deficient cyclin D1 (Mut-CD1) promo[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

16713561

MYB affects CYLD

| 1 11

MYB activates CYLD.

| 9

MYB activates CYLD. 9 / 9

| 9

➶

reach

Notably, we also show that MYB drives the proliferation of CYLD defective cylindroma cells.

26969893

➶

reach

Our experiment supported that silenced MYB suppressed OTSCC malignancy by inhibiting miR-130a and activating CYLD.

32821162

➶

reach

Overexpression of MYB is known to drive proliferation of CYLD defective cylindroma cells, and molecular heterogeneity in the pathogenesis of sporadic and inherited cutaneous cylindromas appears to converge on MYB activation [XREF_BIBR].

29651355

➶

reach

CYLD defective cylindroma cells were treated with MYB siRNAs for 72h, after which total cellular protein was prepared by lysing cells in RIPA lysis buffer (Millipore) supplemented with complete Mini Protease Inhibitors (Roche).

26969893

➶

reach

This resulted in a significant inhibition of MYB target genes and proliferation of cylindroma cells from three independent tumours, suggesting that MYB activation drives the growth of CYLD defective cylindromas and potentially also the growth of MYB-NFIB-positive sporadic cylindromas.

26969893

➶

reach

MYB promotes the proliferation of CYLD defective cylindroma cells.

26969893

➶

reach

MYB Knockdown Activates CYLD to Suppress OTSCC in vivo by Downregulating miR-130a Expression.

32821162

➶

reach

CYLD defective cylindroma cells were treated with MYB siRNAs for 48h before total RNA was extracted using an RNeasy Micro-kit (Qiagen).

26969893

➶

reach

CYLD defective cylindroma cells were treated with MYB siRNAs for 6 consecutive days, after which cell proliferation was assayed using Alamar Blue Reagent (Thermo Fisher Scientific) and a VICTOR-3 multilabel reader (Perkin-Elmer), according to instructions supplied by the manufacturers.

26969893

MYB inhibits CYLD.

| 1 2

MYB inhibits CYLD. 3 / 3

| 1 2

➶

eidos

Additionally , MYB knockdown activated CYLD to suppress OTSCC by downregulating miR-130a .

32821162

➶

reach

Additionally, MYB knockdown activated CYLD to suppress OTSCC by downregulating miR-130a.

32821162

➶

reach

Additionally, knockdown of MYB activated CYLD to suppress OSCC in vivo by inactivating miR-130a expression.

32821162

Notch affects CYLD

| 11

Notch decreases the amount of CYLD.

| 7

Notch decreases the amount of CYLD. 7 / 7

| 7

➶

reach

The results showed that blockade of Notch signal up-regulated expression of CYLD in BMDMs treated with CM from I/R injured hepatocytes (XREF_FIG).

27680285

➶

reach

Previous reports have demonstrated that Notch signal represses the expression of CYLD that negatively regulates NF-kappaB activation in macrophages XREF_BIBR.

27680285

➶

reach

To test whether the Notch pathway and specifically Hes1 was directly repressing CYLD transcription, we used the Genomatix software to identify putative Hes1 binding sites, and found three distinct N-box consensus sites in the promoter and 5 ' UTR of the CYLD transcriptional start site (XREF_FIG, denoted as PRO1 and PRO2).

20832754

➶

reach

Previous studies have reported that the Notch and Hes -1 pathway repressed the expression of CYLD XREF_BIBR, XREF_BIBR, a deubiquitination protease, and that CYLD can regulate the activation of TAK1 XREF_BIBR, XREF_BIBR, which is a member of the mitogen activated protein kinase kinase family.

33414448

➶

reach

On the other hand, activation of Notch signaling in macrophages led to increased inflammatory cytokine production and NF-kappaB activation and decreased CYLD expression in vitro.

27680285

➶

reach

Next, we confirmed that miRNA-9-5p and Thbs-2-induced activation of the Notch pathway can inhibit the expression of CYLD and increase the phosphorylation of TAK1 in neurons, thus promoting activation of ERK and AKT and the expression of synapse proteins.

33414448

➶

reach

In T cell acute lymphoblastic leukemia (T-ALL), CYLD expression is repressed by the Notch and Hes1 pathway to promote persistent IKK activation and cell survival [XREF_BIBR].

21119682

Notch inhibits CYLD.

| 3

Notch inhibits CYLD. 3 / 3

| 3

➶

reach

Similarly, CYLD is downregulated by Notch and Hes1 in T-cell acute lymphoblastic lymphoma (T-ALL), thus leading to constitutive NF-kappaB activation.

22435550

➶

reach

Notch activation in CYLD siRNA transfected cells was normalised to cells transfected with non silencing siRNA.

25565632

➶

reach

Therefore, we reasoned that fibulin-3 stimulation of Notch could downregulate CYLD and indirectly activate NF-kappaB.

28414309

Notch activates CYLD.

| 1

Notch activates CYLD. 1 / 2

| 1

➶

reach

Surprisingly, blockade of Notch signaling with the gamma-secretase inhibitor DAPT 17 did not prevent the downregulation of CYLD (XREF_FIG) and the activation of NF-kappaB p65 (XREF_FIG) by fibulin-3.

28414309

CYLD affects TGFB

| 9

CYLD inhibits TGFB.

| 7

CYLD inhibits TGFB. 7 / 10

| 7

➶

reach

Finally, the deubiquitylase CYLD inhibits TGF-beta signaling by decreasing the stability of Smad3.

22617150

➶

reach

CYLD also negatively regulates signaling and TGFbeta responsiveness, suppressing extrathymic Treg induction and the pTreg pool.

26085205

➶

reach

The deubiquitylating enzyme CYLD additionally inhibits TGF-beta signaling by forming a complex with Smad7 and facilitates its deubiquitylation at two sites in its MH2 domain.

22617150

➶

reach

CYLD negatively regulates TGFbeta responsiveness, adversely affecting extrathymic Treg induction and the pTreg pool.

24777637

➶

reach

It is interesting that CYLD knockdown promoted transforming growth factor-beta (TGF-beta) signalling by inducing stabilization of TGF-beta receptor I (ALK5) in a cell autonomous fashion.

29235674

➶

reach

| 6

Glu-Ala increases the amount of CYLD. 6 / 6

| 6

➶

reach

We have also demonstrated that EA induced both apoptosis and necroptosis in CLL cells by inhibiting LEF1 function and restoring CYLD expression.

26950276

➶

reach

EA interfered with LEF1 binding to DNA and restored CYLD expression.

26950276

➶

reach

CYLD expression was increased by EA so we speculate that the negative feedback may control CYLD activity over time and this may inhibit excessive regulation.

29163038

➶

reach

Interestingly, we found that EA enhanced CYLD expression in all 6 samples.

26950276

➶

reach

Thus, EA upregulated expression of CYLD in peri-ischemic areas after focal cerebral ischemia and reperfusion.

29163038

➶

reach

Thus, we hypothesized that EA would enhance CYLD expressions by restricting LEF1 function.

26950276

Glu-Ala activates CYLD.

| 3

Glu-Ala activates CYLD. 3 / 3

| 3

➶

reach

In addition, EA increased the number of neuronal CYLD positive cells in the ischemic cortical border region at 24 h reperfusion.

29163038

➶

| 2 4

➶

reach

Since CYLD is a major protein in isolated PSDs XREF_BIBR and is phosphorylated by CaMKII, it is presumed that the observed changes in deubiquitination are a result of CaMKII mediated activation of CYLD.

24614225

➶

sparser

It was previously shown that, under excitatory conditions, CaMKII activates CYLD in a Ca 2+ -dependent manner.

24928390

➶

sparser

These results with purified proteins show that CaMKII activates CYLD via phosphorylation.

24614225

➶

reach

These results with purified proteins show that CaMKII activates CYLD via phosphorylation.

24614225

➶

reach

It was previously shown that, under excitatory conditions, CaMKII activates CYLD in a Ca 2+ -dependent manner.

24928390

➶

reach

Activation of CaMKII by the addition of ATP promotes activation of CYLD, as indicated by the increase in the rate of degradation of polyubiquitins (XREF_FIG).

24614225

CYLD affects IKBKE

| 2 9

CYLD activates IKBKE.

| 2 5

CYLD activates IKBKE. 7 / 7

| 2 5

➶

reach

Genetic deficiency in the DUB CYLD causes constitutive activation of TBK1 and IKKepsilon in DCs, rendering the cells hyperresponsive to VSV induced type I IFN expression XREF_BIBR, XREF_BIBR.

27012466

➶

reach

CYLD deficiency causes constitutive activation of IKKepsilon and TBK1, which is associated with hyper-induction of IFNs in virus infected cells.

18467330

➶

reach

CYLD deficiency causes constitutive activation of TBK1 and IKKepsilon in DCs, and the CYLD deficient DCs and MEFs are hyper-responsive to VSV in IFNbeta induction 80.

27012466

➶

sparser

CYLD deficiency causes constitutive activation of TBK1 and IKKε in DCs, and the CYLD-deficient DCs and MEFs are hyper-responsive to VSV in IFNβ induction xref .

27012466

➶

reach

Although this phenotype may involve ubiquitin dependent activation of RIG-I, CYLD also directly targets TBK1 and IKKepsilon to inhibit their ubiquitination 79.

27012466

➶

reach

19489724

➶

sparser

19489724

CYLD inhibits IKBKE.

| 4

CYLD inhibits IKBKE. 4 / 4

| 4

➶

reach

CYLD also negatively regulates the IKK related kinases, IKKepsilon and TBK1, by the same mechanisms.

19489724

➶

reach

The effect of CYLD was not specific to RIG-I, as CYLD also deubiquitinated and inhibited the signaling activities of TBK1 and IKKe.

25023063

➶

reach

Our previous studies as well as others have demonstrated that A20, TAX1BP1, ABIN1 and CYLD inhibit TBK1 and IKKi by antagonizing their Lys63 linked polyubiquitation XREF_BIBR, XREF_BIBR, XREF_BIBR.

23308279

➶

reach

The effect of CYLD was not specific to RIG-I, as CYLD also deubiquitinated and inhibited the signaling activities of TBK1 and IKKepsilon.

25023063

CYLD affects signal transduction

| 1 10

CYLD inhibits signal transduction.

| 1 8

CYLD inhibits signal transduction. 8 / 8

| 1 7

➶

reach

In this study, we used transgenic mouse and human SCC models to investigate how CYLD loss-of-function leads to abnormal signal transduction and promotes tumorigenesis.

21478324

➶

reach

CYLD is a deubiquitination enzyme targeting lysine 63 linked ubiquitin chains and was shown to negatively regulate signal transduction factors and pathways including transforming growth factor-beta and NF-kappaB signaling pathways [XREF_BIBR - XREF_BIBR].

25071012

➶

reach

Because of abnormal activation of NF-kappaB, CYLD deficiency attenuates the signal transduction of NKT cells stimulated by IL-7.

32850399

➶

reach

As both CYLD and OTULIN negatively regulate the NF-kappaB signalling cascade, the impact of these deubiquitinases in different LUBAC dependent signalling cascades may be context dependent.

28446710

➶

reach

34707613

➶

sparser

It has been proposed that CYLD inhibits proinflammatory signal transduction [23,35] .

28629782

➶

reach

Ectopic expression of CYLD inhibits the IRF3 signalling pathway and IFN production triggered by RIG-I; conversely, CYLD knockdown enhances the response.

18636086

➶

reach

These findings suggest that CYLD can both positively and negatively regulate signal transduction and homeostasis of B cells in vivo, depending on the expression of CYLD splice variants.

17923499

CYLD bound to IKBKG inhibits signal transduction. 1 / 1

| 1

➶

reach

CYLD interacts with NEMO, TNF receptor associated factor (TRAF)-2, and TRAF interacting protein and negatively regulates the canonical NF- kappa B signal transduction pathway (Brummelkamp et al., 2003[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

17851586

CYLD activates signal transduction.

| 2

CYLD activates signal transduction. 2 / 2

| 2

➶

reach

Treatment of MEFs with either 12-O-tetradecanoylphorbol-13 acetate (TPA) (XREF_FIG) or TNF-alpha (XREF_FIG) which was shown earlier to regulate CYLD mediated signal transduction XREF_BIBR, XREF_BIBR, were unable to increase the proliferation rate of CYLD-/- MEFs compared to CYLD +/+ over a period of 24-96 hours (XREF_FIG).

21573132

➶

reach

A proposed model explaining how p62 mutations lead to the Paget's disease of bone is the following: mutations of the UBA domain cause an impairment in the interaction between p62 and ubiquitinated TRAF6 and/or CYLD, an enzyme deubiquitinating TRAF6, which in turn enhances the activation of the NF-κB signaling pathway and the resulting increased osteoclastogenesis (Figure 3(b)) [160].

22666256

CYLD affects TP53

| 9

CYLD activates TP53.

| 5

CYLD activates TP53. 5 / 6

| 5

➶

reach

In addition, overexpression of HA-CYLD diminished the ubiquitination and increased the stabilization of endogenous p53 in CpT treated HCT116 cells (XREF_FIG).

27561390

➶

reach

Moreover, CYLD was predicted to regulate p53 in an unbiased bioinformatics approach aiming to build a functional human protein interaction network by combining protein interaction, gene expression and gene ontology annotations with genome-wide cancer data sets XREF_BIBR, further supporting that regulation of p53 signalling by CYLD is functionally relevant for human cancer.

27561390

➶

reach

Recently, CYLD was shown to promote DNA damage induced p53 stabilization and activation in epithelial cells and inhibit chemical carcinogen induced intestinal and skin tumorigenesis [XREF_BIBR].

28031783

➶

reach

Additionally, CYLD upregulated p53 by about 2-fold, which was diminished by c-Jun and MKK7 (XREF_FIG).

22832488

➶

reach

We found that HA-CYLD expressed in HEK-293T cells co-immunoprecipitated with endogenous p53 or overexpressed GFP-p53 in reciprocal IPs and that this interaction was enhanced after DNA damage (XREF_FIG).

27561390

CYLD inhibits TP53.

| 3

CYLD inhibits TP53. 3 / 4

| 3

➶

reach

Therefore, lack of CYLD catalytic activity inhibited the p53 dependent death of IECs in response to DNA damage in vivo and in vitro.

27561390

➶

reach

We did not directly address the specific role of the proteasome in mediating CYLD induced degradation of p53, as any experiment involving proteasome inhibition would result in p53 stabilization and thus would be inconclusive in proving the specific role of CYLD.

27561390

➶

reach

The role of CYLD in regulating p53 is evolutionarily conserved as shown by our findings that CYLD deficiency impairs p53 dependent DNA damage induced germ cell apoptosis in C. elegans.

27561390

CYLD increases the amount of TP53.

| 1

CYLD increases the amount of TP53. 1 / 1

| 1

➶

reach

Moreover, CYLD induced an array of other molecular changes associated with modulation of the ' malignant ' phenotype, including a decreased expression of cyclin D1, N-cadherin and nuclear Bcl3, and an increased expression of p53 and E-cadherin.

22832488

CYLD affects cell migration

| 10

CYLD inhibits cell migration.

| 6

CYLD inhibits cell migration. 6 / 6

| 6

➶

reach

33149672

➶

reach

In addition, CYLD substantially slowed down scratchwounding induced cell migration (XREF_FIG).

22832488

➶

reach

In addition, CYLD m induced an increased rate of cell migration as assessed by a scratch wounding assay, while CYLD WT markedly slowed cell migration (XREF_FIG).

21478324

➶

reach

Moreover, the wound healing assay shows that CYLD WT inhibits cell migration, while S323X and S371X showed significant differences with the WT (XREF_FIG E).

32708712

➶

reach

The data are consistent with CYLD acting as a tumor suppressor gene to inhibit cell migration in vitro and metastasis in vivo.

32708712

➶

reach

The in vitro chamber migration and wound healing assays show that CYLD dramatically suppresses cell migration in both HK1 and C17 (XREF_FIG D, E, Figure S3).

32708712

CYLD activates cell migration.

| 4

CYLD activates cell migration. 4 / 4

| 4

➶

reach

In contrast to the proliferation related activity, CYLD knockdown significantly decreased the cell migration of all the melanoma cell lines (n = 7, p < 0.05), and we demonstrated that the mechanism regulating melanoma cell migration was activation of RAC1 through the action of CYLD.

22469839

➶

reach

CYLD has also been shown to stimulate cell migration and thereby contribute to normal physiological processes.

24552808

➶

reach

Catalytic domain mutation in CYLD inactivates its enzyme function by structural perturbation and induces cell migration and proliferation.

29807073

➶

reach

In addition, CYLD m induced an increased rate of cell migration as assessed by a scratch wounding assay, while CYLD WT markedly slowed cell migration (XREF_FIG).

21478324

CYLD affects TRAF2

1 | 2 4

CYLD inhibits TRAF2.

1 | 2 2

CYLD inhibits TRAF2. 5 / 8

1 | 2 2

➶

reach

CYLD also inhibits TRAF2 and NEMO (NF-kappaB essential modulator, a regulatory subunit of IKK), and blocks NF-kappaB signaling downstream to TLR activation [176] [177] [178].

| DOI

➶

sparser

Similarly to active-site C601 CYLD mutants ( Trompouki et al. , 2003 ; this work), CYLD-D681G was unable to inhibit TRAF2- or TRAF6-mediated activation of NF- κ B and TNF α activation of JNK, and to[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

17851586

➶

signor

12917691

➶

reach

27164085

➶

sparser

CYLD also inhibits TRAF2 and NEMO (NF-κB essential modulator, a regulatory subunit of IKK), and blocks NF-κB signaling downstream to TLR activation [176] [177] [178] .

| DOI

CYLD activates TRAF2.

| 2

CYLD activates TRAF2. 2 / 2

| 2

➶

reach

The regulation of TRAF2 signaling by CYLD was identified by screening an RNAi library targeting DUBs for ones that attenuate NFkappaB activation [XREF_BIBR] and through a two-hybrid screen for proteins that interact with the regulatory subunit of the IkappaB kinase complex that could also bind to TRAF2 [XREF_BIBR].

19007437

➶

reach

In contrast to earlier studies, which had shown that CYLD acts as a Lys-63-specific DUB, Xue et al. found that CYLD removes Lys 48 polyubiquitin chains from TRAF2, thereby preventing TRAF2 proteolytic[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

20347313

Phorbol 13-acetate 12-myristate affects CYLD

1 | 9

Phorbol 13-acetate 12-myristate activates CYLD.

| 8

Phorbol 13-acetate 12-myristate activates CYLD. 8 / 8

| 8

➶

reach

This is supported by the finding that depletion of HDAC6 was not sufficient to induce the interaction of CYLD with Bcl-3, but TPA mediated activation of CYLD is additionally required.

19893491

➶

reach

Interaction of CYLD with tubulin and MT. We have earlier shown that UV or TPA treatment of primary mouse keratinocytes triggers perinuclear accumulation of CYLD, which correlates with its ability to interact with its downstream targets.

19893491

➶

reach

These data suggest that TPA increases tumor promotion in Cyld -/- mice by enhancing tumor cell proliferation.

16713561

➶

reach

16713561

➶

reach

As expected, TPA induced interaction of CYLD with Bcl-3, while this interaction (XREF_FIG), as well as perinuclear localization of CYLD (XREF_SUPPLEMENTARY), was prevented in the presence of nocodazole.

19893491

➶

reach

TPA stimulated Cyld +/+ keratinocytes and EGFP-CYLD-expressing melanoma cells showed reduced levels of BrdU positive nuclei as an indication of delayed S-phase progression in the presence of activated CYLD (XREF_FIG).

19893491

➶

reach

Importantly, nuclear accumulation of Bcl-3 was also significantly increased in DMBA and TPA induced Cyld -/- tumors when compared with tumors from control littermates.

| 3 2

IKBKE inhibits CYLD. 5 / 6

| 3 2

➶

sparser

A similar mechanism is thought to occur in breast carcinogenesis where IKKε phosphorylates and inactivates CYLD ( xref ).

22435550

➶

reach

IKKepsilon inhibits CYLD activity through phosphorylation, which results in the blockage of the deubiquination of TRAF2 and NF-kB essential modulator (NEMO), positive regulators of the classical NF-kB pathway.

27422962

➶

reach

In addition, IKKepsilon has been reported to decrease the activity of CYLD, a deubiquitinating enzyme that negatively regulates IRF3/7 activation, thereby indirectly increasing IRF mediated signaling [XREF_BIBR, XREF_BIBR].

21994600

➶

sparser

IKKɛ also phosphorylates and inactivates the tumor suppressor CYLD, preventing CYLD from deubiquitinating specific substrates in the NF-κB signaling pathway.

23333767

➶

sparser

IKKe also phosphorylates and inactivates the tumor suppressor CYLD, preventing CYLD from deubiquitinating specific substrates in the NF-kB signaling pathway.

23333767

IKBKE activates CYLD.

| 2 1

IKBKE activates CYLD. 3 / 3

| 2 1

➶

eidos

IKKepsilon also phosphorylates and inactivates the tumor suppressor CYLD , preventing CYLD from deubiquitinating specific substrates in the NF-kappaB signaling pathway .

23333767

➶

eidos

IKKe also phosphorylates and inactivates the tumor suppressor CYLD , preventing CYLD from deubiquitinating specific substrates in the NF-kB signaling pathway .

23333767

➶

reach

Moreover, we recognize that IKKepsilon may also modulate other substrates in addition to CYLD during cell transformation.

19481526

IKBKE increases the amount of CYLD.

| 1

IKBKE increases the amount of CYLD. 1 / 1

| 1

➶

reach

TBK1 and IKKi dual inhibitors suppress the expressions of p-CYLD and p-AKT, and angiogenesis.

24150799

GATD3B affects CYLD

| 10

GATD3B inhibits CYLD.

| 6

GATD3B inhibits CYLD. 5 / 5

| 5

➶

reach

The mechanism of Notch induced NF-kappaB activation in T-ALL involves Hes1, which transcriptionally represses CYLD (cylindromatosis), a deubiquitinase which down-regulates NF-kappaB signaling by removing the activator K63 ubiquitin chains from different elements of the NF-kappaB signalosome [XREF_BIBR].

28561798

➶

reach

Hes1 downregulated CYLD, a negative regulator of NF-kappaB signalling, and then activated the IKK/IkappaBalpha/NF-kappaB signalling pathway.

31182110

➶

reach

It has been reported that NF-kappaB is activated via NICD and Hes1 mediated repression of the deubiquitinase CYLD and has a crucial role in the survival and drug resistance of T-ALL cells.

24301524

➶

reach

The experiments performed by Espinosa and collaborators [XREF_BIBR] in T-ALL and HEK293T cells support the notion that HES1 induced CYLD repression results in increased IKK kinase activity, IkappaBalpha degradation, RelA nuclear translocation, and NF-kappaB transcriptional activity.

24281204

➶

reach

Similarly, CYLD is downregulated by Notch and Hes1 in T-cell acute lymphoblastic lymphoma (T-ALL), thus leading to constitutive NF-kappaB activation.

22435550

GATD3B inhibits CYLD. 1 / 1

| 1

➶

reach

Recently, another study implied that Hes1 might repress the deubiquitinase CYLD, which is a negative IKK complex regulator, and thereby sustains NF-kappaB activation in T-ALL [37,43].

21775206

GATD3B decreases the amount of CYLD.

| 4

GATD3B decreases the amount of CYLD. 3 / 3

| 3

➶

reach

In T cell acute lymphoblastic leukemia (T-ALL), CYLD expression is repressed by the Notch and Hes1 pathway to promote persistent IKK activation and cell survival [XREF_BIBR].

21119682

➶

reach

A significant portion of these effects can be attributed to the suppression of CYLD expression by Hes1.

20832754

➶

reach

20832754

Modified GATD3B decreases the amount of CYLD. 1 / 1

| 1

➶

reach

While ectopic expression of a dominant negative Hes1 (dN-Hes1) upregulated Cyld expression, luminal sphere forming activity was not affected (XREF_FIG), suggesting that Hes1 mediated Cyld suppression does not play a role in NF-kappaB-mediated survival of luminal prostate sphere forming cells.

25048699

CYLD affects DUSP1

| 9

CYLD activates DUSP1.

| 5

CYLD activates DUSP1. 5 / 6

| 5

➶

reach

Having shown that CYLD negatively regulates NTHi induced IL-8 expression via the inhibition of ERK and positively regulates MKP-1, we next investigated whether CYLD acts as a negative regulator for ERK dependent IL-8 induction via MKP-1.

25389768

➶

reach

CYLD also enhanced NTHi induced upregulation of MAP kinase phosphatase-1, which led to reduced ERK activation and subsequent suppression of IL-8.

28372529

➶

reach

Therefore, investigating the molecular mechanisms of how CYLD upregulates MKP-1 may bring new insights into the tight regulation of inflammatory responses.

25389768

➶

reach

Taken together, our data suggest that CYLD mediates NTHi induced upregulation of MKP-1.

25389768

➶

reach

Because CYLD has been identified as a DUB, we investigated whether DUB activity is required for the CYLD mediated upregulation of MKP-1 induced by NTHi.

25389768

CYLD increases the amount of DUSP1.

| 2

CYLD increases the amount of DUSP1. 2 / 2

| 2

➶

reach

Thus, our data demonstrate that CYLD upregulates MKP-1 expression in a DUB activity dependent manner.

25389768

➶

| 9

CYLD inhibits transcription, DNA-templated.

| 6

CYLD inhibits transcription, DNA-templated. 6 / 6

| 6

➶

reach

CYLD has deubiquitinating enzyme activity and inhibits the activation of transcription factor NF-kappaB.

16900776

➶

reach

The tumor suppressor gene CYLD, which was recently identified as the cylindromatosis gene, has a deubiquitinating enzyme (DUB) activity and inhibits activation of the transcription factor NF-kappaB, which has key roles in inflammation, immune responses, carcinogenesis, and protection against apoptosis [XREF_BIBR].

20414373

➶

reach

CYLD, a tumor suppressor gene, has deubiquitinating enzyme activity and inhibits the activation of transcription factor NF-kappaB.

18497946

➶

reach

Consequently, CYLD inhibits the activation of the transcription factor NF-kappaB, which plays an important role for immune responses.

23825949

➶

reach

These observations suggest that suppression of CYLD enhances the activity of the IKK kinase and the nuclear localization of NF-kappaB transcription factors.

20832754

➶

reach

In the search for the tumor suppressor function of CYLD, several laboratories reported that CYLD can inhibit the activation of the classical NF-kappaB p65 and p50 transcription factor (Trompouki et al[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

16713561

CYLD activates transcription, DNA-templated.

| 3

CYLD activates transcription, DNA-templated. 3 / 3

| 3

➶

reach

Our study supported the involvement of six candidate genes in susceptibility to psoriasis : SCL12A8, which belongs to the solute carrier gene family; FLG and TGM5, which are involved in epidermal differentiation; CARD15 and CYLD, which modulate the transcription factor NF-kB; and IL1RN, which encodes an IL receptor antagonist.

19554025

➶

reach

These researchers found that the familial cylindromatosis tumour suppressor gene (CYLD), previously of unknown function, could enhance the activation of the transcription factor NF-kappaB, leading to increased resistance to apoptosis.

14585643

➶

reach

CYLD (the familial cylindromatosis tumor suppressor gene) enhances the activation of the transcription factor NFkapa-B [XREF_BIBR], RBBP6, (which binds to the retinoblastoma gene product pRB) [XREF_BIBR], and PNUTL2 (which is an apoptosis related protein in the TGF-beta signaling pathway) [XREF_BIBR].

23056957

CYLD affects RIPK2

| 1 2 6

CYLD inhibits RIPK2.

| 1 1 5

CYLD inhibits RIPK2. 7 / 7

| 1 1 5

➶

reach

CYLD has been reported to inhibit RIPK2 induced signaling when overexpressed, but the function of endogenous CYLD in NOD2 signaling remains unexplored and its role as a DUB is unknown.

26997266

➶

reach

Thus, inhibition of RIPK2 by CYLD leads to impaired pathogen control due to a reduction in antimicrobial responses including pro inflammatory cytokine production, ROS and nitric oxide (NO) production.Another recent study used kinase inhibitors to demonstrate functional specificity of the kinase domain of RIPK2 in controlling bacterial pathogens.

| PMC

➶

eidos

Thus , inhibition of RIPK2 by CYLD leads to impaired pathogen control due to a reduction in antimicrobial responses including pro-inflammatory cytokine production , ROS and nitric oxide ( NO ) production .

| PMC

➶

reach

Thus, the underlying infection determines the impact of RIPK2 and CYLD on the outcome of the disease and our identification of a direct inhibition of RIPK2 by CYLD provides a mechanistical explanation of the antagonistic effects of these two signaling molecules.

26834734

➶

sparser

26834734

➶

reach

| PMC

➶

reach

CYLD Impairs RIPK2 Mediated Activation and Antibacterial Function of BMDM.

26834734

CYLD activates RIPK2.

| 1 1

CYLD activates RIPK2. 2 / 2

| 1 1

➶

reach

To study whether CYLD directly regulates RIPK2 in Lm infected BMDM, we immunoprecipitated CYLD from Lm infected IFN-gamma-stimulated WT and Cyld -/- BMDM.

26834734

➶

sparser

Autophagy is an intrinsic defense mechanism against Lm and, therefore, we further investigated whether CYLD-dependent RIPK2 and ERK1/2 activation influences the formation of autophagosomes.

26834734

CYLD affects AP1

| 1 8

CYLD inhibits AP1.

| 5

CYLD inhibits AP1. 5 / 5

| 5

➶

reach

CYLD loss-of-function promotes human SCC in an AP1 dependent manner.

21478324

➶

reach

We found that CYLD m increased AP1 driven expression both in the presence and absence of EGF; whereas CYLD WT reduced AP1 activity in both conditions (XREF_FIG).

21478324

➶

reach

In contrast, expression of the wild type CYLD inhibited SCC tumorigenesis and AP1 function.

21478324

➶

reach

Taken together, these findings indicated that CYLD negatively regulates the activation of TAK1, p38, and AP-1.

21931165

➶

reach

We therefore examined whether the loss of CYLD also promoted the activation of AP-1.

21931165

CYLD activates AP1.

| 1 3

CYLD activates AP1. 4 / 4

| 1 3

➶

reach

In addition, CYLD WT markedly reduced while CYLD m significantly potentiated AP1 activity driven by exogenous c-Fos expression; conversely, gene silencing of c-Jun or c-Fos abolished AP1-induction by CYLD m (XREF_FIG).

21478324

➶

sparser

Thus, the exact mechanism of MALT1- and CYLD-dependent AP-1 activation and the role of JNK in this pathway remain to be further explored.

26507244

➶

reach

CYLD Inhibits Tumorigenesis and Metastasis by Blocking JNK and AP1 Signaling at Multiple Levels.

21478324

➶

reach

We found that CYLD m increased AP1 driven expression both in the presence and absence of EGF; whereas CYLD WT reduced AP1 activity in both conditions (XREF_FIG).

21478324

CYLD affects Wnt

| 8

CYLD inhibits Wnt.

| 4

CYLD inhibits Wnt. 4 / 5

| 4

➶

reach

In addition, CYLD was proposed to inhibit Wnt signalling by deubiquitinating dishevelled XREF_BIBR.

27561390

➶

reach

In human cylindroma, CYLD negatively regulates Wnt and beta-catenin signaling via deubiquitination of Dishevelled, which is a key component in Wnt mediated beta-catenin nuclear translocation.

22235375

➶

reach

Increased CYLD expression may likewise diminish Wnt pathway activation and beta-catenin accumulation (XREF_FIG) via K63 linked deubiquitination of Dvl.

23034333

➶

reach

XREF_BIBR - XREF_BIBR Additionally, Tauriello et al XREF_BIBR demonstrated that CYLD inhibits the Wnt pathway by deubiquitinating disheveled in familial cylindromatosis tumors.

33149672

CYLD activates Wnt.

| 3

CYLD activates Wnt. 3 / 3

| 3

➶

reach

Therefore, the activity of this DUB should stimulate rather than attenuate the signalling activity of Dvl, which means that the observed downregulation of Wnt signalling by CYLD XREF_BIBR can not be explained by its effect on Dvl polymerization.

25907794

➶

reach

Loss of the tumor suppressor CYLD enhances Wnt and beta-catenin signaling through K63 linked ubiquitination of Dvl.

20227366

➶

reach

The DIX domain is ubiquitinated in vivo at multiple lysines, which can be antagonized by various deubiquitinases (DUBs) including the CYLD tumour suppressor that attenuates Wnt signalling.

25907794

CYLD increases the amount of Wnt.

| 1

CYLD increases the amount of Wnt. 1 / 1

| 1

➶

reach

Knockdown of CYLD in cultured cells strongly enhances Wnt induced beta-catenin stabilization and target gene transcription.

20227366

CYLD affects RHOA

| 8

CYLD activates RHOA.

| 5

CYLD activates RHOA. 5 / 6

| 5

➶

reach

These findings prompted us to investigate whether CYLD modulates other Rho family members.

23405219

➶

reach

We thus studied whether CYLD promoted RhoA activity by interacting with LARG.

23405219

➶

reach

In agreement with the CYLD shRNA result, overexpression of GFP-CYLD promoted RhoA activity (XREF_FIG).

23405219

➶

| 8

➶

reach

Interestingly, CYLD is reported to negatively regulate the innate immune response to infection by Listeria monocytogenes, an intracellular bacterial pathogen recognized by NOD1 and NOD2.

26997266

➶

reach

The higher sensitivity of Cyld -/- mice to DSS induced inflammation indicates a role for CYLD in the negative regulation of the mucosal innate immune response to microorganisms.

18535581

➶

reach

Three human DUBs, CYLD, A20 and DUBA, have been shown to negatively regulate the innate immune response by removing K63-based chains [55, 56] , and USP15 inhibits the NFkB pathway by removing K48-Ub from IkBa, preventing its degradation [57] .

24854014

➶

reach

CYLD inhibits activation of nuclear factor-kappaB (NF-kappaB) and innate immune response.

23300340

➶

reach

22730341

➶

reach

Three human DUBs, CYLD, A20 and DUBA, have been shown to negatively regulate the innate immune response by removing K63-based chains [55], [56], and USP15 inhibits the NFκB pathway by removing K48-Ub from IκBα, preventing its degradation [57].

24854014

➶

reach

Cellular proteins DUBA and CYLD also negatively regulate the innate immune response.

22312431

➶

reach

Three human DUBs, CYLD, A20 and DUBA, have been shown to negatively regulate the innate immune response by removing K63 based chains XREF_BIBR, XREF_BIBR, and USP15 inhibits the NFkappaB pathway by removing K48-Ub from IkappaBalpha, preventing its degradation XREF_BIBR.

24854014

CYLD affects TNFRSF11A

| 8

CYLD inhibits TNFRSF11A. 8 / 8

| 8

➶

reach

Deubiquitinating enzyme cylindromatosis (CYLD) has been shown to negatively regulate RANK ligand-RANK signaling essential for OCL differentiation.

21878516

➶

reach

26085208

➶

reach

Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.

18382763

➶

reach

Thus, CYLD inhibits RANK mediated signaling function by deubiquitinating TRAF6 or its downstream targets involved in NF-kappaB activation.

19373246

➶

reach

CYLD inhibits RANK mediated signaling in osteoclasts in a negative feedback loop by deubiquitinating TRAF6 (XREF_FIG).

22435550

➶

reach

The deubiquitinating enzyme, CYLD has been shown to interact with p62 UBA domain to inhibit TRAF6 ubiquitination and thereby negatively regulates RANK signaling and osteoclastogenesis.

22105856

➶

reach

In addition, CYLD negatively regulates RANK signaling, which is known to be a key factor in bone resorption in cholesteatoma [XREF_BIBR].

20414373

➶

reach

Interestingly, CYLD has been shown to negatively regulate RANK signalling and osteoclastogenesis in mice [XREF_BIBR].

21639951

MIR21 affects CYLD

| 7

MIR21 inhibits CYLD.

| 3

MIR21 inhibits CYLD. 3 / 4

| 3

➶

reach

has shown that miR-21, together with miR-181b-1, inhibit PTEN and cylindromatosis (CYLD) tumor suppressor functions, respectively, leading to increased NF-kB activity thus underlying the epigenetic switch that links inflammation to cancer.

26284192

➶

reach

IL-6 also activates STAT3 causing direct activation of miR-21 and miR-18b-1, which respectively inhibit PTEN and CYLD (tumor suppressor genes).

26464811

➶

reach

This suggests that these miRNAs are part of the regulatory circuit, and indeed they found that their expression is regulated by IL-6 and that both miR-21 and miR-181b-1 can activate NF-kappaB by targeting and inhibiting the tumour suppressors PTEN and CYLD [XREF_BIBR].

21958754

MIR21 activates CYLD.

| 4

MIR21 activates CYLD. 4 / 4

| 4

➶

reach

MiR-21 and miR-181b act as an epigenetic switch to inhibit PTEN and CYLD tumor suppressors, leading to increased NF-kB activity required to maintain the transformed state XREF_BIBR.

21876743

➶

reach

STAT-3 directly activates miR-21 and miR-181b-1, which inhibit PTEN and CYLD tumor suppressors, leading to increased NF-κB activity required to maintain the transformed state.

21786215

➶

reach

STAT-3 directly activates miR-21 and miR-181b-1, which inhibit PTEN and CYLD tumor suppressors, leading to increased NF-jB activity required to maintain the transformed state.

21786215

➶

reach

STAT-3 directly activates miR-21 and miR-181b-1, which inhibit PTEN and CYLD tumor suppressors, leading to increased NF-kappaB activity required to maintain the transformed state.

21786215

CYLD affects TLR2

| 3 1 4

CYLD inhibits TLR2.

| 3 1 3

CYLD inhibits TLR2. 7 / 7

| 3 1 3

➶

reach

For example, CYLD has been proven to negatively regulate TLR2 by TRAF6 and TRAF7 and an antiviral response in an H. influenza co-infection model [XREF_BIBR, XREF_BIBR].

25342597

➶

reach

The TLR2 signaling inhibition by CYLD involves the TRAF6 and TRAF7 inhibition via their deubiquitination (MSK) 1 and 2 are nuclear proteins which share homology with the 90 kDa ribosomal S6 kinase (p90 rsk) family.

| DOI

➶

eidos

Tumor suppressor deubiquitinase ( DUB ) , cylindromatosis ( CYLD ) , inhibits TLR2 signaling responsible for the recognition of Gram-positive bacterial PAMPs [ PGN , LTA , MALP-2 ( Mycoplasma-derived lipopeptide 2 ) , and Pam3CSK4 ( a synthetic triacylated lipopeptide recognized by TLR1 / TLR2 heterodimer ] [ 174 ] .

| PMC

➶

sparser

| DOI

➶

reach

The ubiquitin editing enzyme CYLD inhibits TRAF6 and -7 and TLR2 [XREF_BIBR].

24009023

➶

eidos

The TLR2 signaling inhibition by CYLD involves the TRAF6 and TRAF7 inhibition via their deubiquitination ( MSK ) 1 and 2 are nuclear proteins which share homology with the 90 kDa ribosomal S6 kinase ( p90 rsk ) family .

| DOI

➶

eidos

The TLR2 signaling inhibition by CYLD involves the TRAF6 and TRAF7 inhibition via their deubiquitination ( Table 2 ) [ 174 ] .

| PMC

CYLD activates TLR2.

| 1

CYLD activates TLR2. 1 / 1

| 1

➶

reach

Another interesting finding in this study is the experimental evidence for the negative regulation of S. pneumoniae induced TLR2 up-regulation by tumor suppressor CYLD.

18664270

CYLD affects STAT3

| 8

CYLD inhibits STAT3.

| 7

CYLD inhibits STAT3. 7 / 7

| 7

➶

reach

CYLD reduced activation of p65, JAK2, STAT3, and p38 MAPK as well as fibrin production in livers of Listeria infected WT mice.

23825949

➶

reach

In WT mice, IL-6 neutralization only slightly reduced pSTAT3 without affecting fibrin (XREF_FIG) indicating that IL-6 induced pSTAT3 is strongly regulated by CYLD, which limits STAT3 activity and STAT3 dependent fibrin production.

23825949

➶

reach

CYLD knockdown resulted in an increase of pSTAT3 (XREF_FIG) as well as fibrin (XREF_FIG) in Lm infected WT mice.

23825949

➶

reach

In extension, we newly identified that IL-6 does not only induce STAT3 phosphorylation in hepatocytes XREF_BIBR, but that CYLD strongly reduced IL-6-dependent accumulation of activated STAT3 in hepatic nuclei.

23825949

➶

reach

The observation that siRNA mediated inhibition of CYLD in WT mice increased hepatic p-STAT3 and fibrin levels, diminished hemorrhage and significantly increased survival indicates that inhibition of CYLD might be a therapeutic option in severe listeriosis and potentially other infectious diseases including acute lung injury induced by S. pneumoniae XREF_BIBR.

23825949

➶

reach

In extension to current knowledge, we uncover that the CYLD dependent suppression of STAT3 activity in hepatocytes resulted in a decreased fibrin production, which identifies CYLD as an important regulator of IL-6-induced STAT3 dependent fibrin production.

23825949

➶

reach

In addition, CYLD diminished IL-6-induced STAT3 activity by reducing nuclear accumulation of phosphorylated STAT3.

23825949

CYLD activates STAT3.

| 1

CYLD activates STAT3. 1 / 1

| 1

➶

reach

CYLD impairs production of fibrin in Listeria infection in mice by inhibiting NF-kB-mediated activation of IL-6 production and IL-6 's activation of the STAT3 pathway that leads to fibrosis [XREF_BIBR].

25342597

CYLD affects IL6

| 8

CYLD inhibits IL6.

| 6

CYLD inhibits IL6. 6 / 6

| 6

➶

reach

CYLD overexpression clearly inhibited hypoxia induced synthesis and secretion of IL-6.

25071012

➶

reach

In fact, CYLD overexpression significantly inhibited hypoxia triggered induction of IL-6 and IL-8.

25071012

➶

reach

CYLD Enhances Severe Listeriosis by Impairing IL-6 and STAT3-Dependent Fibrin Production.

23825949

➶

reach

Previously, we have shown that CYLD inhibits IL-6 production by macrophages, which in turn induces STAT3 dependent protective fibrin production by hepatocytes in listeriosis.

28203236

➶

reach

CYLD reduced IL-6, ROS production and killing of Lm in Listeria infected macrophages by impairing NF-kappaB activation.

23825949

➶

reach

In fact, CYLD overexpression completely blocked hypoxia mediated induction of those inflammatory mediators and suppressed basal expression of some cytokines (IL-6, IL-8, IL1beta, IL-1F5, IL-1F8, and CXCL2).

25071012

CYLD activates IL6.

| 2

CYLD activates IL6. 2 / 2

| 2

➶

reach

25342597

➶

reach

29259980

CYLD affects localization

| 8

CYLD inhibits localization.

| 7

CYLD inhibits localization. 6 / 6

| 6

➶

reach

These observations suggest that suppression of CYLD enhances the activity of the IKK kinase and the nuclear localization of NF-kappaB transcription factors.

20832754

➶

reach

While the molecular mechanisms by which these proteins regulate the ciliary role of HDAC6 are elusive, our data demonstrate that HDAC6 is enriched at the centrosome and basal body and that this localization is enhanced by the loss of Cyld.

27028867

➶

reach

Loss of CYLD in HMCLs was found to enhance β-catenin stabilization and localization to the nucleus, increase β-catenin-LEF/TCF reporter activity, and enhance MM cell growth and survival.

29776381

➶

reach

The inhibitory action of Bcl-3 nuclear translocation is executed by the tumour suppressor protein cylindromatosis (CYLD), which can bind directly to Bcl-3 and prevent its nuclear localization [XREF_BIBR].

25929479

➶

reach

Interestingly, the ubiquitin ligase CYLD, which negatively regulates bcl3 nuclear localization, was increased 2.7-fold in the RNA-Seq analysis (XREF_SUPPLEMENTARY).

25873381

➶

reach

27028867

CYLD bound to CEP350 inhibits localization. 1 / 1

| 1

➶

reach

25134987

CYLD activates localization.

| 1

CYLD activates localization. 1 / 1

| 1

➶

reach

Moreover, this M719V variant of CYLD impairs autophagosome maturation and increases the cytosolic localization of TDP-43.

32403254

CYLD affects RELA

| 1 7

CYLD inhibits RELA.

| 4

CYLD inhibits RELA. 4 / 4

| 4

➶

reach

CYLD reduced activation of p65, JAK2, STAT3, and p38 MAPK as well as fibrin production in livers of Listeria infected WT mice.

23825949

➶

reach

Moreover, transfection of p65 alone or in combination with p50 increased the 3XkappaB luciferase reporter activity to a similar extent in Cyld +/+ and Cyld -/- keratinocytes, confirming that Cyld nega[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

16713561

➶

reach

Based on these data, we conclude that loss of Cyld in keratinocytes does not promote the activity of the p65 and p50 NF-kappaB but rather promotes the synergistic activation of p50 and Bcl -3 or p52/B[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

16713561

➶

reach

16713561

CYLD decreases the amount of RELA.

| 2

CYLD decreases the amount of RELA. 2 / 2

| 2

➶

reach

As shown in XREF_FIG, the si-miR, CYLD, si-miR + NC4 and si-miR + si-C groups exhibited significantly higher apoptotic rates, as well as increased Bax, cleaved caspase-3 and p-IkappaBalpha and IkappaBalpha expression levels, and decreased Bcl-2 and p-p65 and p65 levels compared with the BC group.

| 1 4

➶

reach

17548520

➶

sparser

Recently, we, along with others, have demonstrated that CYLD also inhibits MAPKs including p38 and JNK xref – xref .

25389768

➶

reach

CYLD was shown to negatively regulate NF-kappaB and MAPK activation by removing ubiquitin chains from key signalling molecules including NEMO, TRAF2, TRAF6 and RIPK1.

27561390

➶

reach

Moreover, knockdown of CYLD enhanced mitogen activated protein kinase (MAPK) ERK- and p38 mediated expression of c-jun, c-fos, and c-myc, which govern Nrf2 expression in cardiomyocytes.

25935309

➶

reach

CYLD also negatively regulates the c-Jun N-terminal kinase (JNK) signaling pathway and mitogen activated protein kinase (MAPK) pathway, which are known to participate in a wide range of cellular processes, including proliferation, differentiation, and apoptosis of cholesteatoma [XREF_BIBR, XREF_BIBR].

20414373

OPTN affects CYLD

| 7

OPTN activates CYLD.

| 5

OPTN activates CYLD. 5 / 5

| 5

➶

reach

The main feature of this model is that optineurin mediates binding of CYLD to ubiquitinated RIP.

21408173

➶

reach

We further showed that Optn targets the deubiquitinase CYLD to TBK1 in order to downregulate the antiviral innate immune pathway.

25923723

➶

reach

We therefore concluded that Optn targets the deubiquitinase activity of CYLD to TBK1 to prevent its activity and to dampen the antiviral response.

25923723

➶

reach

Furthermore, optineurin inhibits the antiviral innate immune response by targetting CYLD to TBK1 to suppress its kinase activity, subsequently inhibiting interferon production.

29867991

➶

reach

The results presented in this manuscript suggest that optineurin mediates interaction of deubiquitinase CYLD with polyubiquitinated RIP and this interaction is essential for deubiquitination of RIP by CYLD.

21408173

OPTN inhibits CYLD.

| 2

OPTN inhibits CYLD. 2 / 2

| 2

➶

reach

Of note, optineurin, a gene in one of the other Paget 's susceptibility loci can also attenuate TNF-alpha signaling by recruiting CYLD to RIP1.

25025000

➶

reach

In conclusion, our observations strongly suggest that optineurin mediates targeting of CYLD to its substrate (i.e ubiquitinated RIP) which facilitates its deubiquitination.

21408173

IKBKB affects CYLD

7 |

IKBKB inhibits CYLD.

4 |

IKBKB inhibits CYLD. 4 / 4

4 |

➶

signor

Thus, serine 418 is phosphorylated in vivo.Cyld phosphorylation may serve as a mechanism to inactivate its traf2 deubiquitination activity.

24614225

➶

signor

The phosphorylation of cyld was completely abolished by the combined mutations of the entire serine cluster (m4, lane 5). Similar results were obtained with the ikk holoenzyme (fig. 4c, panel 1), recombinant ikk_ (panel 2), and recombinant ikk_cyld phosphorylation may serve as a mechanism to inactivate its traf2 deubiquitination activity.

24614225

➶

signor

24614225

➶

signor

24614225

IKBKB activates CYLD.

3 |

IKBKB activates CYLD. 3 / 3

3 |

➶

signor

24614225

➶

signor

24614225

➶

signor

24614225

CYLD affects autophagy

| 1 5

CYLD inhibits autophagy.

| 1 2

CYLD inhibits autophagy. 3 / 4

| 1 2

➶

reach

Yin et al. reported that CYLD could increase apoptosis and decrease autophagy to improve the chemosensitivity to gemcitabine in bladder cancer [XREF_BIBR].

| PMC

➶

reach

Noteworthy, CYLD also inhibited autophagy of Listeria in a RIPK2-ERK1/2-dependent manner.

26834734

➶

eidos

Yin et al. reported that CYLD could increase apoptosis and decrease autophagy to improve the chemosensitivity to gemcitabine in bladder cancer [ 26 ] .

| PMC

CYLD activates autophagy.

| 3

CYLD activates autophagy. 3 / 3

| 3

➶

reach

As the aforementioned results suggested that NAC could inhibit the generation of ROS in HPCCs, it is possible that mTOR, ULK1, AKT, 4E-BP1 and CYLD participate in wogonin induced autophagy, acting as upstream signals of autophagy.

28105213

➶

reach

The K63 deubiquitinase CYLD modulates autism-like behaviors and hippocampal plasticity by regulating autophagy and mTOR signaling.

34782467

➶

reach

By providing evidence that CYLD can modulate mechanistic target of rapamycin (mTOR) signaling and autophagy at the synapse, we propose that synaptic K63-linked ubiquitination processes could be fundamental in understanding the pathomechanisms underlying autism spectrum disorder.

34782467

CYLD affects Fibrin

| 7

CYLD inhibits Fibrin.

| 6

CYLD inhibits Fibrin. 6 / 6

| 6

➶

reach

Before, we have shown that CYLD inhibits protective fibrin production by hepatocytes in listeriosis.

26834734

➶

reach

25342597

➶

reach

In addition, in vivo Cyld siRNA treatment increased STAT3 phosphorylation, fibrin production, pathogen control and survival of Lm infected WT mice illustrating that therapeutic inhibition of CYLD augments the protective NF-kappaB/IL-6/STAT3 pathway and fibrin production.

23825949

➶

reach

23825949

➶

reach

CYLD reduced activation of p65, JAK2, STAT3, and p38 MAPK as well as fibrin production in livers of Listeria infected WT mice.

23825949

➶

reach

23825949

CYLD activates Fibrin.

| 1

CYLD activates Fibrin. 1 / 1

| 1

➶

reach

23825949

CYLD affects CASP8

| 6

CYLD activates CASP8.

| 4

CYLD activates CASP8. 4 / 5

| 4

➶

reach

CYLD was also found to promote the assembly of an alternative caspase-8 activating complex containing RIP1 and FADD [XREF_BIBR].

20532807

➶

reach

Increased caspase-8 activation was also observed in selenite treated cells transfected with CYLD, indicating that CYLD promoted caspase-8 activation via RIP1 deubiquitination (XREF_FIG).

24577083

➶

reach

An alternative explanation holds that CYLD is the target of caspase-8 during the decision point between apoptosis vs. necroptosis, although this model is not mutually exclusive from the aforementioned.

25364712

➶

reach

These changes in sensitivity to TNF-alpha cytoxicity, mediated by the treatment of siCLIPR-59 or siCYLD, correlated with differences in RIP1 ubiquitination (XREF_SUPPLEMENTARY) These findings thus suggest that both CLIPR-59 and CYLD are essential for activation of Caspase-8 by TNF-alpha in the presence of Compound-3.

22297296

CYLD inhibits CASP8.

| 2

CYLD inhibits CASP8. 2 / 2

| 2

➶

reach

Consistent with the data above, silencing CYLD largely abolished caspase 8 activation and necroptotic cell death induced by 5z-7 plus TNFalpha (XREF_FIG).

27685625

➶

reach

As shown in XREF_FIG, upon selenite treatment, cIAPs were degraded, and CYLD transcription was upregulated, causing degradation of RIP1 K63 ubiquitin chains and subsequent DISC formation, caspase-8 activation and apoptosis.

24577083

CHUK affects CYLD

7 |

CHUK inhibits CYLD.

5 |

CHUK inhibits CYLD. 5 / 5

5 |

➶

signor

24614225

➶

signor

Thus, serine 418 is phosphorylated in vivo. Cyld phosphorylation may serve as a mechanism to inactivate its traf2 deubiquitination activity.

24614225

➶

signor

24614225

➶

signor

24614225

➶

signor

24614225

CHUK activates CYLD.

2 |

CHUK activates CYLD. 2 / 2

2 |

➶

signor

24614225

➶

signor

24614225

LEF1 affects CYLD

1 | 6

LEF1 inhibits CYLD.

| 3

LEF1 inhibits CYLD. 3 / 3

| 3

➶

reach

TNFa induced necrotic signaling can be blocked in some chronic leukemias by the action of LEF1 (Lymphoid Enhancer binding Factor 1), which acts on the Wnt and betaCatenin pathway to downregulate CYLD at the transcriptional level [XREF_BIBR].

| 2 2

CYLD activates CDKN2C. 4 / 4

| 2 2

➶

eidos

Loss of CYLD causes the degradation of p18 and induces the G1 / S transition .

33654169

➶

eidos

Results ( Fig. 3a , b ) indicated that neither overexpression or knockdown of CYLD changed the expression of cyclin D or CDK4 or 6 , but influenced the protein level of p18 and pRb , and increasing CYLD expression caused an elevation in p18 levels in a dose-dependent manner in all cell lines ( Fig. 3c ) .

33654169

➶

| 4

CYLD decreases the amount of CDH2. 2 / 2

| 2

➶

reach

But in these cells, CYLD also inhibited the expression of N-cadherin, a protein known to promote tumor spread.

| PMC

➶

reach

Snail1 dependent inhibition of CYLD transcription results in stimulation of Cyclin D1 and N-cadherin expression in melanoma cells, leading to enhanced proliferation, migration, and invasiveness of melanoma cells in vitro, as well as tumor growth and metastasis in vivo.

19124656

Modified CYLD decreases the amount of CDH2. 2 / 2

| 2

➶

reach

6 |

➶

ctd

No evidence text available

27188386

➶

ctd

No evidence text available

19101580

➶

ctd

No evidence text available

26272509

➶

ctd

No evidence text available

21318169

➶

ctd

No evidence text available

22083351

➶

ctd

No evidence text available

23179753

MIB2 affects CYLD

| 4

MIB2 inhibits CYLD. 4 / 6

| 4

➶

reach

Here, using the cell-free based AlphaScreen and pulldown assays to detect protein protein interactions, along with immunofluorescence assays and murine Mib2-knockout cells and animals, we demonstrate that MIB2 promotes proteasomal degradation of CYLD and enhances NF-kappaB signaling.

31366726

➶

reach

The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.

31366726

➶

reach

Mib2 can enhance NF-kappaB signaling in inflammatory response by promoting ubiquitin dependent CYLD degradation in the Notch pathway.

33584827

➶

reach

Together, these results suggest that MIB2 enhances NF-kappaB signaling in inflammation by promoting the ubiquitin dependent degradation of CYLD.

31366726

MAP3K7 affects CYLD

| 6

MAP3K7 activates CYLD. 6 / 6

| 6

➶

reach

These data collectively suggest that sustained Tak1 activation in Itch -/- and Cyld -/- BMDMs results in chronic production of proinflammatory cytokines.

22057290

➶

reach

Tak1 activation in Itch -/- and Cyld -/- BMDMs.

22057290

➶

reach

To determine whether Tak1 is a functional target of CYLD, we analyzed the effect of CYLD on Tak1 ubiquitination.

17548520

➶

reach

27 Of note, deregulated Tak1 ubiquitination also contributes to the hyperactivation of NF-kappaB and JNK in CYLD deficient T cells, 26 suggesting that Tak1 is a common target of CYLD in the innate and adaptive immune responses.

19373246

➶

reach

Furthermore, consistent with the constitutive Tak1 activation in Cyld -/- T cells, transfected CYLD potently suppressed the catalytic activity of Tak1 (XREF_FIG).

17548520

➶

reach

In mature T cells, CYLD targets TAK1 for inactivation to downregulate IKK and NF-kappaB activation [XREF_BIBR].

21119682

CYLD affects IKBKB

| 6

CYLD inhibits IKBKB. 6 / 6

| 6

➶

reach

We next used an alternative approach to confirm that the loss of CYLD in T cells causes the constitutive activation of IKKbeta.

17548520

➶

reach

However, because Cyld deficiency did not cause the activation of ERK, the target of CYLD might be an intermediate signaling factor specifically mediating the activation of JNK and IKKbeta.

17548520

➶

reach

YM155 activated CYLD activity which led to suppressed IKKbeta activity and stabilization of inhibitory IkappaBalpha.

29980758

➶

reach

Augmented CYLD activity suppressed IKKbeta which stabilized IkappaBalpha and retained NF-kappaB dimers in their inactive states in the cytosol.

29980758

➶

reach

Surprisingly, the loss of CYLD did not result in the basal activation of IKKbeta or Tak1 in macrophages.

17548520

➶

reach

These results establish a pivotal role for CYLD in controlling Tak1 function and explain how CYLD negatively regulates IKKbeta and JNK.

17548520

CYLD affects GS26575

| 6

CYLD inhibits GS26575. 6 / 6

| 6

➶

reach

CYLD, another DUB, is reported to limit NF-kappaB activation by removing K63- and M1 linked poly-ubiquitin chains on several complex I components (including TRAF2, NEMO and RIPK1), thereby disrupting the ubiquitin scaffold required for the recruitment and activation of the TAB2/3-TAK 1 and NEMO-IKKalpha-IKKbeta complexes [XREF_BIBR, XREF_BIBR - XREF_BIBR].

27424290

➶

reach

Once recruited, CYLD limits NF-kappaB activation by removing K63 linked and M1 linked poly-Ub chains on several components of complex I, including RIPK1 [XREF_BIBR, XREF_BIBR - XREF_BIBR].

27066894

➶

reach

Moreover, in addition to cleaving K63 ubiquitin linkages, CYLD has been shown to degrade M1 linked polyubiquitin chains from various components of the TNF-R1 and NOD2 signalling complexes, including RIP1.

28829404

➶

reach

Previous studies report that CYLD negatively regulates NF-kappaB signaling by removing K63- and M1 linked polyubiquitin chains from key signaling molecules, including NF-kappaB essential modulator, tumor necrosis factor (TNF)-associated factor (TRAF) 2, TRAF6, and Receptor interacting serine/threonine protein kinase 1, in familial cylindromatosis tumors.

33149672

➶

reach

CYLD inhibited M1 microglial activation and improved M2 microglial activation after 72 h of reperfusion.

34045881

➶

reach

We show here that A20 binding to M1 chains in the TNF-RSC stabilizes them, whereas CYLD antagonizes M1 chains in this complex.

26670046

Glucose affects CYLD

| 6

Glucose decreases the amount of CYLD.

| 5

Glucose decreases the amount of CYLD. 5 / 5

| 5

➶

reach

Our data showed that high glucose significantly inhibited the protein and mRNA expression of CYLD in a dose- and time dependent manner (both p < 0.05).

29259980

➶

reach

29259980

➶

reach

High Glucose Inhibits the Expression of CYLD in GMCs.

29259980

➶

reach

In conclusion, the present study found that high glucose significantly inhibited the expression of CYLD and activated NF-kappaB inflammatory signaling in a dose- and time dependent manner.

29259980

➶

reach

These data suggest that high glucose inhibited CYLD expression in GMCs (SV40 MES 13 and HBZY-1) in a time- and dose dependent manner.

29259980

Glucose inhibits CYLD.

| 1

Glucose inhibits CYLD. 1 / 1

| 1

➶

reach

Compared with the NC group, the relative CYLD mRNA and protein expressions were inhibited by different concentrations of high glucose at 24h, particularly in the 30mmol/L glucose group (p < 0.05; XREF_FIG).

29259980

CYLD affects cell cycle

| 6

CYLD inhibits cell cycle.

| 3

CYLD inhibits cell cycle. 3 / 3

| 3

➶

reach

In the current work, we found that CYLD mainly prevents the G1/S cell cycle progression, but no significant change occurred in cyclin D or CDK4 and 6.

33654169

➶

reach

RNAi mediated CYLD knockdown prolongs the pro mytotic stage of cell cycle, thus suggesting a role for CYLD in the control of mitotic entry.

19373246

➶

reach

CYLD negatively regulates the cell cycle by inactivating HDAC6, a histone deactylase, and increases the concentration of acetylated tubulin.

26370355

CYLD activates cell cycle.

| 3

CYLD activates cell cycle. 3 / 3

| 3

➶

reach

The CYLD mediated deubiquitylation of certain substrates can affect different phases of the cell cycle, and ultimately, cellular proliferation.BCL3 was originally identified in a subgroup of B cell le[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

20347313

➶

reach

In a different study of HDAC6 and its role in tumorigenesis, it was found that CYLD mediated inhibition of HDAC6 was essential for CYLD activation and delay in the cell cycle.

21076528

➶

reach

The increased expression of CYLD triggers cell cycle arrest and apoptotic induction [36].

20347313

CYLD affects NFKB1

| 5

CYLD activates NFKB1.

| 3

CYLD activates NFKB1. 3 / 4

| 3

➶

| 3

ERK inhibits CYLD. 3 / 3

| 3

➶

reach

Moreover, we demonstrate that suppression of CYLD by ERK1/2 signaling plays an important role in maintaining RIP1 expression, and that melanoma cells with acquired resistance to BRAF inhibitors are more critically dependent on RIP1 for survival.

29880840

➶

| 3

CYLD inhibits reactive oxygen species. 3 / 3

| 3

➶

reach

CYLD Impairs Production of Cytokines, ROS, and NO and Reduces Activation of NF-kappaB, ERK1/2, and p38MAPK in Lm Infected BMDM.

26834734

➶

| 4

CYLD inhibits CTNNB1. 4 / 4

| 4

➶

reach

In the Wnt signal transduction pathway, CYLD inhibits beta-catenin signaling by removing Lysine 63 linked ubiquitination from Dishevelled.

24756567

➶

reach

Loss of CYLD in HMCLs was found to enhance β-catenin stabilization and localization to the nucleus, increase β-catenin-LEF/TCF reporter activity, and enhance MM cell growth and survival.

29776381

➶

reach

In human cylindroma, CYLD negatively regulates Wnt and beta-catenin signaling via deubiquitination of Dishevelled, which is a key component in Wnt mediated beta-catenin nuclear translocation.

| 2

Salicylate inhibits CYLD. 2 / 2

| 2

➶

reach

Sal A pretreatment inhibited OX-LDL-induced CYLD upregulation.

29081889

➶

reach

Furthermore, the downregulation of CYLD by Sal A may be dependent on PI3K/Akt/mTOR, but not ERK.

29081889

Salicylate activates CYLD.

| 2

Salicylate activates CYLD. 2 / 2

| 2

➶

reach

Sal A Modulates CYLD via PI3K/Akt/mTOR Pathway.

| 2

CYLD activates NFKBIA. 1 / 2

| 1

➶

reach

29050336

CYLD-C601A activates NFKBIA. 1 / 1

| 1

➶

reach

Consistent with our previous study [XREF_BIBR], the inhibitory function of CYLD on NF-kappaB relies on its intact catalytic activity because expression of a catalytically inactive CYLD C601A mutant, in which cysteine601 is substituted by alanine, could not enhance the abundance of IkappaBalpha to the equivalent extent as wild-type CYLD did (XREF_SUPPLEMENTARY).

29050336

CYLD inhibits NFKBIA.

| 2

CYLD inhibits NFKBIA. 2 / 2

| 2

➶

reach

Treatment with BAY 11-7085, a known NF-kappaB antagonist that blocks IkappaBalpha phosphorylation and NF-kappaB transactivation, effectively abrogated the CYLD siRNA induced IkappaBalpha degradation.

29050336

➶

reach

While the CYLD deficiency slightly decreased the basal expression levels of IkappaBalpha and IkappaBbeta proteins, it did not affect the basal expression of IkappaBepsilon in RASMCs (XREF_FIG).

22406061

CYLD decreases the amount of NFKBIA.

| 1

Modified CYLD decreases the amount of NFKBIA. 1 / 1

| 1

➶

reach

In this study, high glucose inhibited expression of IkappaBalpha was significantly reversed by the overexpression of CYLD, and p-IkappaBalpha, NF-kappaBp65, and p-NF-kappaBp65 proteins levels were significantly decreased.

29259980

CYLD affects p38

| 5

CYLD inhibits p38. 5 / 5

| 5

➶

reach

Taken together, these findings indicated that CYLD negatively regulates the activation of TAK1, p38, and AP-1.

21931165

➶

reach

By interacting with TRAF2, CYLD prevents p38MAPK activation.

25824820

➶

reach

CYLD reduced activation of p65, JAK2, STAT3, and p38 MAPK as well as fibrin production in livers of Listeria infected WT mice.

23825949

➶

reach

CYLD Impairs Production of Cytokines, ROS, and NO and Reduces Activation of NF-kappaB, ERK1/2, and p38MAPK in Lm Infected BMDM.

26834734

➶

reach

Thus, CYLD prevents excessive activation of TAK1 and p38, which results in reduced FOXP3 expression and Treg generation.

28524749

CREB1 affects CYLD

5 |

CREB1 decreases the amount of CYLD. 5 / 5

5 |

➶

biopax:msigdb

No evidence text available

➶

biopax:msigdb

No evidence text available

➶

biopax:msigdb

No evidence text available

➶

biopax:msigdb

No evidence text available

➶

biopax:msigdb

No evidence text available

PDE4 affects CYLD

| 5

PDE4 inhibits CYLD.

| 3

PDE4 inhibits CYLD. 3 / 3

| 3

➶

reach

As shown in XREF_FIG and XREF_SUPPLEMENTARY, inhibition of PDE4 using Rolipram still enhanced NTHi induced upregulation of CYLD in JNK1 depleted cells but not in JNK2 depleted cells, confirming the selective requirement of JNK2 in mediating PDE4B-depenent negative regulation of CYLD expression.

23575688

➶

reach

Having demonstrated that inhibition of PDE4 enhanced upregulation of CYLD and suppressed NTHi induced inflammation, it is still unclear whether inhibition of PDE4 suppresses inflammation via upregulating the expression of CYLD, a key negative regulator of inflammation, or via inhibiting key positive regulators of inflammation, for example, IKKbeta.

23575688

➶

reach

Interestingly, PDE4 inhibition using Rolipram no longer enhanced NTHi induced upregulation of CYLD and suppressed inflammation in HMEEC cells that had been already pretreated with SP600125 (XREF_FIG).

23575688

PDE4 activates CYLD.

| 2

PDE4 activates CYLD. 2 / 2

| 2

➶

reach

In addition to Rolipram, Roflumilast, the clinically approved PDE4 specific inhibitor, also significantly enhanced NTHi induced upregulation of CYLD (XREF_FIG).

23575688

➶

reach

PDE4 inhibition suppresses inflammation by inducing CYLD.

23575688

CYLD affects cell growth

| 5

CYLD inhibits cell growth.

| 4

CYLD inhibits cell growth. 4 / 4

| 4

➶

reach

32901872

➶

reach

Exogenous expression of CYLD inhibited melanoma cell growth and migration in vitro.

22832488

➶

reach

miR-362 targeted cylindromatosis (CYLD) activation of the NF-kappaB pathway induced cell growth and apoptosis tolerance in gastric cancer.

30155491

➶

reach

Loss of CYLD in HMCLs was found to enhance β-catenin stabilization and localization to the nucleus, increase β-catenin-LEF/TCF reporter activity, and enhance MM cell growth and survival.

29776381

CYLD activates cell growth.

| 1

CYLD activates cell growth. 1 / 1

| 1

➶

reach

Further in line with these animal data, exogenous expression of CYLD (m) in A431, a human squamous cell carcinoma (SCC) cell line, markedly enhanced cell growth, migration, and subcutaneous tumor growth in an AP1-depdendent manner.

21478324

CYLD affects cell adhesion

| 5

CYLD inhibits cell adhesion.

| 3

CYLD inhibits cell adhesion. 3 / 3

| 3

➶

| 4

CYLD inhibits Multiple Myeloma. 4 / 4

| 4

➶

reach

Altogether, our findings identify CYLD as a negative regulator of NF-kappaB and Wnt and beta-catenin signaling in MM and indicate that loss of CYLD enhances MM aggressiveness through Wnt pathway activation.

27775078

➶

reach

Loss of the deubiquitinating enzyme CYLD, which acts as a negative regulator of nuclear factor kappa-light-chain-enhancer of activated B cells (NFkappaB) and Wnt Signaling, increases the aggressiveness of MM [XREF_BIBR].

33327527

➶

reach

Functional assays revealed that CYLD represses MM cell proliferation and survival.

27775078

➶

reach

Loss of the deubiquitinating enzyme CYLD has been shown to enhance MM aggressiveness via Wnt pathway activation [XREF_BIBR].

28476164

CYLD activates Multiple Myeloma.

| 1

CYLD activates Multiple Myeloma. 1 / 1

| 1

➶

reach

Intriguingly, LEF1 depletion mediated CYLD upregulation was sufficient to negatively modulate NF-kappaB signaling pathway in MM cells.

34269120

CYLD affects Leu-Met

| 5

CYLD inhibits Leu-Met.

| 3

CYLD inhibits Leu-Met. 3 / 3

| 3

➶

| 1

CYLD inhibits Death. 1 / 2

| 1

➶

reach

Therefore, lack of CYLD catalytic activity inhibited the p53 dependent death of IECs in response to DNA damage in vivo and in vitro.

27561390

STAT3 affects CYLD

| 5

STAT3 activates CYLD.

| 3

STAT3 activates CYLD. 3 / 3

| 3

➶

reach

Importantly, STAT3 siRNA treatment induced 100% mortality of Lm infected Cyld -/- mice, thus, resembling WT mice (XREF_FIG).

23825949

➶

reach

Accordingly, knockdown of STAT3 significantly reduced serum IL-6 levels in Lm infected Cyld -/- mice as compared to mock treated infected Cyld -/- mice as well as untreated infected Cyld -/- mice (XREF_FIG).

| 3

CYLD-Y485A bound to ITCH inhibits cytokine production. 2 / 2

| 2

➶

reach

22057290

➶

reach

22057290

CYLD inhibits cytokine production. 1 / 1

| 1

➶

reach

Instead, CYLD limits extension of Lys63-Ub and Met1-Ub conjugated to RIPK2 to restrict signaling and cytokine production.

26997266

CYLD activates cytokine production.

| 2

CYLD activates cytokine production. 2 / 2

| 2

➶

reach

28106845

➶

reach

CYLD Augments Cytokine Production in the Brain of PbA Infected Mice.

28203236

CYLD affects SMAD7

| 5

CYLD activates SMAD7.

| 3

CYLD activates SMAD7. 3 / 3

| 3

➶

reach

The study performed in CYLD-knockout mice reported that CYLD targets SMAD7 protein for deubiquitylation and inhibits TGF-beta signalling in the development of regulatory T cells.

22724073

➶

reach

The Deubiquitinase CYLD Targets Smad7 Protein to Regulate Transforming Growth Factor beta (TGF-beta) Signaling and the Development of Regulatory T Cells *.

| 4

CYLD increases the amount of NDRG1. 2 / 2

| 2

➶

reach

Interestingly, Western blot results indicated that CYLD overexpression increased NDRG1 protein levels, whereas CYLD knockdown decreased NDRG1 levels (XREF_FIG).

33149672

➶

reach

Moreover, as a tumor suppressor, CYLD upregulated NDRG1 levels to subsequently suppress NPC progression.

33149672

Modified CYLD increases the amount of NDRG1. 2 / 2

| 2

➶

reach

Furthermore, IHC staining results showed that CYLD overexpression increased the NDRG1 level in tumor tissue samples relative to that in control tissue samples, whereas Ki-67 and PCNA protein levels decreased following CYLD overexpression (XREF_FIG).

33149672

➶

reach

Interestingly, Western blot results indicated that CYLD overexpression increased NDRG1 protein levels, whereas CYLD knockdown decreased NDRG1 levels (XREF_FIG).

33149672

CYLD activates NDRG1.

| 1

CYLD activates NDRG1. 1 / 1

| 1

➶

reach

CYLD Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Regulating NDRG1.

33149672

GLI1 affects CYLD

| 4

GLI1 inhibits CYLD.

| 1

GLI1 inhibits CYLD. 1 / 2

| 1

➶

| 1

GLI1 increases the amount of CYLD. 1 / 1

| 1

➶

reach

Loss of CYLD in these cells is rescued by inhibition of GLI1.

26370355

Hsa-miR-362-5p affects CYLD

4 |

Hsa-miR-362-5p decreases the amount of CYLD. 4 / 4

4 |

➶

biopax:mirtarbase

No evidence text available

25449782

➶

biopax:mirtarbase

No evidence text available

25909817

➶

biopax:mirtarbase

No evidence text available

26893711

➶

biopax:mirtarbase

No evidence text available

24495516

TLR4 affects CYLD

| 4

TLR4 activates CYLD. 4 / 4

| 4

➶

reach

Cleavage of CYLD induced by TLR4 stimulation was not affected in the Myd88 -/- BMDMs (XREF_FIG), but was abrogated in the Trif -/- BMDMs (XREF_FIG), indicating that CASPASE-8 activation was dependent on TRIF.

27264187

➶

reach

The LPS induced TLR-4 ligation recruits FADD and caspase-8 in a complex and initiates the cleavage of CYLD.

32381176

➶

reach

The Pseudomonas aeruginosa HSP90 like protein HtpG regulates IL-8 expression through NF-kappaB and p38 MAPK and CYLD signaling triggered by TLR4 and CD91.

32896641

➶

reach

The LPS induced TLR-4 ligation recruits FADD and caspase-8 in a complex and initiates the cleavage of CYLD (Legarda et al., 2016) .

| DOI

Cyclin affects CYLD

| 4

Cyclin activates CYLD. 4 / 4

| 4

➶

reach

Importantly, the increased cyclin D1 promoter activity in Cyld -/- keratinocytes was normalized after re-expression of Cyld and completely abolished in the absence of a functional NF-kappaB binding si[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

16713561

➶

reach

Interestingly, TPA also triggered the recruitment of p50 or p52, but not p65, to the cyclin D1 promoter in Cyld -/- keratinocytes.

16713561

➶

reach

TNF-alpha treatment failed to activate the cyclin D1 promoter in Cyld +/+ as well as Cyld -/- keratinocytes, consistent with the inability of TNF-alpha to stimulate keratinocyte proliferation.

16713561

➶

reach

The increased cyclin D1 activation in Cyld -/- keratinocytes was normalized upon reintroduction of the Cyld protein.

16713561

CYLD affects bsk

| 4

CYLD inhibits bsk. 4 / 4

| 4

➶

reach

beta1-integrin and pJNK are downregulated by CYLD and display crosstalk.

22832488

➶

reach

At the molecular level, CYLD decreased beta1-integrin and inhibited pJNK induction by tumor necrosis factor-alpha or cell attachment to collagen IV.

22832488

➶

reach

At the molecular level, CYLD decreased beta1-integrin and inhibited pJNK induction by TNFalpha or cell-attachment to collagen IV.

22832488

➶

reach

Further in line with these data, CYLD inhibited pJNK induction not only by TNFalpha but also by cell adhesion to collagen IV, a natural substrate and activator of beta1-integrin (XREF_FIG).

22832488

CYLD affects Tax

| 4

CYLD inhibits Tax. 4 / 4

| 4

➶

reach

Importantly, expression of wildtype CYLD, but not its catalytically inactive mutant, strongly inhibited Tax stimulated activation of IKK, supporting a role for Tax ubiquitination in the activation of IKK signaling.

21824392

➶

reach

CYLD inhibits Tax stimulated IKK activation via deubiquitinating Tax, although the CYLD mediated Tax deubiquitination does not affect Tax activation of Tak1.

21824392

➶

reach

CYLD inhibits Tax stimulated activation of IKK but not that of Tak1.

21824392

➶

reach

These findings suggest that CYLD negatively regulates the signaling function of Tax through inhibition of Tax ubiquitination.

21824392

CYLD affects TRAF7

2 |

Bisphenol A decreases the amount of CYLD. 2 / 2

2 |

➶

ctd

No evidence text available

20739668

➶

ctd

No evidence text available

20678512

Proteasome affects CYLD

| 4

Proteasome inhibits CYLD.

| 3

Proteasome inhibits CYLD. 3 / 3

| 3

➶

reach

HeLa and SiHa cells were exposed to MG132 (10 microM) for one hour prior to harvesting protein in order to prevent E6 mediated, proteasome dependent degradation of CYLD.

18977328

➶

reach

CYLD may be functionally inactivated through its phosphorylation, degraded by the ubiquitination and proteasome pathway, or repressed at the level of transcription.

19373246

➶

reach

The HPV encoded oncogenic protein E6 promotes hypoxia induced NF-kappaB activation by triggering the ubiquitination and proteasome mediated degradation of CYLD [XREF_BIBR].

21119682

Proteasome increases the amount of CYLD.

| 1

Proteasome increases the amount of CYLD. 1 / 1

IKK_complex inhibits CYLD. 3 / 3

| 1 2

➶

sparser

Reiley et al have shown that NEMO is required for the IKK complex to phosphorylate and inhibit the deubiquitinase CYLD [ xref ], a critical component of the necrotic machinery [ xref ], as can the TNF-inducible IKKε [ xref ].

21232018

➶

reach

On the contrary, ectopic expression of IKK significantly reduced CYLD protein abundance in 293T cells ectopically expressing HA tagged CYLD.

24961988

➶

reach

IKK blockade reactivates CYLD, as evidenced by the reduction in RIPK1 ubiquitination, which leads to the association of RIPK1 with the death inducing signaling complex (DISC) to trigger cell death.

32024820

IKK_complex activates CYLD.

| 1

IKK_complex activates CYLD. 1 / 1

| 1

➶

reach

IKK mediated CYLD activation is expected to remove K63 linked polyubiquitins from PSD proteins and thus regulate their trafficking.

24928390

HDAC6 affects CYLD

| 4

HDAC6 activates CYLD.

| 3

HDAC6 activates CYLD. 3 / 3

| 3

➶

reach

However, TSA treatment or HDAC6 depletion alone did not induce interaction of CYLD with Bcl-3 (XREF_FIG).

19893491

➶

reach

This is supported by the finding that depletion of HDAC6 was not sufficient to induce the interaction of CYLD with Bcl-3, but TPA mediated activation of CYLD is additionally required.

19893491

➶

reach

In addition, modulation of HDAC6 activity or localization has been shown to mediate the actions of CYLD, Dio3, Plk1, and ribosylation factor like proteins in ciliogenesis XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR.

26246421

HDAC6 inhibits CYLD.

| 1

HDAC6 inhibits CYLD. 1 / 1

| 1

➶

reach

Small-molecule inhibitors of HDAC6 could partially rescue the ciliary defects in CYLD knockout mice.

25342559

CYLD affects homeostatic process

| 4

CYLD inhibits homeostatic process.

| 3

CYLD inhibits homeostatic process. 3 / 3

| 3

➶

reach

21900959

➶

reach

These findings suggest that CYLD can both positively and negatively regulate signal transduction and homeostasis of B cells in vivo, depending on the expression of CYLD splice variants.

17923499

➶

reach

At a genomic level, we established that neither TRKB and TRKC amplification, nor that of BDNF and NT3/4 was demonstrated to account for the overexpression seen in cylindroma tumours, suggesting that CYLD dysfunction perturbs normal TRK homeostasis.

21552290

CYLD activates homeostatic process.

| 1

CYLD activates homeostatic process. 1 / 1

| 1

➶

reach

CYLD contributes to hepatic homeostasis and restoration upon liver injury.

26763122

CYLD affects cell

| 4

CYLD inhibits cell.

| 3

CYLD inhibits cell. 3 / 3

| 3

➶

eidos

Consistent with this , CYLD deficiency causes constitutive activation of TBK1 and IKKepsilon in dendritic cells .

28959952

➶

| 2

CYLD activates STAT1. 2 / 2

| 2

➶

reach

This indirect regulation of STAT1 signaling by CYLD resembles the function of the deubiquitinating enzyme A20, which also inhibits STAT1 activation indirectly by suppressing NF-kappaB activation.

26834734

➶

| 2

CYLD inhibits MAPK8. 2 / 3

| 2

➶

reach

The increased proliferation was thought to be mediated by MAPK8 signalling, which is negatively regulated by CYLD.

26370355

➶

reach

23575688

CYLD activates MAPK8.

| 1

CYLD activates MAPK8. 1 / 1

| 1

➶

reach

Taken together, it is evident that PDE4B negatively regulates CYLD expression and mediates NTHi induced inflammation via specific activation of JNK2 but not JNK1 pathway.

23575688

CYLD affects Fibroblasts

| 4

CYLD inhibits Fibroblasts.

| 2

CYLD inhibits Fibroblasts. 2 / 2

| 2

➶

eidos

32708712

➶

eidos

Additionally , CYLD was able to inhibit fibroblast and endothelial stromal cell infiltration into the NPC tumor microenvironment .

32708712

CYLD activates Fibroblasts.

| 2

CYLD activates Fibroblasts. 2 / 2

| 2

➶

eidos

Cylindromatosis Lysine 63 Deubiquitinase ( CYLD ) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma Nasopharyngeal carcinoma ( NPC ) is a malignant epithelial carcinoma of the nasopharynx .

32708712

➶

eidos

Cylindromatosis Lysine 63 Deubiquitinase ( CYLD ) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma .

32708712

CYLD affects FOS

| 3

CYLD increases the amount of FOS.

| 2

CYLD increases the amount of FOS. 2 / 2

| 2

➶

| 2

CYLD activates Carcinogenesis. 2 / 2

| 2

➶

reach

CYLD has also been shown to deubiquitinate (and inactivate) the coactivator BCL‐3 (117), which switches the transcriptional properties of NF‐κB from repressive to activating, and is known to strongly promote cell proliferation and oncogenesis (118, 119).

20073038

➶

reach

CYLD has also been shown to deubiquitinate (and inactivate) the coactivator BCL-3 (117) , which switches the transcriptional properties of NF-jB from repressive to activating, and is known to strongly promote cell proliferation and oncogenesis (118, 119) .

20073038

SRF affects CYLD

| 4

SRF decreases the amount of CYLD.

| 2

SRF decreases the amount of CYLD. 2 / 2

| 2

➶

reach

Knockdown of SRF by siRNA significantly reduced levels of CYLD, indicating that CYLD expression is regulated by SRF.

| 3

NIBAN2 decreases the amount of CYLD. 2 / 2

| 2

➶

reach

The combined results identified that MEG3 suppressed melanoma cell proliferation and invasion by regulating the expression of CYLD mediated by sponging miR-499-5p.

29808164

➶

reach

Overexpression of MEG3 dramatically decreased the level of miR-499-5p and promoted CYLD protein expression; however, downregulation of MEG3 distinctly increased the miR-499-5p expression and inhibited CYLD protein expression.

29808164

Modified NIBAN2 decreases the amount of CYLD. 1 / 1

| 1

➶

reach

29808164

NIBAN2 increases the amount of CYLD.

| 1

Modified NIBAN2 increases the amount of CYLD. 1 / 1

| 1

➶

reach

29808164

IL6 affects CYLD

| 4

IL6 activates CYLD.

| 2

IL6 activates CYLD. 2 / 2

| 2

➶

reach

| 2

BCL3 decreases the amount of CYLD. 2 / 2

| 2

➶

reach

In light of our current findings, it will be important to determine whether the increased nuclear Bcl-3 levels in these tumor cell lines are (like in cylindromas and epidermal tumors) also caused by a[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

| 2

➶

reach

TSA was shown to raise CYLD mRNA and protein levels in Huh7 and HepG2 cells [XREF_BIBR].

33299889

➶

reach

However, TSA treatment or HDAC6 depletion alone did not induce interaction of CYLD with Bcl-3 (XREF_FIG).

19893491

Selenite(2-) affects CYLD

| 3

Selenite(2-) activates CYLD. 3 / 3

| 3

➶

reach

These data prompted us to investigate the role of LEF1 in selenite triggered CYLD upregulation.

24577083

➶

reach

Collectively, our findings demonstrate that selenite caused CYLD upregulation via LEF1 and cIAP downregulation, both of which contribute to the degradation of ubiquitin chains on RIP1 and subsequent caspase-8 activation and apoptosis.

24577083

➶

reach

We found that selenite triggered cIAP degradation, and CYLD upregulation via the transcription factor lymphoid enhancer factor-1 (LEF1).

24577083

Doxorubicin affects CYLD

| 2

Doxorubicin increases the amount of CYLD. 2 / 3

| 2

➶

reach

Doxorubicin, which is a common agent used for transarterial chemoembolization procedures in HCC, induced CYLD expression in various subcellular compartments, including nucleoli.

25329885

➶

reach

Induction of CYLD expression by doxorubicin treatment led to increased cytoplasmic and nuclear expression of CYLD.

25329885

TNFSF11 affects CYLD

| 3

TNFSF11 increases the amount of CYLD. 3 / 3

| 3

➶

reach

40 RANKL stimulated osteoclastogenesis potently induces the expression of CYLD, and the accumulated CYLD targets TRAF6 by interacting with the adaptor protein, p62.

19373246

➶

reach

32 In mouse bone marrow derived macrophages, CYLD expression is strongly induced by RANKL, but not by TNF-alpha or LPS.

19373246

➶

reach

Furthermore, MG132 treatment extended the half-life of endogenous CYLD protein following RANKL stimulation in RAW264.7 mouse macrophage cells, as RANKL stimulation induces CYLD mRNA expression, thereby bypassing the down-regulation of CYLD mRNA expression by MG132.

24961988

TCF3 affects CYLD

3 |

TCF3 decreases the amount of CYLD. 3 / 3

3 |

➶

biopax:msigdb

No evidence text available

➶

biopax:msigdb

No evidence text available

➶

biopax:msigdb

No evidence text available

SDC4 affects CYLD

| 2

SDC4 activates CYLD. 2 / 3

| 2

➶

reach

Third, knockdown of SDC4 apparently abolished the perinuclear localization of RIG-I and CYLD (XREF_SUPPLEMENTARY).

27279133

➶

reach

First, our co-IP experiments showed that SDC4 overexpression indeed enhanced the interaction between CYLD and RIG-I, whereas SDC4 knockdown reduced the association of CYLD with RIG-I (XREF_FIG).

27279133

NDRG1 affects CYLD

| 3

NDRG1 activates CYLD. 3 / 3

| 3

➶

reach

Additionally, we revealed that CYLD bound and upregulated N-Myc downstream regulated 1 (NDRG1), and that silencing NDRG1 abolished the tumor-suppressor effect of CYLD on NPC cells.

33149672

➶

reach

NDRG1 is a Functional Target of CYLD in NPC.

33149672

➶

reach

Additionally, we observed that the CYLD specific promotion of NPC cell apoptosis was reversed by NDRG1 silencing (XREF_FIG and XREF_FIG).

33149672

KITLG affects CYLD

| 3

KITLG inhibits CYLD. 3 / 3

| 3

➶

reach

Altogether, these results support the model that CYLD degradation by SCF beta-TRCP plays a critical role in governing the timely activation of the NF-kappaB signaling pathway to control the osteoclast differentiation process (XREF_SUPPLEMENTARY).

24961988

➶

reach

Taken together, these results indicated that SCF beta-TRCP might negatively regulate the protein stability of CYLD.

24961988

➶

reach

24961988

DDX58 affects CYLD

| 2

DDX58 activates CYLD. 2 / 3

| 2

➶

reach

The data indicate that CYLD targets RIG-I as well as TBK1 for deubiquitination that leads to inactivation of the signaling.

18703349

➶

reach

Based on the in vitro assessments, this miRNA directly targets cylindromatosis (CYLD) (a negative regulator of antiviral responses through removing lysine (K)-63-linked polyubiquitin of RIG-I), increases RIG-I ubiquitination and thereupon production of IFNs-I [109].7 hsa-miRNAs and SARS-CoV-2-induced interfering factors.

| PMC

CYLD affects sub

| 3

CYLD inhibits sub. 3 / 3

| 3

➶

reach

Similarly, CYLD Ser418 phosphorylation upon co-expression of IKKepsilon was found to decrease its DUB activity.

29755980

➶

reach

Interestingly, phosphorylation of CYLD has been shown to inhibit its DUB activity XREF_BIBR - XREF_BIBR.

29789521

➶

reach

We also checked in both lines of transgenic mice, that, as expected, the CYLD C/S mutant was catalytically inactive and inhibited the DUB function of the endogenous CYLD, as we previously described that occurred in the epidermal HaCaT-CYLD C/S and PDVC57-CYLD C/S cells [XREF_BIBR, XREF_BIBR] (XREF_SUPPLEMENTARY).

30631004

CYLD affects protein deubiquitination

| 3

CYLD inhibits protein deubiquitination. 3 / 3

| 3

➶

eidos

SUMO2 and SUMO3 bind to Lysine residue 277 of NEMO and prevent its deubiquitination by CYLD ( a deubiquitinase ) and thus , causing stronger activation of IKK upon stimulation of cells with TLR4 , TLR3 , and TLR7-specific agonists [ 263 ] .

| DOI

➶

eidos

Inhibition of cIAPs or deubiquitination of RIPK1 by cylindromatosis ( CYLD ) can block the activation of NF-kappaB pathway , leading to the dissociation of RIPK1 and TRADD from the plasma membrane-associated complex28 .

33088682

➶

eidos

| PMC

CYLD affects epithelial to mesenchymal transition

| 1 2

CYLD activates epithelial to mesenchymal transition. 3 / 3

| 1 2

➶

reach

CYLD downregulation or inactivation induced an epithelial to mesenchymal transition of mammary epithelial cells that was dependent on the concomitant activation of the transcription factors Yes associated protein (YAP)/transcriptional coactivator with PDZ binding motif (TAZ) and transforming growth factor beta (TGF) signaling.

32722292

➶

reach

The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP and TAZ and TGF Signaling.

32722292

➶

eidos

We found that downregulation of either YAP or TAZ prevented the EMT that is induced by CYLD downregulation ( Figure 5d ) .

32722292

CYLD affects TLR4

| 3

CYLD inhibits TLR4. 3 / 3

| 3

➶

reach

However, the specific CYLD target modulating TLR3 and TLR4 responses remains to be determined XREF_BIBR (Sidebar A).

24375678

➶

reach

TLR4 engagement in the presence of zVAD-fmk did not lead to MLKL oligomerization in CYLD deficient cells (XREF_FIG), demonstrating that removal of CYLD prevents TLR4 from inducing necroptosis.

27264187

➶

reach

CYLD also negatively regulates NF-kappaB activation in IL-1R and TLR4 signaling through its DUB activity (Sun, 2010b).

25175772

CYLD affects PSMD4

| 1 2

CYLD activates PSMD4. 3 / 3

| 1 2

➶

reach

The silencing of CYLD significantly inhibited AF transdifferentiation and activation as evidenced by the expression of contractile proteins, the production of the proinflammatory cytokines MCP-1 (monocyte chemotactic protein 1) and IL-6 (interleukin-6), the deposition of extracellular matrix, and cell migration.

28751569

➶

reach

We further asked whether CYLD mediates AF activation via the regulation of nicotinamide adenine dinucleotide phosphate oxidase 4 (Nox4) as it is an essential factor during AF transdifferentiation.

28751569

➶

sparser

Indeed, the silencing of CYLD repressed transforming growth factor-β1-induced and homocysteine-induced Nox4 upregulation and reactive oxygen species production, whereas Nox4 overexpression greatly rescued the inhibitory effect on AF activation by CYLD silencing.

28751569

CYLD affects PPP2

Deubiquitinase CYLD negatively regulates MyD88 mediated signaling by directly interacting with MyD88 and deubiquitinating nontypeable Haemophilus influenzae (NTHi)-induced K63 linked polyubiquitination of MyD88 at lysine 231.

26719415

➶

sparser

Thus, CYLD inhibits MyD88, RIP1 (receptor-interacting serine/threonine-protein kinase 1), TRAF2, TRAF6, TRAF7 and NEMO downstream to TLR signaling and regulates exaggerated inflammation which can lead to the development of severe infection causing sepsis and associated organ damage.

| DOI

CYLD affects MTOR

| 1 2

CYLD activates MTOR. 3 / 3

| 1 2

➶

eidos

By providing evidence that CYLD can modulate mechanistic target of rapamycin ( mTOR ) signaling and autophagy at the synapse , we propose that synaptic K63-linked ubiquitination processes could be fundamental in understanding the pathomechanisms underlying autism spectrum disorder .

34782467

➶

reach

34782467

➶

reach

The K63 deubiquitinase CYLD modulates autism-like behaviors and hippocampal plasticity by regulating autophagy and mTOR signaling.

34782467

CYLD affects IRF3

| 3

CYLD inhibits IRF3. 3 / 3

| 3

➶

reach

Interestingly, CYLD is a negative regulator of the RIG-I and MAVS pathway as silencing of CYLD enhances the IRF3 response to sendai virus.

25459879

➶

reach

Ectopic expression of CYLD inhibits the IRF3 signalling pathway and IFN production triggered by RIG-I; conversely, CYLD knockdown enhances the response.

18636086

➶

reach

34707613

CAMK2B affects CYLD

3 |

CAMK2B activates CYLD. 3 / 3

3 |

➶

signor

Purified camkii phosphorylates cyld on at least three residues (s-362, s-418, and s-772 on the human cyld protein q9nqc7-1) and promotes its deubiquitinase activity.

24614225

➶

signor

Purified camkii phosphorylates cyld on at least three residues (s-362, s-418, and s-772 on the human cyld protein q9nqc7-1) and promotes its deubiquitinase activity.

24614225

➶

signor

Purified camkii phosphorylates cyld on at least three residues (s-362, s-418, and s-772 on the human cyld protein q9nqc7-1) and promotes its deubiquitinase activity.

24614225

ATF3 affects CYLD

3 |

ATF3 decreases the amount of CYLD. 3 / 3

3 |

➶

biopax:msigdb

No evidence text available

➶

biopax:msigdb

No evidence text available

➶

biopax:msigdb

No evidence text available

Ply affects CYLD

| 3

Ply activates CYLD.

| 2

Ply activates CYLD. 2 / 2

| 2

➶

reach

CYLD was highly induced by PLY and it inhibited MKK3-p38 induced expression of PAI-1 in the lung potentiating ALI [XREF_BIBR, XREF_BIBR].

| PMC

➶

reach

CYLD was highly induced by PLY, and it inhibited MKK3-p38 kinase dependent expression of plasminogen activator inhibitor-1 (PAI-1) in lung, thereby potentiating ALI and mortality.

17723219

Ply increases the amount of CYLD.

| 1

Ply increases the amount of CYLD. 1 / 1

| 1

➶

reach

| PMC

Pirinixic acid affects CYLD

3 |

Pirinixic acid decreases the amount of CYLD.

2 |

Pirinixic acid decreases the amount of CYLD. 2 / 2

2 |

➶

| 1

➶

reach

18535581

SMARCE1 affects CYLD

1 | 2

SMARCE1 activates CYLD.

| 2

SMARCE1 activates CYLD. 2 / 2

| 2

➶

| 2

JNK activates CYLD. 2 / 2

| 2

➶

| 2

EFEMP1 inhibits CYLD. 2 / 2

| 2

➶

| 2

| 1

➶

reach

18313383

CYLD affects CD274

| 1 2

CYLD decreases the amount of CD274.

| 2

CYLD decreases the amount of CD274. 2 / 2

| 2

➶

| 1

➶

reach

TBK1 and IKKi dual inhibitors suppress the expressions of p-CYLD and p-AKT, and angiogenesis.

24150799

TBK1 activates CYLD.

| 1

TBK1 activates CYLD. 1 / 1

| 1

➶

| 1

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal inhibits CYLD. 1 / 1

| 1

➶

reach

The proteasome inhibitor MG132 activated the Nrf2/ARE signalling pathway, thereby reversing the promoting effect of CYLD knockdown on oxidative stress.

34711178

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases the amount of CYLD.

| 1

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases the amount of CYLD. 1 / 1

| 1

2 |

➶

biopax:msigdb

No evidence text available

➶

biopax:msigdb

No evidence text available

RB1 affects CYLD

| 2

RB1 activates CYLD. 2 / 2

| 2

➶

reach

Vinblastine acts by RB, APOP and RTK pathways targeting CDKN2A, CYLD and NF1 genes which have role in melanoma, pilotrichomas and neurofibroma respectively.

29859466

➶

reach

Lutein and hydroxyl radicals act by APOP, RTK and RB pathways targeting CYLD, NF, RB genes which are responsible for pilotrichomas, neurofibroma and intraocular melanoma respectively.

29859466

N-methyl-D-aspartic acid affects CYLD

| 2

N-methyl-D-aspartic acid activates CYLD. 2 / 2

| 2

➶

| 2

MAPK increases the amount of CYLD. 2 / 2

| 2

| 2

| 1

➶

reach

CYLD targets Plk1 and contributes to regulating mitotic entry.

27516771

CYLD affects NOD2

| 2

CYLD inhibits NOD2. 2 / 2

| 2

➶

| 1

➶

eidos

Viral infection and antiviral cytokine production reduces CYLD protein levels , thereby relieving its repressive activity on RIG-I .

25023063

Viral process activates CYLD.

| 1

Viral process activates CYLD. 1 / 1

| 1

➶

| 1

Reactive oxygen species decreases the amount of CYLD. 1 / 1

| 1

➶

reach

ROS negatively regulate transcription of CYLD so we suggest that reduced CYLD expression before 48 h may be related and anti-inflammation only depends on endogenous CYLD during the acute phase of focal cerebral ischemia and reperfusion.

29163038

Reactive oxygen species activates CYLD.

| 1

Reactive oxygen species activates CYLD. 1 / 1

| 1

➶

1 |

Cyclosporin A increases the amount of CYLD. 1 / 1

1 |

➶

ctd

No evidence text available

20106945

Cyclosporin A decreases the amount of CYLD.

1 |

Cyclosporin A decreases the amount of CYLD. 1 / 1

1 |

➶

1 |

Cisplatin increases the amount of CYLD. 1 / 1

1 |

➶

ctd

No evidence text available

27594783

Cisplatin decreases the amount of CYLD.

1 |

Cisplatin decreases the amount of CYLD. 1 / 1

1 |

➶

1 |

Atrazine increases the amount of CYLD. 1 / 1

1 |

➶

ctd

No evidence text available

25929836

Atrazine decreases the amount of CYLD.

1 |

Atrazine decreases the amount of CYLD. 1 / 1

1 |

➶

| 1

TLR inhibits CYLD. 1 / 1

| 1

➶

reach

TLR signaling normally prevents caspase-8-, FADD- and RIPK3 dependent cell death pathways both through transcriptional upregulation of pro survival genes and through post-translational modification of key signaling proteins such as RIPK1 [XREF_BIBR], as well as inducing caspase-8-dependent cleavage of the pro necroptotic molecule CYLD [XREF_BIBR].

27737018

TLR activates CYLD.

| 1

TLR activates CYLD. 1 / 1

| 1

➶

| 1

SNAIL increases the amount of CYLD. 1 / 1

| 1

➶

reach

The transcriptional repressor SNAIL regulates E-cadherin and represses the expression of the deubiquitinating enzyme CYLD.

22085498

SNAIL decreases the amount of CYLD.

| 1

SNAIL decreases the amount of CYLD. 1 / 1

| 1

➶

| 1

CYLD inhibits proteolysis. 1 / 1

| 1

➶

reach

In agreement with this finding, CYLD m did not induce protein degradation, instead resulted in an elevation of c-Fos and c-Jun in response to cell starvation and subsequent treatment with EGF (XREF_SUPPLEMENTARY).

21478324

CYLD activates proteolysis.

| 1

CYLD activates proteolysis. 1 / 1

| 1

➶

| 1

CYLD inhibits elaD. 1 / 1

| 1

➶

reach

However, cotransfection of IKKepsilon with CYLD resulted in the stabilization of NEMO ubiquitination, suggesting that phosphorylation of CYLD decreases its deubiquitinase activity.

19481526

CYLD activates elaD.

| 1

CYLD activates elaD. 1 / 1

| 1

➶

reach

| 1

CYLD inhibits TLR. 1 / 1

| 1

➶

reach

However, a more recent study has shown that CYLD inhibits TLR signaling by deubiquitinating NTHi induced K63 linked polyubiquitination of MyD88 at lysine 231 [181].

| DOI

CYLD activates TLR.

| 1

CYLD activates TLR. 1 / 1

| 1

➶

| 1

CYLD inhibits TARDBP. 1 / 1

| 1

➶

reach

Overexpression of CYLD inhibited transport of TDP-43 into the nucleus from the cytoplasm.

33333804

CYLD activates TARDBP.

| 1

CYLD activates TARDBP. 1 / 1

| 1

➶

| 1

Modified CYLD increases the amount of Pulmonary Arterial Hypertension. 1 / 1

| 1

➶

reach

In vivo results demonstrated that the local suppression of CYLD expression could attenuate the increased levels of PAH and its associated pulmonary vascular remodeling in MCT-AV-induced PAH rats.

33507567

CYLD activates Pulmonary Arterial Hypertension.

| 1

Modified CYLD activates Pulmonary Arterial Hypertension. 1 / 1

| 1

➶

| 1

CYLD decreases the amount of NLRP3. 1 / 1

| 1

➶

reach

CYLD overexpression decreased the NLRP3 mRNA level.

34045881

CYLD activates NLRP3.

| 1

CYLD activates NLRP3. 1 / 1

| 1

➶

reach

CYLD suppressed microglial overactivation by inhibiting NLRP3 activation.

34045881

CYLD affects MALT1

| 2

CYLD inhibits MALT1.

| 1

CYLD inhibits MALT1. 1 / 1

| 1

CYLD inhibits IL10. 1 / 1

| 1

➶

reach

CYLD, but not C/S-CYLD, abrogated BCL-3 binding of IL-10 promoter, confirming the important role of CYLD in the regulation of BCL-3.

19124656

CYLD activates IL10.

| 1

CYLD activates IL10. 1 / 1

| 1

➶

reach

In addition, CD11c-Cre Cyld (ex7/8 fl/fl) DCs produced more TNF, IL-10, and IL-12 upon infection, which led to enhanced stimulation of IFN-gamma-producing NK cells.

CYLD increases the amount of CYCD1-1. 1 / 1

| 1

➶

reach

We have reported earlier that CYLD decreases the proliferation of keratinocytes and melanoma cells by retaining Bcl-3 in the cytoplasm and thereby reducing the expression of cyclin-D1.

19893491

CYLD decreases the amount of CYCD1-1.

| 1

CYLD decreases the amount of CYCD1-1. 1 / 1

| 1

➶

biopax:msigdb

No evidence text available

VSX1 affects CYLD

1 |

➶

biopax:msigdb

No evidence text available

SP1 affects CYLD

1 |

SP1 decreases the amount of CYLD. 1 / 1

1 |

➶

biopax:msigdb

No evidence text available

SH3-like domain affects CYLD

| 1

SH3-like domain activates CYLD. 1 / 1

| 1

➶

reach

The possession of both proline rich motifs and an SH3 like domain could allow CYLD to interact with target proteins containing either SH3 domains or proline rich motifs.

18535581

SERPINE1 affects CYLD

| 1

➶

biopax:msigdb

No evidence text available

RBCK1 affects CYLD

| 1

RBCK1 inhibits CYLD. 1 / 1

| 1

➶

reach

Possibly, HOIL-1 or another factor with Met1-Ub-binding capacity would prevent CYLD from gaining access to and cleaving the Met1-Ub on HOIP, whereas OTULIN would have access via its higher affinity toward Met1-Ub.

26997266

RAF1 affects CYLD

| 1

RAF1 decreases the amount of CYLD. 1 / 1

| 1

➶

reach

25329885

RAB11FIP5 affects CYLD

| 1

biopax:msigdb

No evidence text available

OTULIN affects CYLD

| 1

OTULIN activates CYLD. 1 / 1

| 1

➶

eidos

Interestingly , recent findings also suggest that OTULIN deficiency results in spontaneous inhibitory phosphorylation of CYLD , thereby limiting CYLD activity , which can be rescued by LUBAC inhibition [ 47 ] .

33288901

CYLD is modified

| 1

1 |

➶

biopax:msigdb

No evidence text available

MAPK9 affects CYLD

| 1

MAPK9 decreases the amount of CYLD. 1 / 1

| 1

➶

reach

Thus, we sought to determine whether increased cAMP does have an important role in inhibiting JNK2 activation, which in turn enhances CYLD expression and suppresses inflammation.

23575688

MAPK8 affects CYLD

| 1

MAPK8 increases the amount of CYLD. 1 / 1

| 1

| 1

➶

reach

To examine how CYLD affects epidermal homeostasis and tumorigenesis, we generated transgenic mice with keratin 14 promoter driven expression of a human CYLD mutant-932 (CYLD m) which lacks the 21 amino acid residues at the C-terminal end (XREF_SUPPLEMENTARY).

21478324

KIAA1191 affects CYLD

| 1

KIAA1191 increases the amount of CYLD. 1 / 1

| 1

➶

reach

Furthermore, KIAA1191 high expression suppressed the proliferation and migration of MM cells; upregulated the expression of RIP1, RIP3, and CYLD, and restored the TNF-α/z-VAD-induced necroptosis.

34989828

JUN affects CYLD

1 |

➶

reach

To further confirm the role of CYLD, stable CYLD knockdown HK1 and HONE1 cells were constructed using a lentiviral based CYLD small hairpin RNA.

33654169

HES affects CYLD

| 1

reach

27155333

CYLD affects ST13

| 1

| 1

➶

reach

28694140

CYLD affects RPS15

| 1

CYLD inhibits RPS15. 1 / 1

| 1

| 1

| 1

➶

reach

Remarkably, silencing of CYLD with a shRNA lentiviral vector largely blocked PARP cleavage and GAPDH release induced by 5z-7 plus TNFalpha (XREF_FIG).

27685625

CYLD affects NTRK3

| 1

Modified CYLD decreases the amount of NTRK3. 1 / 1

| 1

➶

reach

As it was shown that CYLD can interfere with Trk signaling [XREF_BIBR], although it is not entirely clear how loss of CYLD can promote overexpression of TrkC, a block of TRK receptor signaling has been proposed to represent a novel therapeutic target in tumors with loss of CYLD function including BCC [XREF_BIBR].

22235375

CYLD affects NTRK1

| 1

| 1

➶

reach

25093162

CYLD affects MFT1

| 1

CYLD activates MFT1. 1 / 1

| 1

➶

reach

In 1996, the gene locus for BSS was mapped to 16q12-13, and, in 2000, mutations in the cylindromatosis (CYLD) gene were determined to cause BSS, familial cylindromatosis (FC; OMIM 132700) and multiple familial trichoepithelioma type 1 (MFT1; OMIM 601606).

25782638

CYLD affects MCP-1

| 1

| 1

➶

reach

We next determined whether cAMP dependent PKA pathway also has a critical role in mediating NTHi induced CYLD expression and inflammation.

23575688